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Abstract 
 
Mechanical ventilation (MV) is the primary form of therapeutic support for patients 
with acute respiratory failure (ARF) or acute respiratory distress syndrome (ARDS) 
until the underlying disease is resolved. However, as patient disease state and 
response to MV are highly variable, clinicians often rely on experience to set MV. 
The result is more variable care, as there are currently no standard approaches to MV 
settings. As a result of the common occurrence of MV and variability in care, MV is 
one of the most expensive treatments in critical care. Thus, an approach capable of 
guiding patient-specific MV is required and this approach could potentially save 
significant cost.  
 
This research focuses on developing models and model-based approaches to analyse 
and guide patient-specific MV care. Four models and metrics are developed, and each 
model is tested in experimental or clinical trials developed for the purpose. Each 
builds the understanding and methods necessary for an overall approach to guide MV 
in a wide range of patients. 
 
The first model, a minimal recruitment model, captures the recruitment of an injured 
lung and its response to positive end expiratory pressure (PEEP). However, the model 
was only previously validated in diagnosed ARDS patients, and was not proven to 
capture behaviours seen in healthy patients. This deficiency could potentially negate 
its ability to track disease state, which is crucial in providing rapid diagnosis and 
patient-specific MV in response to changes in patient condition. Hence, the lack of 
validation in disease state progression monitoring from ARDS to healthy, or vice-
xiii 
 
versa, severely limits its application in real-time monitoring and decision support. To 
address this issue, an experimental ARDS animal model is developed to validate the 
model across the transition between healthy and diseased states. 
 
The second model, a single compartment linear lung model, models the lung as a 
conducting airway connected to an elastic compartment. This model is used to 
estimate the respiratory mechanics (Elastance and Resistance) of an ARDS animal 
model during disease progression and recruitment manoeuvres. This model is later 
extended to capture high resolution, patient-specific time-varying respiratory 
mechanics during each breathing cycle. This extended model is tested in ARDS 
patients, and was used to titrate patient-specific PEEP using a minimum elastance 
metric that balances recruitment and the risk of lung overdistension and ventilation-
induced injury. 
 
Studies have revealed that promoting patients to breathe spontaneously during MV 
can improve patient outcomes. Thus, there is significant clinical trend towards using 
partially assisted ventilation modes, rather than fully supported ventilation modes. In 
this study, the patient-ventilator interaction of a state of the art partially assisted 
ventilation mode, known as neurally adjusted ventilatory assist (NAVA), is 
investigated and compared with pressure support ventilation (PS). The matching of 
patient-specific inspiratory demand and ventilator supplied tidal volume for these two 
ventilation modes is assessed using a novel Range90 metric. NAVA consistently 
showed better matching than PS, indicating that NAVA has better ability to provide 
patient-specific ventilator tidal volume to match variable patient-specific demand. 
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Hence, this new analysis highlights a critical benefit of partially assisted ventilation 
and thus the need to extend model-based methods to this patient group. 
 
NAVA ventilation has been shown to improve patient-ventilator interaction compared 
to conventional PS. However, the patient-specific, optimal NAVA level remains 
unknown, and the best described method to set NAVA is complicated and clinically 
impractical. The Range90 metric is thus extended to analyse the matching ability of 
different NAVA levels, where it is found that response to different NAVA levels is 
highly patient-specific. Similar to the fully sedated MV case, and thus requiring 
models and metrics to help titrate care. More importantly, Range90 is shown to 
provide an alternative metric to help titrate patient-specific optimal NAVA level and 
this analysis further highlights the need for extended model-based methods to better 
guide these emerging partially assisted MV modes.  
 
Traditionally, the respiratory mechanics of the spontaneously breathing (SB) patient 
cannot be estimated without significant additional invasive equipment and tests that 
interrupt normal care and are clinically intensive to carry out. Thus, respiratory 
mechanics and model-based methods are rarely used to guide partially assisted MV. 
Thus, there is significant clinical interest to use respiratory mechanics to guide MV in 
SB patients. The single compartment model is extended to effectively capture the 
trajectory of time-varying elastance for SB patients. Results show that without 
additional invasive equipment, the model was able estimate unique and clinically 
useful respiratory mechanics in SB patients. Hence, the extended single compartment 
model can be used as ‘a one model fits all’ means to guide patient-specific MV 
xv 
 
continuously and consistently, for all types of patient and ventilation modes, without 
interrupting care. 
 
Overall, the model-based approaches presented in this thesis are capable of capturing 
physiologically relevant patient-specific parameters, and thus, characterise patient 
disease state and response to MV. With additional, larger scale clinical trials to test 
the performance and the impact of model-based methods on clinical outcome, the 
models can aid clinicians to guide MV decision making in the heterogeneous ICU 
population. Hence, this thesis develops, extends and validates several fundamental 
model-based metrics, models and methods to enable standardized patient-specific MV 
to improve outcome and reduce the variability and cost of care. 
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Chapter 1 
Introduction 
 
1.1 The Human Lung                                           
The primary function of the human lung is ventilation-perfusion matching, such that 
gas exchange between alveolar air and alveolar capillary blood is efficient. Oxygen 
(O2) is delivered from surrounding air into the body tissues through inspiration. 
Carbon dioxide (CO2) is transferred out from the body tissues via the blood and to the 
air through expiration (Levitzky, 2007, Robert J. Mason et al., 2010).  Thus, incoming 
oxygen is efficiently exchanged for outgoing CO2. 
 
During inspiration in normal breathing, the diaphragm moves down and the 
intercostal muscle moves the rib cage outwards and upwards. This combined 
movement expands the chest cavity and creates a negative pressure gradient in the 
lung with respect to atmospheric pressure. The negative pressure draws air into the 
lung through the airway passage allowing the pressure inside the lung to equilibrate. 
The process of transporting air into the lung is known as ventilation. Oxygen in the 
inspired air is absorbed into the blood at the alveolar level via gas exchange with the 
blood at the alveolar capillaries. Known as perfusion, this exchange process provides 
the human body a constant supply of air (oxygen, O2) to enable conversion of glucose 
in the cells to energy, and, at the same time, the exchange of CO2 and the other 
  
2 
 
metabolism end products back to the air during expiration. (Levitzky, 2007, Robert J. 
Mason et al., 2010). Figure 1.1 shows the mechanism of inspiration and expiration.  
 
Figure 1.1: Diaphragm and rib cage movement during inspiration and expiration 
(Sebel, 1985). (Left) When breathing in, the diaphragm contracts and intercostal 
muscle moves upward creating negative pressure gradient in the lung. (Right) When 
breathing out, the diaphragm relaxes and intercostal muscle moves down pushing the 
air out from the lung. 
 
1.2 Acute Respiratory Distress Syndrome 
Patients admitted to the intensive care unit (ICU) often experience difficulties in 
breathing  denoted as acute respiratory failure (ARF) which affects lung ventilation 
and perfusion matching (Pappert et al., 1994). Loss of ventilation perfusion matching 
reduced O2 supply and CO2 removal, affecting other organs and tissues, and thus 
creating significant physiological stress (Ferring and Vincent, 1997, Slutsky and 
Tremblay, 1998, Ranieri et al., 2000a). Acute respiratory distress syndrome (ARDS) 
is a form of severe ARF, which occurs due to severe inflammatory response of the 
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lung, resulting in direct alveolar injury, pulmonary oedema and alveolar collapse 
(Ashbaugh et al., 1967, Bernard et al., 1994b, Kollef and Schuster, 1995). This 
dynamic response further reduces ventilation and perfusion matching, and lung 
function. The clinical disorders associated with the development of ARDS are shown 
in Table 1.1 (Ware and Matthay, 2000). Overall, these lung injuries greatly impair the 
breathing process, reducing alveolar gas exchange and resulting in increased risk of 
organ failure and mortality if not treated (Slutsky and Tremblay, 1998, Ranieri et al., 
2000a, Mortelliti and Manning, 2002, Rouby et al., 2004, Ferguson et al., 2005, 
Girard and Bernard, 2007). 
 
Table 1.1: Clinical disorders associated with the development of the acute respiratory 
distress syndrome (Ware and Matthay, 2000) 
Direct Lung Injury  Indirect Lung Injury 
Common Causes 
 Pneumonia 
 Aspiration of gastric contents 
Common Causes 
 Sepsis 
 Severe Trauma with shock and 
multiple transfusions  
Less common causes  
 Pulmonary contusion 
 Fat emboli 
 Near-drowning 
 Inhalational injury 
 Reperfusion pulmonary oedema 
after lung transplantation or 
pulmonary embolectomy 
Less common causes 
 Cardiopulmonary bypass 
 Drug Overdose 
 Acute pancreatitis 
 Transfusions of blood products 
 
 
ARDS was first described by Ashbaugh et al. (Ashbaugh et al., 1967, Petty and 
Ashbaugh, 1971) in 1967 and its definition has changed in several ways over the 
years due to the lack of specification (Ware and Matthay, 2000). The definition was 
redefined in 1994 as: 
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 A syndrome of acute onset of respiratory failure with findings of bilateral 
infiltrates on chest radiograph, the absence of elevated left heart filling 
pressure determined either diagnostically with a pulmonary artery catheter 
(pulmonary artery occlusion pressure of < 18 mmHg) or clinically (absence of 
evidence of left arterial hypertension) (Bernard et al., 1994b, Burleson and 
Maki, 2005).  
 If partial pressure of arterial oxygen to fraction of inspired oxygen ratio 
(PaO2/FiO2) is less than 300 mmHg, the patients is diagnosed with acute lung 
injury (ALI), and if PaO2/FiO2 ratio is less than 200 mmHg, the patients is 
diagnosed with acute respiratory distress syndrome (ARDS). 
 
ARDS was again redefined in 2012 by the acute respiratory distress syndrome task 
force (ADTF), with added additional clinical implications (The ARDS Definition 
Task Force, 2012). The use of ALI was removed and ARDS was graded based on the 
arterial blood gases information into 3 severities: 
 
 Mild ARDS (200 < PaO2/FiO2 ≤ 300 mmHg),  
 Moderate ARDS (100 < PaO2/FiO2 ≤ 200 mmHg), or 
 Severe ARDS (PaO2/FiO2 ≤ 100 mmHg). 
 
The acute time frame is also specified to be within 1 week. Overall, it is clear that 
ARDS defines respiratory failure, and, in particular, failure to achieve adequate gas 
exchange. 
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As might be expected, ARDS and respiratory failure patients have associated high 
morbidity and mortality. ARF or ARDS are also relatively common, affecting 33% of 
the ICU patients (Dasta et al., 2005). It is estimated that in U.S., the mortality of the 
ARDS patients is higher than patients with acquired immune deficiency syndrome 
(AIDS) (Goss et al., 2003), and mortality can range from 30% up to 60% 
(Montgomery et al., 1985, Lewandowski et al., 1995, Reynolds et al., 1998, Luhr et 
al., 1999, Zambon and Vincent, 2008, Phua et al., 2009). They entail significant 
medical cost of almost double that of a non-mechanically ventilated patient without 
ARDS (Valta et al., 1999, Dasta et al., 2005, Zilberberg et al., 2008). In particular, the 
estimated cost of ARDS survivor was USD 73,000 (Valta et al., 1999, Dasta et al., 
2005). Therefore, giving the proper treatment to the ARDS patient is an important 
clinical and economic challenge. 
 
1.3 Mechanical Ventilation  
Over the years, various treatments have been suggested for patients with respiratory 
failure. These treatments can be divided into 2 categories; 1) pharmacological 
treatments and 2) non-pharmacological treatments. While some pharmacological 
treatments were able to show improvement for ARDS patients (Ware and Matthay, 
2000, Günther et al., 2002), mechanical ventilation (MV), a non-pharmacological 
treatment, remains as the dominant therapeutic approach for these patients (Rouby et 
al., 2004, Hasan, 2010). In particular, MV has evolved from a supporting therapy to a 
therapy that is actively directed and can influence the progression of the lung disease 
and patient outcome (Esteban et al., 1999, Esteban et al., 2002, Desai and Deep, 2006, 
Girard and Bernard, 2007, Gama de Abreu et al., 2009). 
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MV is fundamentally about delivering a supply of oxygen to a patient for breathing 
support through the use of a mechanical ventilator (Hasan, 2010). The ventilator can 
either partially assist or fully replace the patient’s breathing effort depending on the 
patient’s condition (Ranieri et al., 2000a, Hasan, 2010, Marini, 2011). The breathing 
support provided by the ventilator reduces the patient’s work of breathing, and 
increases the lung’s ability to recruit and retain lung units (alveoli), thus improving 
gas exchange (ventilation-perfusion matching) while also allowing a better chance for 
the lung to recover (Cabello and Mancebo, 2006). 
 
Various MV modes and strategies have been introduced for the support of patients 
with ARDS (Stock et al., 1987, Younes, 1992, The Acute Respiratory Distress 
Syndrome Network, 2000, Sinderby, 2002, Putensen and Wrigge, 2004, Brower et al., 
2004, Mireles-Cabodevila et al., 2009). Several methods are applied separately, but 
combined methods also exist in an attempt to improve patient condition (Amato et al., 
1998, Marini and Gattinoni, 2004). Some specific approaches: include low tidal 
volume ventilation (The Acute Respiratory Distress Syndrome Network, 2000), 
control of positive end-expiratory pressure (PEEP) (Suter et al., 1975, Sundaresan and 
Chase, 2011, Slutsky and Hudson, 2006, Brower et al., 2004), monitoring lung 
recruitment using lung imaging method and several others (Gattinoni and Caironi, 
2008). Each mode offers different potential advantages (Mireles-Cabodevila et al., 
2009). However, different modes and approaches for MV treatment further 
complicate clinical decision making and introduce significant variability in care 
within and between patients. An important complicating factor is that it is not 
clinically practical to assess internal lung status regularly to optimise therapy. Thus, 
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clinicians often “drive” the therapy partly blind, which is another course of variability 
in care and outcome. Hence, there is a significant clinical, social and economic need 
to standardise MV treatment based on measurable, directly quantified patient-specific 
needs.  
 
1.4 Research Focus 
This research focuses on model-based MV research for mechanically ventilated 
patients. Model-based method offer the ability to uniquely capture patient-specific 
condition and their response to different MV and treatment approaches from typically 
measured clinical data (Chase et al., 2011). In particular, model-based approaches 
provide the opportunity to individualise MV therapy based on patient-specific needs 
quantified in real-time from that date (Sundaresan and Chase, 2011). Several models 
are developed and studied in this research for their ability to provide useful clinical 
and patient-specific information at the bedside, and in real-time to monitor condition, 
as well as to subsequently guide and optimise care.  The thesis can be divided into 5 
sections as follows: 
 
a) Section 1 - Introduction and Literature Review 
The first section of the thesis is composed of introductory chapters and literature 
reviews including: 
 
 Chapter 1 (Introduction): This Chapter gives an overview of the thesis 
outline with the focus of this research. 
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 Chapter 2 (Mechanical Ventilation Management): Chapter 2 covers 
existing mechanical ventilation management in treating ARDS patients. 
 
b) Section 2 - Sedated Patients - Fully dependant on MV 
In the second section, three model-based methods to optimise MV treatment are 
presented. More specifically, three models are developed for ICU patients who are 
anesthetised and fully dependent on MV for breathing support. 
 
 Chapter 3 (Application of a Minimal Recruitment Model): The 
performance of a minimal lung recruitment model is investigated. An 
experimental ARDS animal model is developed for this purpose. Materials 
included in Chapter 3 are published in (Chiew et al., 2012a, Chiew et al., 
2012c). 
 Chapter 4 (Respiratory Mechanics Monitoring: Single Compartment 
Linear Lung Model): A single compartment linear lung model and patient-
specific identification method are used to capture respiratory mechanics of 
experimental ARDS animal models during disease progression. 
 Chapter 5 (Proof of Concept Study using Respiratory Mechanics 
Monitoring): The single compartment model is further modified to capture 
patient-specific dynamic response (Time-varying elastance, Edrs) during 
standard clinical care to optimise MV settings. The materials used in this 
chapter has been published (Chiew et al., 2011, Chiew et al., 2012b). 
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c) Section 3 - Spontaneous Breathing Patients- Partially Dependant on MV 
The model-based methods in Section 2 are developed and validated for sedated 
patients. However, only 20–40% of all ventilated ICU patients are fully sedated, and 
other patients breathe, at least in part, spontaneously with their own work of breathing 
(Putensen et al., 1999, Kuhlen and Putensen, 1999, Putensen et al., 2001). Hence, a 
different metric to account for spontaneously breathing patients is required to provide 
useful information for clinical decision making. Section 3 focuses on the development 
and study of these metrics. 
 
 Chapter 6 (Spontaneous Breathing and Assisted Ventilation: Pressure 
Support (PS) and Neurally Adjusted Ventilatory Assist (NAVA)): The 
performance of  a new MV mode, dubbed NAVA is investigated and 
compared with commonly used pressure support ventilation mode (PSV or 
PS) . A new metric (Range90) to quantify the matching of patients 
ventilatory supply and demand is introduced. This metric is used to assess 
the supply and demand matching between PS and NAVA ventilation 
(Moorhead et al., 2012). 
 Chapter 7 (Application of NAVA for the Noninvasively Ventilated 
Patients): In this Chapter, the performance of NAVA compared to PS is 
investigated in non-invasively ventilated patients. The effect of various 
NAVA levels is also investigated, and an optimal NAVA setting can be 
obtained using the Range90 metric. Materials used in this chapter has been 
published (Piquilloud et al., 2011a, Chiew et al., 2012d) 
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d) Section 4 - Combine MV 
4 different models and metrics are presented in Section 2 and Section 3. More 
specifically, these models and metrics are only fully applicable in either fully sedated 
patients or spontaneously breathing patients. Thus, there is a need to have a model 
that is applicable across both patient groups. In this section, a proof of concept study 
is presented. This study provides a platform to extend a model in previous section to 
account for both spontaneous breathing patients and fully sedated patients.  
 
 Chapter 8 (Respiratory Mechanics Estimation for Spontaneously Breathing 
Patient): The model used in Section 2 is extended to estimate respiratory 
mechanics of the spontaneously breathing patients. This model 
investigates the time-varying elastance (Edrs) of patients ventilated during 
pressure support and NAVA as presented in Chapter 6 and Chapter 7. A 
metric which investigates average Edrs of a spontaneous breathing patient 
is developed. This metric allows comparison of ventilation mode in 
spontaneous breathing patients, revealing potential to titrate care in 
spontaneously breathing patient without interrupting treatment. 
 
e) Section 5 - Conclusions and Future Works 
In Section 5, the conclusion and potential future works are presented. 
 
 Chapter 9 (Conclusions): This chapter concludes the finding of the 
research.  
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 Chapter 10 (Future Work): The future works that are required to improve 
the performance, validity and clinical feasibility of the models and 
methods are presented.  
 
1.5 Summary 
This chapter presented the fundamental background on human respiratory function, 
respiratory failure and the use of mechanical ventilation as the primary form of 
treating these ICU patients. The thesis outline is also presented to show the overall 
content of this research. In the next chapter, the existing and state of the art in 
mechanical ventilation management strategies for ICU patients is presented to provide 
a more comprehensive understanding on MV and the challenges it presents. 
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Chapter 2 
Mechanical Ventilation Management 
 
Mechanical ventilation (MV) is a form of therapeutic support, supporting breathing 
work and function for ICU patients until the underlying disease processes are resolved. 
The primary goal is to support breathing by applying positive pressure during 
respiration to retain lung volume for gas exchange and to provide flow to reduce or 
replace the work of breathing. Thus, MV assists the breathing process, and seeks to 
maintain ventilation-perfusion matching rather than being a curative treatment.  
 
Patients treated with suboptimal ventilation are exposed to the risk of ventilator 
associated lung injuries (Slutsky, 1999, Ricard et al., 2003, Carney et al., 2005, Garcia 
et al., 2006, Pavone et al., 2007), such as barotrauma and volutrauma due to excessive 
pressure or volume being applied (Dreyfuss and Saumon, 1992, Rouby et al., 1993, 
Chao and Scheinhorn, 1996, Cooper et al., 1999). These lung injuries further 
complicate patient disease state and prolong the length of ventilation required, with 
any resulting further injuries repeating this injurious cycle. Hence, it is important to 
have optimal MV management to support patient recovery and improve outcome 
(Weinacker and Vaszar, 2001, Marini and Gattinoni, 2004, Esteban et al., 2005, Desai 
and Deep, 2006, Girard and Bernard, 2007).  
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In this chapter, several fundamental concepts on MV management and recent 
developments on ventilation strategy are presented to give a comprehensive overview 
and understanding of the clinical and physiological problem. The field of MV is 
extremely large in clinical research with literally thousands of articles. Hence, this 
overview focuses on providing a definition of the clinical problem, the measurements 
metrics and main issues that define it. 
 
2.1 Tidal Volume (Vt) 
MV supports patient breathing through delivering a fixed or variable amount of air 
supply (Marini, 1992, Hasan, 2010). This air supply, also known as tidal volume (Vt), 
can have different oxygen concentration depending on the fraction of inspired oxygen 
(FiO2) set in the ventilator (Allardet-Servent et al., 2009). Gas exchange only occurs 
in the alveoli sacs. Thus, it is important to provide patients with sufficient tidal 
volume and oxygen concentration, after accounting for physiological dead space 
(Aboab et al., 2006, Robert J. Mason et al., 2010).  
 
Physiological dead space is the sum of the anatomical dead space and alveolar dead 
space where no gas exchange occurs. Anatomical dead space is the conducting 
airways (tracheal, bronchus, bronchiole), as shown in Figure 2.1. The alveolar dead 
space is formed when there is little or no blood flow to the capillaries surrounding the 
alveoli for gas exchange. Thus, alveolar dead space is the sum of the alveoli, that are 
ventilated, but not perfused, and is normally found in diseased lung regions.  
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Figure 2.1: Example of dead space in a human lung. The area shaded dark grey is the 
anatomical dead space where there is no gas exchange. The lighter grey area is the 
lung region with alveoli and potential gas exchange. Alveolar dead space is normally 
found in the light grey area for a diseased lung. 
 
The optimal tidal volume settings have been widely debated over the years (Schultz et 
al., 2007). High tidal volume is often associated with ventilator induced lung injury or 
VILI (Slutsky, 1999, Gajic et al., 2004, Bonetto et al., 2005). Equally, several reports 
and randomised controlled trials (RCT) have shown patients ventilated with low tidal 
volume (6~8 ml/kg) have lower mortality rate compared to higher tidal volume 
(10~12 ml/kg)  (Brochard et al., 1998, The Acute Respiratory Distress Syndrome 
Network, 2000, Malhotra, 2007, Meade et al., 2008, Putensen et al., 2009). However, 
not all such studies have shown the same trend of outcome, with some relatively little 
effect (Stewart et al., 1998). A recent debate on low tidal volume ventilation by Dr. 
Gattinoni and Dr. Hubmayr concluded that while low tidal volume ventilation has 
shown better patient outcome, this ventilation is not a ‘one size fit all’ for all patients, 
and tidal volume management should be patient-specific based on lung size (Hubmayr, 
2011a, Gattinoni, 2011a, Hubmayr, 2011b, Gattinoni, 2011b). However, there are 
currently no metrics or methods for guiding or achieving this patient-specific Vt 
without additional invasive procedures that can be done regularly or in real-time. 
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2.2 Positive End-Expiratory Pressure (PEEP)  
Positive end-expiratory pressure (PEEP) is the additional pressure applied at the end 
of expiration in each breath during mechanical ventilation (Falke Konrad, 2003). The 
goal of using PEEP is to recruit alveoli and retain these alveoli at expiration by 
preventing their collapse between breaths, which damages them further (Slutsky and 
Hudson, 2006, Grasso et al., 2007, Albert et al., 2009, Gattinoni et al., 2010).  There 
is equally no gold standard for setting the optimal PEEP (Lichtwarck-Aschoff et al., 
1999, Levy, 2002, Suh et al., 2003, Brower et al., 2004, Kallet and Branson, 2007, 
Mercat et al., 2008, Markhorst et al., 2008, Meade et al., 2008, Spieth and Gama de 
Abreu, 2012).  
 
In particular, several studies have revealed that higher PEEP can be beneficial for 
ARDS patients (Villar et al., 2006, Mercat et al., 2008, Briel M and et al., 2010). 
Higher PEEP allows the recruitment of collapsed alveoli in the ARDS patient, 
improving gas exchange and minimising damage due to collapse (Mercat et al., 2008, 
Putensen et al., 2009). Similarly, while high PEEP is beneficial for recruiting diseased 
alveoli, it is also possible that high PEEP has detrimental effects on healthy and 
mildly injured alveoli, causing barotrauma (Chao and Scheinhorn, 1996, Slutsky, 
1999, Lucangelo et al., 2008). Such damage negates positive effects and further 
complicates the patient condition (Cooper et al., 1999). Thus, setting optimal PEEP 
during MV must balance risk and reward (Sundaresan and Chase, 2011, Chiew et al., 
2011), and is an important task for clinicians. Since every patient and disease states 
are different, it is clear that a patient- and time-specific solution is required, especially 
as patient condition and response to therapy evolves. 
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2.2.1 Setting PEEP - Lower and Upper Inflection Point 
One of the earliest methods for setting PEEP is through the use of the patient’s static  
compliance curve, also known as the static pressure volume (PV) curve (Maggiore et 
al., 2003, Cagido and Zin, 2007). Each patient’s PV and compliance curve is uniquely 
shaped (Venegas et al., 1998, Albaiceta et al., 2007), and can thus be used to 
characterise patient-specific lung condition (Harris et al., 2000) and their response to 
specific treatment choice. It is suggested that PEEP can be set above the lower 
inflection point (LIP) and below upper inflection point (UIP) (Jonson et al., 1999, 
Mergoni et al., 2001, Ward et al., 2002, Takeuchi et al., 2002, Markhorst et al., 2004, 
Albaiceta et al., 2004, Albaiceta et al., 2005, Pestaña et al., 2005, Rossi et al., 2008) in 
the patient-specific static compliance curve, as shown in Figure 2.2. LIP is defined as 
the point where lung volume begins to increase rapidly with increasing pressure. UIP 
is detected in the upper part of the PV curve, when the overall lung begins to over-
inflate, and increasing pressure only obtains a relatively small amount of increased 
volume. In consideration of units and sign convention, while these are collected PV 
curves, the plot has volume (V) on the y-axis; the slope is thus compliance, not 
stiffness. Thus, setting PEEP above LIP will theoretically maximise recruitment and 
below UIP will theoretically avoid over-distension.  
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Figure 2.2: Example of LIP and UIP location in a static compliance curve. The curve 
defines 3 average compliances in a tri-linear approximation used to find these points. 
The intersections for the tri-linear approximation are the location for LIP and UIP. 
 
The concept of LIP and UIP provides a guideline for clinicians to set PEEP (Albaiceta 
et al., 2008). However, the patient’s static compliance curve is highly variable 
between patients and over time, as well as disease state dependant. In addition, the 
location of the LIP and UIP are normally not identifiable during normal tidal 
ventilation, requiring a separate manoeuvre to obtain them that interrupts therapy 
(Lichtwarck-Aschoff et al., 2000, NÈVE et al., 2000).  
 
Furthermore, as seen in Figure 2.2, it is clear that how one defines the centre 
compliance line will significantly offset the identified LIP and UIP, creating a further 
source of variability (Servillo et al., 2002). Finally, the methods to obtain patient-
specific static compliance curves, such as the super-syringe method (Janney, 1959, 
Lee et al., 2002), inspiration occlusion (Ranieri et al., 1994, Servillo et al., 1997), and 
quasi-static low-flow ventilation,  are invasive (Servillo et al., 1997, Lu and Rouby, 
2000), interrupt treatment, time consuming, clinically intensive, and not normally 
performed for ICU patients (Servillo et al., 1997, Karason et al., 2000b, Kondili et al., 
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2000, Karason et al., 2001, Oostveen et al., 2003). Thus, the application of setting 
PEEP based on LIP and UIP is limited by clinical practicality.  
 
More importantly, the application of LIP and UIP in ICU patients has not been shown 
to affect clinical outcome (Jonson and Svantesson, 1999, Kondili et al., 2000, 
Hickling, 2002, Nieszkowska et al., 2004, Victorino et al., 2004). Hence, this 
approach is risky, not clinically practical in some cases, and not proven to affect 
outcomes. There is thus a need to improve the approach to care. 
 
2.2.2 Setting PEEP - Maximum Compliance 
Several studies suggested that PEEP should be selected at maximum lung compliance 
or minimal lung elastance (Elastance = 1/compliance) (Suarez-Sipmann et al., 2007, 
Carvalho et al., 2007, Lambermont et al., 2008). In particular, these authors have 
studied this concept on ARDS animal models and all resulted in similar findings. 
These studies showed that after a recruitment manoeuvre, PEEP can be titrated to 
subject specific minimal elastance (or maximum compliance) (Suarez-Sipmann and 
Bohm, 2009, Huh et al., 2009). The PEEP selection at maximum compliance revealed 
that ventilation at maximum compliance (minimal elastance) potentially benefits 
mechanically ventilated subjects in lung recruitment, improve gas exchange and avoid 
over-distension (Ward et al., 2002, Suarez-Sipmann et al., 2007, Carvalho et al., 2007, 
Lambermont et al., 2008).  
 
Figure 2.3 shows the ARDS animal model response to PEEP titration in Suarez-
Sipmann’s et al.’s study (Suarez-Sipmann et al., 2007). It was found that when 
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ventilated at PEEP 10~15 cmH2O, most subjects had the highest compliance, higher 
PaO2/FiO2 ratio (PF ratio) and lower pulmonary shunt. Pulmonary shunt is the 
opposite condition of alveolar dead space. Pulmonary shunt occurs during regional 
lung collapse when there is blood flow in the capillaries of the alveoli, but there is no 
ventilation (air supply) in the perfused region.  Lambermont et al. (2008) showed that 
highest compliance occurred during PEEP of 15 and 20 cmH2O during a similar PEEP 
titration. In addition, these PEEP levels are associated with significant improvement 
in PaO2 and higher functional residual capacity (FRC), which may be contributed by 
alveolar recruitment at these PEEP levels (Lambermont et al., 2008). 
       
 
Figure 2.3: Findings by Suarez-sipmann (Suarez-Sipmann et al., 2007). (Top) Change 
of dynamic compliance with PEEP. (Bottom) Amount of aerated tissue and arterial 
blood gas at different PEEP settings.  
Baseline     PEEP levels during decremental PEEP titration (cmH2O) 
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Overall, it should be noted that maximum compliance is preferred because it implies 
that volume is opening for minimal pressure increase. If compliance is rising (or 
elastance is falling) in a breath, it implies that lung volume is opening faster than 
pressure is being delivered. Hence, this method seeks the best point of recruiting with 
minimal chance of over-distension or excess pressure.  
 
Equally, the LIP and UIP methods described earlier also define a potential range of 
compliance at which to set PEEP. However, what is missing is the dynamic aspect 
where compliance changes over time and potentially within a breath. Hence, LIP and 
UIP are hindered by their inability to assess the true dynamic patient-specific response.  
 
These studies were performed on experimental ARDS animal models, where ARDS 
formation was controlled and these models only capture specific ARDS physiology 
and mechanics (Rosenthal et al., 1998, Matute-Bello et al., 2008, Ballard-Croft et al., 
2012). Hence, the result may not generalise well. Importantly, this approach to PEEP 
selection is yet to be tested in an ICU setting, where the course, impact and response 
to ARDS and MV therapy are patient-specific, variable and time-varying. 
 
2.3 Imaging Guided Therapy 
2.3.1 Computer Tomography (CT) 
Computer Tomography (CT) is considered as a gold standard in lung condition 
monitoring. Sections of lung CT images allow the clinicians to assess patient 
condition, response to different PEEP levels, alveoli recruitment/ distension and gas 
distributions (Schlesinger et al., 1995, Vieira et al., 1998, Malbouisson et al., 2001, 
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Gattinoni et al., 2001, Caironi and Gattinoni, 2007, Caironi et al., 2010). However, 
performing CT imaging for ICU patients is largely impractical. It is a costly and over-
demanded hospital resource and exposes the patient to the risk involved when 
transferring them to a radiology unit (Pesenti et al., 2001). The risk of radiation 
exposure is another important factor that deters regular CT application for MV 
optimisation (Brunet et al., 1995, Lu et al., 2001, Brenner and Hall, 2007, Tubiana et 
al., 2008). Nevertheless, while CT to guide bedside MV therapy is limited, it has 
provided a research platform for better understanding on disease state and lung 
physiology of the ARDS patient (Luecke et al., 2012).  
 
2.3.2 Electric Impedance Tomography (EIT) 
Another emerging form of lung imaging is Electrical Impedance Tomography (EIT). 
EIT has been introduced as a potential bedside tool for real-time monitoring of 
patients ventilation aside from CT imaging (Holder et al., 1996, Rao et al., 1997, 
Adler et al., 1998, Kunst et al., 2000a, Kunst et al., 2000b, Frerichs, 2000, Bodenstein 
et al., 2009, Fagerberg et al., 2009, Zhao et al., 2009, Denai et al., 2010, Luecke et al., 
2012). During EIT, a high frequency, low amplitude electrical currents is injected 
around subject’s thorax, to obtain images of the lung during ventilation. The resulting 
electrical potential during ventilation is then measured and the ventilation process can 
be monitored using a reconstruction algorithm (Dong et al., 2003, Costa et al., 2009, 
Zhao et al., 2010a).  EIT has demonstrated good correlation with CT findings, such 
that it has been proposed to guide ventilation therapy, (Zhao et al., 2010b, Muders et 
al., 2010). However, the complex algorithm required for image reconstruction 
(Lionheart, 2004) and limited availability of the EIT technology along with cost and 
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lack of trained personnel remain issues against its widespread application, despite the 
advantages it may provide. 
 
2.4 Safe Plateau Pressure and Maximum Recruitment Strategy 
Several studies (Marini and Gattinoni, 2004, Hager et al., 2005, Shiu and Rosen, 2006) 
have suggested that the peak ventilation plateau pressure should not exceed 30~35 
cmH2O. This pressure can be measured by performing an end inspiratory breathing 
hold for 1~5 seconds, and this capability is normally available in most ventilators. 
This range of plateau pressures has been considered as the safe range (Slutsky, 1993, 
Bernard et al., 1994a, Barberis et al., 2003, Gattinoni et al., 2003) and a threshold to 
prevent injury caused by excessive pressure (Slutsky, 1993, Bernard et al., 1994a, 
Barberis et al., 2003, Gattinoni et al., 2003). Hence, it provides an upper bound for 
applied pressure during MV, which can further help guide treatment. 
 
In a related approach, Borges et al. (Borges et al., 2006) and de Matos et al. (de Matos 
et al., 2012) have conducted maximum recruitment manoeuvres (RM) on patients 
during the early stage of ARDS. This manoeuvre requires patients to be ventilated to a 
PEEP setting up to 45 cmH2O with a resulting peak airway pressure as high as 60 
cmH2O. The studies found that this maximum recruitment approach, when applied 
early, was able to reverse ARDS lung collapse and improve patient outcome. 
However, the approach was questionable based on previous studies and was criticized 
by the medical community for its risk, as it may also cause barotrauma and have long 
term negative effects (Borges Sobrinho et al., 2006, Gattinoni et al., 2006a, Guerin, 
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2008). Thus, it is clear that there is little consensus on pressure limits, both minimum 
and maximum, that can provide best MV treatment and outcome. 
 
One limitation of these methods that they only monitor pressure and they do not 
consider volume, Vt. Hence, only a part of the problem has been addressed. Any 
pressure that does not recruit volume will cause damage. Similarly, high pressure that 
recruits a lot of volume may be beneficial. Thus, all these pressure based approaches 
neglect patient-specific aspect of the problem in attempting to find a “one size fits all” 
solution, with the result that these in no clear consensus approach or limit. 
 
2.5 Partial Assist Ventilation 
Traditionally, acute respiratory failure patients on MV require an adequate amount of 
sedation to enable the patient to breathe with the ventilator (Kress et al., 2002). But 
recent studies have shown that patients who more actively participate in the breathing 
process, have a greater chance of recovery and a higher success rate in weaning 
(Kuhlen and Putensen, 1999, Putensen et al., 1999, Slutsky et al., 2005b, Kogler, 2009, 
Marini, 2011). Thus, assisted ventilation modes, such as partial ventilator support 
using pressure support (PS) (MacIntyre, 1986, Brochard et al., 1991, Jaber et al., 2005, 
Spieth et al., 2009a), biphasic positive airway pressure (Bi-PAP) or airway pressure 
release ventilation (APRV) (Frawley and Habashi, 2001, Varpula et al., 2004, 
Putensen and Wrigge, 2004, Rose and Hawkins, 2008, Modrykamien et al., 2011), 
and neurally adjusted ventilatory assist (NAVA) (Sinderby, 2002, Slutsky et al., 
2005a, Terzi et al., 2010, Branson and Johannigman, 2009, Schmidt et al., 2010), all 
of which promote the patient’s spontaneous breathing effort, have captured significant 
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clinical attention (Esteban et al., 2000, Rose et al., 2009). The management of 
spontaneous breathing patients is also highly variable and patient-specific, if not more 
so, and there are various investigations on-going to optimise spontaneous breathing 
therapy (Gama de Abreu et al., 2008, Barwing et al., 2011, Carvalho et al., 2011). 
However, like the prior discussion, there are several conflicting results, and no clear 
consensus, and the impact on patient outcome is similar. 
 
2.6 Model-based Approaches 
Modelling respiratory mechanics in conjunction with clinical data enables patient-
specific understanding of lung mechanics in a real-time basis, breath to breath. An in-
depth understanding of patient condition would allow clinicians to select MV therapy 
based on a patient’s exact-current condition and needs (Sundaresan and Chase, 2011, 
Chase et al., 2011), which could then balance the risk of lung injury and benefit of 
optimal ventilator support (MacIntyre, 2008). Respiratory system modelling has been 
carried out extensively over the years, ranging from simple lumped parameter models 
to highly complex finite element models (Burrowes et al., 2005, Ben-Tal, 2006, 
Schranz et al., 2011). The following section outlines several models and metrics that 
have been developed in recent years.  
 
2.6.1 Recruitment Models 
Recruitment explains the lung expansion theory through opening or closing of the 
alveoli. This model is first introduced by Hickling (Hickling, 1998) and has been 
incorporated into models to capture patient-specific parameters that can be used to 
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guide therapy (Sundaresan et al., 2009, Schranz et al., 2012). However, the use of 
these models is yet to be validated in a clinical setting.  
 
2.6.2 Model-based LIP and UIP  
The use of static PV curves, more specifically, LIP and UIP have provided the first 
guideline to select PEEP. It has been extensively studied in characterising patient-
specific condition (Suter et al., 1975, Amato et al., 1998, Murray et al., 1988, Venegas 
et al., 1998, Pelosi et al., 2001, Heller et al., 2002, Henzler et al., 2003, Albaiceta et 
al., 2004). More specifically, these studies use different sigmoid equations to 
characterise the shape of the static PV curve. They were able to mathematically define 
the location of the LIP and UIP. However, the location of the LIPs and UIPs were 
found to deviate depending on the sigmoid equation (Albaiceta et al., 2007). This 
problem has resulted in inconsistency of setting PEEP and thus, the application of 
model based LIP and UIP in setting PEEP remains limited. 
 
2.6.3 Non-invasive Static PV Curve Estimation 
One of the major problems of patient-specific static PV curves is that it is not 
normally available without additional invasive and burdensome protocols. Karason et 
al. proposed an algorithm to estimate a alveoli pressure-volume curve similar to the 
static PV, known as the dynostatic algorithm (Karason et al., 1999, Karason et al., 
2000b, Karason et al., 2000a, Karason et al., 2001, Sondergaard et al., 2003). This 
algorithm assumes the flow resistance at iso-lung volume during inspiration and 
expiration are the same. With this assumption, a surrogate of the alveolar pressure, 
dubbed the dynostatic pressure, can be estimated during tidal ventilation. This 
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dynostatic pressure at iso-lung volume curve can be used as an alternative for the 
static PV curve. However, as stated earlier; LIP and UIP may not be present during 
tidal ventilation (Lichtwarck-Aschoff et al., 2000, NÈVE et al., 2000). 
 
2.6.4 Complex and Finite Element Models 
Complex and finite element models of the respiratory system have been developed 
based on specific patient airway dimensions (Donovan, 2011, Tawhai et al., 2004, 
Tawhai and Bates, 2011). These models were able to simulate realistic description of 
disease formation, ventilation flow profile in the airway and gas distribution 
(Burrowes et al., 2008, Burrowes et al., 2011, Xia et al., 2010, Swan et al., 2012, 
Clark et al., 2011, Werner et al., 2009). However, these models are computationally 
intense and are thus not suitable for bedside monitoring to guide patient-specific care. 
 
2.6.5 Detailed Perfusion and Ventilation Models 
Models of perfusion and ventilation are comparatively simpler compared to the finite 
element models (Sharan et al., 1988, Busso and Robbins, 1997, Mogensen et al., 2011, 
Steimle et al., 2011, Rees et al., 2002, Richard et al., 2005, Hardman and Aitkenhead, 
2003). They have shown capability in simulating pulmonary capillary perfusion and 
alveolar ventilation of a healthy human lung based on clinically available 
measurement. These models were able to provide comprehensive understanding of 
ventilation and perfusion. However, they require assumptions and unknown 
parameters. Thus, they are yet to be applied to guide clinical MV and tested in clinical 
settings. 
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2.6.6 Other Model-based Methods 
The growth in computational technology has opened a wide range of possible options 
to improve mechanical ventilation support. Each model-based method and monitoring 
tool offers different theoretical advantages for patient-centred care. A summary of 
several other model-based methods are listed in Table 2. 
 
Nevertheless, there is still no consensus in a ‘standard’ model or method to guide MV 
therapy due to large patient heterogeneity, combined with the limited human and 
economic available resources to add to clinical care. While modelling approaches  are 
capable of providing unique and physiological insight to patient-specific disease state, 
to date, only a few have been tested (Quaglini et al., 2001, Carvalho et al., 2007, 
Sundaresan et al., 2011a)  and their potential in critical care is not yet validated, either 
technologically or clinically.  
 
Table 2.1: List of model-based methods in their respected categories 
No. Categories and 
Functions 
References 
1. Compartment Models (Lucangelo et al., 2007, Bates, 2009a, Abboud et 
al., 1995, Ma and Bates, 2010, Massa et al., 2008) 
2. SLICE Methods (Guttmann et al., 1994, Zhao et al., 2012a, Zhao et 
al., 2012b) 
3. Stress Index (Ranieri et al., 2000b, Grasso et al., 2007) 
4. Stress Strain 
Approaches 
(Sundaresan et al., 2011b, Chiumello et al., 2008) 
5. Alveolar and Surface 
tension Models 
(Reddy et al., 2011, Kitaoka et al., 2007, de Ryk et 
al., 2007, Schirrmann et al., 2010) 
6 Spontaneous Breathing 
Models 
(Schuessler et al., 1997, Khirani et al., 2010) 
7. Mechanical Lung 
Models 
(DiCarlo, 2008, Chase et al., 2006, Kuebler et al., 
2007) 
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2.7 Summary 
There remains a huge area of research interest in developing a patient-specific models 
or methods to optimise MV management. Importantly, the model and metrics should 
be patient-specific, physiologically relevant and computationally simple. They should 
also avoid interrupting care, or requiring significant added input or cost. This thesis 
addresses these issues through the development and validating of several model-based 
methods that are capable of guiding patient-specific MV in a heterogeneous patient 
population.  
 
In the next chapter, a model-based approach derived by Sundaresan et al. (Sundaresan 
et al., 2009), which is capable of capturing alveolar recruitment during MV, is further 
investigated. More specifically, the model is tested in an experimental setting, 
investigating its performance and ability to capture physiological relevant condition of 
ARDS, and thus, validating its clinical and technological applicability.  
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Chapter 3 
Application of Minimal Recruitment Model 
 
3.1 The Concept of Recruitment 
Conventional lung mechanics described alveolar expansion as isotropic and balloon 
like (Chevalier et al., 1978, Hickling, 2002, Albaiceta et al., 2007). These models 
assume all alveoli are engaged and expand with increasing inspiratory pressure and 
flow. The most well-known model is the Venegas Model that defines a sigmoid 
equation for patient static PV curve (Venegas et al., 1998). These models fit overall 
static pressure volume (PV) curves well, but show no further insight into the proven 
heterogeneous nature of the ARDS lung (Gattinoni et al., 2001, Gattinoni et al., 
2006b, Caironi and Gattinoni, 2007, Mertens et al., 2009, Fagerberg et al., 2009, 
Grant et al., 2009), where it is clear that the model is not applicable, even though it 
captures overall PV curves data. 
 
Several in-vivo studies and measurements have suggested a different alveolar 
expansion theory. This theory, known as recruitment (Cheng et al., 1995, Hickling, 
1998, Schiller et al., 2003, Albert et al., 2009), describes the alveoli state as either 
opened or collapsed. During respiration, after a certain threshold pressure is reached, 
the alveolar will open and assume an alveolar volume (Crotti et al., 2001, Pelosi et al., 
2001). Once the alveoli are opened, they do not have significant volume change 
(Carney et al., 1999, Schiller et al., 2003). Hence, this approach can capture the 
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internal heterogeneity observed in the ARDS lung. The difference between traditional 
theory and the recruitment theory is shown in Figure 3.1. 
 
 
 
Figure 3.1: Different alveolar expansion theories during pressure increase. (Top) 
Traditional Theory describes the alveolar expansion as isotropic balloon like. (Bottom) 
Recruitment Theory shows that the alveolus is either open or closed. 
 
The concept of recruitment provides new insight to lung physiology and thus, 
opportunity for new modelling approaches to guide clinical therapy. Hickling 
(Hickling, 1998) had proposed a mathematical model to characterise ARDS lung 
physiology based on this concept of recruitment. This model describes the lung as a 
collection of lung units, distributed in layers subjected to a superimposed pressure, as 
shown in Figure 3.2, where the lung units at each layer had a distribution of opening 
pressure.  
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Figure 3.2: Human lung is described as a collection of lung units with the effect of 
superimposed pressure (Hickling, 1998, Sundaresan et al., 2009). 
 
During inspiration, the lung units are normally closed and can be opened (Recruited) 
with positive pressure through mechanical ventilation. To open a lung unit, the MV 
pressure has to overcome an effective threshold opening pressure (TOP). Once the 
lung units are recruited, they will assume a unit volume that forms the pressure 
volume curve. It is important to note that the healthy, non-diseased lungs are typically 
recruited at all times (Schiller et al., 2003). 
 
3.2 A Model of Recruitment (Minimal Model) 
Sundaresan et al. have developed a minimal model to capture ARDS lung physiology 
using similar recruitment concept (Sundaresan et al., 2009). In this model, the lung is 
modelled as a collection of healthy and injured lung units. The healthy lung units are 
normally open and assumed a unit volume at zero added pressure. Injured lung units 
are collapsed and have relatively no residual volume. Similar to the Hickling’s model 
(Hickling, 1998), the collapsed lung units can be opened with positive pressure 
overcoming the effective threshold pressure. Once the alveoli are opened, they 
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assume a unit volume similar to healthy lung units. The opening and closing of 
collapsed lung units are governed by a distribution of  effective threshold opening 
pressure (TOP) and threshold closing pressure (TCP)  at each superimposed level 
(Crotti et al., 2001, Pelosi et al., 2001). The discretisation in number of layers and 
distribution is up to the modeller.  
 
During inflation, if airway pressure exceeds a lung unit’s effective TOP, the lung unit 
will assume a lung unit volume. Each opened unit volume is added to form the 
inflation PV curve. Similarly, if the airway pressure during deflation drops below the 
effective closing pressure, the lung unit collapses and loses the unit volume, which 
forms the deflation curve. Each lung unit has different effective opening pressure and 
closing pressure, and they are assumed normally distributed (Pelosi et al., 2001, Crotti 
et al., 2001, Pulletz et al., 2012), and saturated at zero pressure to capture open 
healthy lung units. 
 
The minimal model calculates the mean and standard deviation of the TOP and TCP 
distribution of the estimated static pressure volume curve from measured patient-
specific dynamic pressure volume curves, as shown in Figure 3.3. These parameters 
provides unique insight to patient-specific physiological condition, response to 
different MV settings, and thus the opportunity to optimise patient-specific MV 
settings  (Sundaresan et al., 2011a). 
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Figure 3.3: Patient-specific pressure volume curve and relation to normal distribution 
curve. 
 
In a TOP distribution, the mean of the distribution is the pressure when the maximum 
rate of recruitment occurs. The mean TOP also indicates the mean of recruitable lung 
units when ventilated at that pressure. Equally, the mean of TCP distribution indicates 
the maximum rate of derecruitment during deflation and, the mean lung units that will 
remain recruited during deflation. The standard deviation (SD) describes the shape of 
the TOP or TCP distribution, and it is an indication of lung heterogeneity. The 
combination of mean TOP and SD thus reflect the lung condition.  
 
Figure 3.4 shows examples of different lung conditions affect the shape (SD) and 
location of the mean TOP distribution. The upper figures are the PV curves and the 
lower figures are the corresponding TOP distribution. Compared to a normal lung, a 
collapsed lung requires higher pressure to open and recruit the lung units. Mean TOP 
for a collapsed lung is higher than normal lung, as shown in Figure 3.4 (Left) and 
reflect in the clinical need to add PEEP. The SD is the “spread” of the TOP 
distribution and thus, a heterogeneous lung will result in higher SD, as shown in 
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Figure 3.4 (Right). Combination of TOP and SD thus give the information on the 
overall lung compliance at that time, and can be tracked to monitor disease state and 
response to therapy in a patient-specific fashion.  
 
  
Figure 3.4: Effect of TOP and SD towards a PV curve (Top - PV curve during 
inflation, Bottom - TOP distribution based on PV curves). (Left) From a normal lung 
to collapse Lung. (Right) From a normal lung to heterogeneous lung. 
 
Similar concepts apply to the TCP distribution. An increase of mean TCP means that 
there are more lung units that are prone to collapse. During mechanical ventilation, 
the collapsed lung units can be recruited with additional PEEP. These newly recruited 
lung units are likely to be unstable and prone to collapse, resulting in the increase of 
mean TCP. Thus, the minimal model captures the patient-specific lung condition, 
recruitment status and response to different PEEP. This information can be used to set 
PEEP to recruit collapsed lung units and, equally, a PEEP  to prevent these newly 
recruited lung units from collapsing (Sundaresan et al., 2011a). 
 
The minimal model was retrospectively tested in the ICU and has shown the 
capability of monitoring the patient-disease state, predicting recruitment for changes 
in PEEP, and to guide MV therapy in the ICU (Sundaresan et al., 2009, Sundaresan et 
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al., 2011a). However, the model was only tested in ARDS patients, and not for 
healthier patients’ disease tracking. A healthy lung normally has no collapsed alveoli 
(Schiller et al., 2003). Thus, recruitment models are only considered applicable to 
characterise lung mechanics in ARDS patient or similar conditions that resulted in 
lung collapse. The lack of validation in disease state progression monitoring from 
ARDS to healthy or vice-versa limits its application in real-time monitoring, as well 
as leaving the model not fully validated. Validation for generality across healthy and 
diseased state would significantly strengthen and extend the model potential. 
 
3.3 ARDS Animal Models for the Study of Lung Mechanics 
In this study, animal trials are carried out to test the minimal model’s physiological 
relevance and performance in both healthy and ARDS lungs. An animal model is used 
for ethical reasons as intubating and sedating healthy individuals is not possible. We 
hypothesise that the minimal model is able to represent both diseased and healthy 
lungs, as well as being able to monitor the progression of the disease state from the 
healthy case in a physiologically and clinically expected fashion.  
 
More specifically, it is assumed that the open alveoli in a healthy lung will have lower 
overall threshold opening pressures (lower mean TOP) compared to ARDS lungs, and 
that the difference between healthy and ARDS states will be evident in lowered 
compliance and greater variability in threshold opening pressures (Higher standard 
deviation, SD) for the ARDS lung. Satisfying these hypotheses would assist in 
validating the model’s generality and thus its application in MV patients. 
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3.4 Methodology 
3.4.1 Subject Preparation 
Pure pietrain piglets weighing 20~30 kg were used in this experiment conducted at the 
hemodynamics laboratory of GIGA-Cardiovascular Research in Centre Hospital 
University of Liege. The experimental piglets were first premedicated with tiletamin 
zolazepam 5 mg/kg and subsequently anaesthetised by a continuous infusion of 
sufentanil 0.5 μg/kg/h, pentobarbital 5 mg/kg/h and cisatracurium 2 mg/kg/h.  
 
The piglets were then ventilated through a tracheotomy intubation using Engström 
CareStation ventilator (Datex, General Electric Healthcare, Finland).  The mechanical 
ventilator was set in volume control mode, with tidal volume, Vt = 10~12 ml/kg, 
inspired oxygen fraction (FiO2) 0.5, and at PEEP of 5 cmH2O. Throughout the trial, 
subject airway pressure, flow and volume profile were recorded using the Eview 
module (Datex, General Electric Healthcare, Finland) provided with the ventilator. 
 
3.4.2 Protocol-based Recruitment Manoeuvre 
Each piglet underwent 3 phase protocol. Each phase will provide unique information 
of the piglet’s condition and specific response to PEEP. 
 Phase 1 - Healthy state staircase recruitment manoeuvre (RM) 
 Phase 2 - Progression to ARDS state 
 Phase 3 - Disease state RM during ARDS 
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a) Phase 1 - Healthy State Recruitment Manoeuvre 
At the start of the trial, the subject underwent a step-wise PEEP increase manoeuvre, 
also known as staircase recruitment manoeuvre (RM) (Hodgson et al., 2011a). During 
the RM, PEEP was increased with a 5 cmH2O step from baseline 5 cmH2O until 20 
cmH2O. Other ventilator settings were maintained constant throughout the RM. Each 
PEEP level was maintained for 10~15 breaths before increasing to a higher PEEP 
level. After reaching 20 cmH2O, PEEP was decreased by steps of 5 cmH2O to the 
baseline PEEP. An example of the recorded pressure flow and volume profile during 
the PEEP increasing phase of RM is shown in Figure 3.5. 
 
 
Figure 3.5: Pressure, flow and volume profile during recruitment manoeuvre. 
 
b. Phase 2 - Progression State - Oleic Acid injections  
The piglets were then injected with oleic acid to induce ARDS. Oleic acid was 
administrated slowly at 0.1ml/10 minutes until 0.1 ml/kg of the subject’s weight. 
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Arterial blood gases were monitored half hourly using a RAPIDPoint 500 (Siemens 
Healthcare Diagnostics, Tarrytown, NY). All blood samples were taken at baseline 
PEEP of 5 cmH2O. 
 
c) Phase 3 - Disease State Recruitment Manoeuvre 
In this study, the animal model ARDS criterion is defined as hypoxemia when 
subjects’ arterial blood gas, PaO2/FiO2 (PF ratio) is less than 200 mmHg (The ARDS 
Definition Task Force, 2012). Once the piglet is diagnosed with ARDS, a second RM 
similar to Phase 1 was performed.  
 
All experimental procedure, protocols and the use of data in this study were reviewed 
and approved by the Ethics Committee of the University of Liege Medical Faculty 
(Comité d'éthique du centre hospitalier universitaire de Liège, Faculté de Médecine). 
 
3.4.3 Data Processing for the Minimal Model 
To examine the subject-specific response to PEEP, a representative breath is selected 
from the last 2 breaths at each PEEP level during Phase 1 and Phase 3. When PEEP 
increases from a lower to higher level, recruitment occurs and the deflation/unloading 
of the lung is not complete, with additional air “trapped” in lung. This recruitment and 
“trapped” volume is the estimated lung volume increase for the PEEP increment. 
Figure 3.6 shows an example of the estimated lung volume increase, and the 
associated post-processed pressure volume curve (PV) is shown in Figure 3.7. 
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Figure 3.6: Estimation of volume increase during PEEP increment. 
 
 
Figure 3.7: Example of pressure volume curves with volume increase with PEEP. 
 
3.4.4 Model Fitting and Data Analysis 
The processed PV curves were fitted to the minimal model (Sundaresan et al., 2009) 
to identify model-based mean TOP, mean TCP, and the standard deviations (SD) of 
both TOP and TCP distributions. Fitting errors are presented as mean absolute 
percentage error. Model-based mean TOP, TCP and SD in both healthy and ARDS 
states are compared to examine the effect of ARDS on model parameters, and their 
physiological and clinical relevance. 
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3.4.5 Disease State Grouping (DSG) 
The estimated patient-specific parameters (mean TOP and SD) can be used to group 
patients based on their disease state using the 4 panel disease state grouping metric 
(DSG) shown in Figure 3.8. In general, patients grouped in Panel B (low SD and TOP) 
are healthier compared to other panels. A decrease of SD or mean TOP indicate a less 
heterogeneous lung and/or an overall decrease in collapsed lung units. This change is 
illustrated in Figure 3.9 (Left) and show improvement in lung condition. Conversely, 
an increase of either of these parameters indicates that lung condition is worsening 
over time as shown in Figure 3.9 (Right). Hard boundaries are deliberately not shown 
as specific because it may be patient- or group-specific. However, the overall diagram 
of Figure 3.8 can be used to clarify and monitor changes in patient condition, which is 
a main goal that must be validated for any model proposed for clinical use; as 
illustrated in Figure 3.9. 
 
 
Figure 3.8: Patients-specific disease state grouping. 
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Figure 3.9: A metric for disease state tracking. (Left) Lung is recovering over time. 
(Right) Lung condition worsening. 
 
3.5 Results and Discussion 
9 piglets weighing median [Interquartile range (IQR)] 24.0 kg [IQR: 21.0-29.6] were 
included in the study. 3 of 9 subjects reached an ARDS state (Subjects 5, 6 and 9) 
after oleic acid injection. The mean TOPs, mean TCPs and SD of these 3 piglets that 
reached ARDS state are compared between the healthy and ARDS state. 
 
3.5.1 Model Fitting 
The minimal model fitting during inflation and deflation for healthy and ARDS 
subjects are shown in Tables 3.1-3.3. An example of model fit to measured PV curves 
of a healthy subject, and the resulting TOP and TCP distributions at PEEP of 10 
cmH2O and 15 cmH2O are shown in Figure 3.10. 
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Table 3.1: Model fitting error during inflation at different PEEP levels for healthy 
subjects 
Subject 
Mean Absolute Percentage Fitting Error (%), Inflation 
Median [IQR] 
PEEP 5 PEEP 10 PEEP 15 PEEP 20 
1 6.46 5.97 2.66 0.84 4.31 [2.20-6.09] 
2 12.45 9.56 2.25 0.31 5.91 [1.77-10.28] 
3 27.46 4.81 3.11 0.86 3.96 [2.55-10.47] 
4 9.96 3.36 2.49 0.53 2.92 [2.00-5.01] 
5 32.48 2.19 1.56 0.72 1.88 [1.35-9.76] 
6 24.94 2.08 2.25 1.71 2.17 [1.98-7.93] 
7 15.46 3.36 2.74 1.09 3.05 [2.33-6.38] 
8 10.93 5.25 2.75 0.36 4.00 [2.15-6.67] 
9 24.62 7.43 3.05 2.63 5.24 [2.95-11.73] 
Median 
[IQR] 
15.45 
[10.93-24.94] 
4.81 
[3.36-5.97] 
2.66 
[2.25-2.75] 
0.84 
[0.53-1.09] 
2.90 
[1.98-7.97] 
 
 
Table 3.2: Model fitting error during deflation at different PEEP levels for healthy 
subjects 
Subject 
Mean Absolute Percentage Fitting Error (%), 
Deflation Median [IQR] 
PEEP 5 PEEP 10 PEEP 15 PEEP 20 
1 13.84 4.07 2.89 1.48 3.48 [2.53-6.51] 
2 13.35 7.48 3.21 1.00 5.35 [2.66-8.95] 
3 9.48 2.41 0.92 0.98 1.70 [0.96-4.18] 
4 9.93 1.77 1.00 0.167 1.39 [0.79-3.81] 
5 8.94 1.77 1.91 0.66 1.84 [1.49-3.67] 
6 4.54 1.12 1.01 0.76 1.07 [0.95-1.97] 
7 10.09 2.49 0.84 0.50 1.67 [0.75-4.39] 
8 12.05 5.46 3.34 2.05 4.40 [3.01-7.11] 
9 12.06 11.40 10.01 4.52 10.70 [8.63-11.56] 
Median 
[IQR] 
10.09 
[9.48-12.06] 
2.49 
[1.77-5.46] 
1.91 
[1.00-3.21] 
0.98 
[0.66-1.48] 
2.69 
[1.00-9.07] 
 
 
Table 3.3: Model fitting error for subjects with ARDS 
Subject 
Mean Absolute Percentage Fitting Error (%)  
Inflation Median [IQR] 
PEEP 5 PEEP 10 PEEP 15 PEEP 20 
5 5.81 7.27 3.08 1.08 4.45 [2.58-6.18] 
6 2.85 5.64 4.13 0.69 3.49 [2.31-4.51] 
9 41.44 9.62 2.17 3.63 6.62 [3.27-17.57] 
 Deflation  
 PEEP 5 PEEP 10 PEEP 15 PEEP 20  
5 9.98 3.66 0.90 1.46 2.56 [1.32-5.24] 
6 9.64 1.19 3.63 0.37 2.40 [0.99-5.13] 
9 6.34 3.92 1.80 1.91 2.91 [1.88-4.52] 
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Figure 3.10: Model Fitting with TOP and TCP distribution shift for healthy Subject 2. 
(Upper) Model Fitting for PV curve in PEEP 10 and 15cmH2O. (Bottom) TOP shifts 
left and TCP shifts right with PEEP increase. 
 
Median [IQR] fitting errors in healthy subjects during inflation is 2.90% [IQR: 1.98-
7.97] and 2.69% [IQR: 1.00-9.07] during deflation. Similar to healthy subjects, the 
model fits well for ARDS subjects with median absolute percentage error less than 
7% during inflation and less than 3% during deflation (Table 3.3). There is a 
noticeable high fitting error for ARDS subject 9 at PEEP 5 cmH2O, at 41.44% during 
inflation. The model was not able to capture these specific physiological conditions at 
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low PEEP. In particular, this case can be associated with the effect of Auto-PEEP 
distorting the actual lung condition (Sundaresan et al., 2009). The recruitment model 
fits better when Subject 9 is ventilated at higher PEEP (p < 0.005) compared to lower 
PEEP. However, the relatively low median error overall subjects indicates the model 
is capable of capturing fundamental mechanics of both healthy and ARDS lungs.  
 
3.5.2 TOP, TCP and SD Response to PEEP 
Table 3.4 shows the model estimated mean TOP and TCP at different PEEP for 
healthy subjects, and Table 3.5 for the ARDS subjects (5, 6 and 9). Table 3.6 shows 
the SD of the TOP and TCP distribution for the subjects that developed ARDS in both 
healthy and ARDS state.  
 
Table 3.4: Mean TOP and TCP for healthy subjects 
Subject 
Threshold Opening Pressure 
(TOP, cmH2O) 
Threshold Closing Pressure 
(TCP, cmH2O) 
PEEP 
5 
PEEP 
10 
PEEP 
15 
PEEP 
20 
PEEP 
5 
PEEP 
10 
PEEP 
15 
PEEP 
20 
1 42.4 39.2 32.9 27.2 9.6 13.4 16.6 19.8 
2 36.3 40.0 33.8 29.3 8.2 13.5 16.8 20.4 
3 44.6 37.4 32.2 25.1 10.2 13.2 16.4 19.7 
4 39.0 33.9 29.0 19.2 10.4 13.7 16.6 19.0 
5 42.6 32.7 24.8 19.2 10.2 13.2 15.7 18.4 
6 31.3 28.1 23.8 21.5 9.03 12.5 15.5 18.8 
7 47.7 40.8 34.1 27.0 11.1 14.6 17.2 19.6 
8 46.0 40.2 33.4 27.9 10.6 13.4 16.6 19.5 
9 38.2 33.9 29.4 22.8 8.7 12.3 15.8 19.3 
Median 
[IQR] 
42.4 
[38.2-
44.6] 
37.4 
[33.9-
40.0] 
32.2 
[29.0-
33.3] 
25.0 
[21.5-
27.1] 
10.2 
[9.0-
10.4] 
13.3 
[13.2-
13.5] 
16.6 
[15.8-
16.6] 
19.5 
[19.0-
19.7] 
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Table 3.5: Mean TOP and TCP for ARDS subjects 
Subject 
Threshold Opening Pressure 
(TOP, cmH2O) 
Threshold Closing Pressure 
(TCP, cmH2O) 
PEEP 
5 
PEEP 
10 
PEEP 
15 
PEEP 
20 
PEEP 
5 
PEEP 
10 
PEEP 
15 
PEEP 
20 
5 48.1 44.1 33.3 22.7 10.2 14.0 16.7 19.0 
6 49.5 41.6 31.1 19.1 10.2 13.7 16.7 18.9 
9 68.1 64.7 58.7 49.4 9.6 14.1 18.2 21.8 
Average 55.2 50.1 41.0 30.4 10.0 13.9 17.2 19.9 
 
Table 3.6: SD in healthy and ARDS lung 
Subject 
Healthy ARDS 
Inflation Deflation  Inflation Deflation 
5 23 4 25 4 
6 14 3 25 4 
9 21 3 23 3 
Average 19.3 3.3 24.3 3.7 
 
In healthy subjects, the overall mean TOP is decreased with increasing PEEP, from 
42.4 cmH2O [IQR: 38.2-44.9] to 25.0 cmH2O [IQR: 21.5-27.1]. Mean TCP increases 
from 10.2 cmH2O [IQR: 9.0-10.4] to 19.5 cmH2O [IQR: 19.0-19.7] with increasing 
PEEP. The TOP and TCP distribution shift of a subject during PEEP increase is 
observed in Figure 3.10 (Bottom), and are capturing the recruitment as expected.  
 
Similar mean TOP and TCP trends are also observed in ARDS subjects. However, an 
overall higher TOP is observed compared to healthy subjects, which is also expected 
for an ARDS lung. The overall higher mean TOP indicates that the ARDS lung 
consists of relatively more collapsed alveoli and higher pressure is needed to recruit 
the collapsed alveoli.  
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An example of the PV curve shift from a healthy state to an ARDS state is shown in 
Figure 3.11 (Upper). The change in TOP and TCP distributions between healthy and 
ARDS state for the 3 subjects in Tables 3.5-3.6 is shown in Figure 3.11 (bottom). 
 
  
  
 
Figure 3.11: Pressure-volume curve of Subject 5 and overall TOP and TCP 
comparison between healthy and ARDS. (Top) Inflation curve right shift from healthy 
to ARDS. (Bottom) TOP in healthy lung is lower than in ARDS. Relatively little 
change in TCP during healthy and ARDS state.  
 
Healthy lungs normally consist of only opened or recruited lung units, and a model 
based on the concept of recruitment may not be applicable. However, in a healthy 
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anesthetised and sedated subject, pulmonary atelectasis can be observed, but it is less 
severe compared to an ARDS lung and can be easily recruited (Tusman et al., 1999, 
Rusca et al., 2003, Tusman et al., 2012). Thus, during inflation, relatively lower 
pressure is needed to ventilate the healthy “collapsed” lung compared to ARDS lung. 
Therefore, for a given tidal volume, the area within the PV curve for a healthy lung 
should be smaller than ARDS lung. Equally, the healthy lung is less heterogeneous 
and the lower SD will keep the PV loop area smaller. Figure 3.11 shows a clear 
comparison of a healthy and ARDS PV curve, in which the ARDS PV curve has 
greater area than the healthy PV curve and correspondingly higher SD for this Subject 
5 in Table 3.6. The change thus shows the expected higher work of breathing in the 
heterogeneous ARDS lung. 
 
Comparing the healthy and ARDS state, mean TOP for healthy lungs are lower when 
compared to ARDS lungs in Figure 3.11 (Bottom). A healthy lung is a less 
heterogeneous lung and the effect of superimposed pressure to alveoli is less 
detrimental. As suggested earlier, a healthy lung is normally open, which results in a 
lower mean TOP. Thus, the model captures the fact that, for the same subject at a 
healthy and ARDS state, higher pressure is required to recruit and open the lung. The 
inter-subject variability in this behaviour is evident in Figure 3.12. Overall, these 
model results match clinical observation and expectation, which further validates the 
model. 
 
The deflation curve remains unchanged in ARDS compared to healthy subjects, as 
shown in Figure 3.11 (Upper), which results in relatively no change in TCP, as seen in 
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Figure 3.11 (Lower Right) and Table 3.3. Hypothetically, mean TCP should be higher 
in the ARDS state compared to the healthy state (Sundaresan et al., 2009, Pulletz et 
al., 2012). ARDS lung units are more unstable and vulnerable to collapse. Thus, 
higher pressure is required to retain recruitment. However, this hypothesis was neither 
observed nor apparent in these results. Only a small increase in TCP is observed 
during ARDS state compared to healthy state as shown in Figure 3.11. 
 
3.5.3 Application of DSG Metric 
The DSG for the ARDS subjects are shown in Figure 3.12. It is observed that all 3 
subjects experienced different SD and TOP increase when transitioning from healthy 
to ARDS state. In particular, Subject 5 has a relatively small increase in both SD and 
TOP between healthy and ARDS state. Subject 6 had very large increase in SD 
(heterogeneity) but less change in TOP (Collapsed lung units). Subject 9 had a very 
high TOP change (Lung collapse) but minimal changes in SD (Heterogeneity).  These 
results show the diversity in the impact of the ARDS induced and thus the overall 
difficulty of the clinical problem in general. Clearly, patient-specific solutions will be 
required.  
 
It is  known that ARDS induced in animal model using oleic acid are highly variable 
(Schuster, 1994). A small variation in ventilation and hemodynamic management 
during preparation, time and dosage may alter the severity or extensiveness of the 
lung injury, resulting in different pathophysiological consequences (Schuster, 1994, 
Rosenthal et al., 1998, Ware, 2008, Bastarache and Blackwell, 2009, Ballard-Croft et 
al., 2012). That behaviour is clearly evident in these results.  
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Figure 3.12: Change of TOP and SD for healthy subject which later develop ARDS. 
(Top) Subject 5, with slight increase of SD and TOP. (Middle) Subject 6, large 
increase of SD. (Bottom) Subject 9, slight increase of SD with high TOP change. 
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Importantly, this research focuses on minimal model performance in healthy and 
ARDS lungs. Combining the DSG for all 3 subjects, as shown in Figure 3.13, the 
healthy subjects have overall lower TOP and SD than in the ARDS state. This finding 
suggests that the DSG application is not limited to patient-specific disease state 
tracking, but can be expanded into population monitoring. Capturing 3 different 
ARDS respiratory mechanics or pathophysiological consequences, thus encourages 
the model’s application in clinical setting, where the presentation of ARDS and its 
evolution over time and treatment can be variable. 
 
 
Figure 3.13: The 4 panel DSG and the mean TOP and SD changes with PEEP for the 
3 ARDS subjects. 
 
This DSG application is unique and observing DSG shifts should provide useful 
information for clinical decision support. For example, patients who are grouped in 
Panel D (High TOP, low SD), have a less heterogeneous lung, but with overall higher 
lung unit opening pressure. For example, it is hypothesised that a high PEEP can be 
used in MV to recruit overall collapsed lung units and improve gas exchange 
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(Takeuchi et al., 2005, Spieth and Gama de Abreu, 2012). For patients who are 
grouped in Panel A (Low TOP, high SD), ventilation modes with 2 PEEP levels (Bi-
Level PEEP ventilation, airway pressure release ventilation (APRV)) can reduce 
cyclic opening and collapse of lung units and improve patient outcome (Varpula et al., 
2004, Brower et al., 2004, Barbas et al., 2005). Tracking patient DSG with time will 
also show the effect and patient’s response to specific treatment. In this research, the 
effect of oleic acid can be seen in increase of TOP and SD. However, the exact limits 
of these groupings remain to be determined, although it does not affect the ability to 
track patient condition and response to therapy as in Figure 3.12 or compared as in 
Figure 3.13. 
  
Overall, the difference of mean TOP and SD between the healthy and ARDS state can 
be identified using the minimal model. The application of minimal model is not 
limited to the diseased lung, and allows comparison between healthy and ARDS 
lungs, and thus encourages its application and future investigation in the ICU to 
monitor patients-specific condition to guide MV therapy. An overall down shift of 
mean TOP and/or lowered SD will indicate that the lung recovering for injurious state. 
In contrast, an up-shift of TOP and/or SD, will show that the lung is more injured. 
This unique pair of metric thus provides the ability to track the disease state from 
healthy to injured state and vice-versa. However, mean TCP appears to have little 
change between healthy and ARDS state, indicating that the TCP parameter was less 
significant in this clinical use. 
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3.6 Limitations 
3.6.1 Repeatability of ARDS Piglets 
After oleic acid injections, only 3 of 9 subjects successfully developed ARDS. Others 
experienced hemodynamic failure before ARDS could develop fully or detected. This 
result shows that oleic acid induced ARDS animals are less reproducible and the 
subject preparation method should be re-examined (Julien et al., 1986, Schuster, 1994, 
Grotjohan et al., 1996, Rosenthal et al., 1998). The estimation and comparison of 
TOP, TCP and SD during healthy and ARDS state is thus, not conclusive with 
statistical significance given low subject numbers. However, individual data revealed 
that subjects that developed ARDS had overall higher TOP compared to subject in a 
healthy state. This physiologically relevant result is supported by past literature that 
examines similar clinical conditions (Lu et al., 2001, Crotti et al., 2001, Pelosi et al., 
2001). In addition, all other results follow clinically expected trends. 
 
3.6.2 Ventilation Tidal Volume 
In this study, tidal volume is set to 10~12 ml/kg to ventilate the experimental piglets. 
It is known that such a high tidal volume is injurious with higher mortality (The Acute 
Respiratory Distress Syndrome Network, 2000). However, the focus of the study is 
the investigation of the model’s performance in healthy and ARDS states. During a 
healthy state, the recruitment manoeuvre with airway pressure and flow 
measurements were performed at the very beginning of the trial. This time frame is 
relatively short and thus, the effect of high tidal volume ventilation was minimal and 
likely did minimal or no damage. Moreover, a more injurious ventilation strategy 
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would indirectly benefit the overall study goals comparing healthy and damaged lung 
state. 
 
3.6.3 Estimation of the Volume Change 
The measurement of volume change was estimated during RM PEEP increase. The 
calculation method assumes that deflation of the lung is not fully complete and the air 
remained in the lung due to PEEP. This estimation based on Figure 3.6 may not be 
entirely true. However, direct measurement of the lung volume during short PEEP 
increases is not available at the bedside. In particular, FRC estimation using nitrogen 
washout requires several breathing cycles and a long stabilisation period and thus, 
was not suitable in this trial or for regular clinical use (1-4 times per day). The volume 
change estimation is this study is thus a surrogate of the actual lung volume increase. 
This estimation method can be validated in future studies using nitrogen or oxygen 
washin/washout method (Weismann et al., 2006, Maisch et al., 2007, Olegard et al., 
2010, Dellamonica et al., 2011). However, all trends remain valid, and it is these 
changes that are critical here. Equally, low fitting errors indicate it did not appear to 
affect the model.  
 
3.6.4 Minimal Model and Patient DSG 
The minimal model is a model that estimates TOP, TCP and SD during PEEP titration 
of the mechanically ventilated. It is unable to predict the alveolar over-distension 
directly. However, the use of TOP mean shift as proposed by Sundaresan et al 
(Sundaresan et al., 2011a), it is possible to monitor the recruitability of the lung and 
thus, indirectly reveal potential over-distension that may cause lung injury. 
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The DSG provides a unique metric to monitor patient’s condition and potentially be 
used to guide ventilator settings. However, there are currently insufficient samples to 
validate this metric, or to prove the patients outcome for different TOP and SD. In 
particular, questions such as: “what is the actual physiological findings in patients 
with particular SD/ TOP value”, “what SD or TOP values are considered as high or 
low” need to be addressed. Figure 3.13 is an example of the metric application, but 
there is insufficient information to determine which specific TOP/SD is high/low. In 
addition, the estimated TOP and SD in animals may be different if compared with 
human subjects. Future clinical trials or clinical PV data from other trials are required 
to validate this proof of concept. 
 
3.7 Summary  
The minimal model fits well in both healthy and ARDS lungs, and is capable of 
capturing the fundamental lung mechanics of the healthy and ARDS lung. The 
application of minimal model is thus not limited to diseased lung cases, but can be 
even used for healthy lungs. The model was able to estimate clinically and 
physiological relevant parameters for healthy and ARDS piglets thus allowing disease 
state tracking (DSG), which in turn illustrates the difficult problem and need for 
patient-specific solution, as well as showing the potential to use this model to assist in 
clinical decision making.  
 
In the next chapter, a compartment model that describes the respiratory mechanics 
during mechanical ventilation is presented. This model estimates the respiratory 
elastance and the airway resistance of the experimental piglets. Hence, it captures 
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metrics that cannot be obtained with simple clinical metrics or static approaches, as it 
identifies underlying patient-specific parameters with clinical relevance to the 
problem. Therefore, similar to the minimal model presented here, the compartment 
model can provide clinically useful information in setting MV. 
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Chapter 4 
Respiratory Mechanics Monitoring:  
Single Compartment Linear Lung Model  
 
Modelling the respiratory mechanics of mechanically ventilated (MV) patients is an 
emerging clinical research area. These models can potentially provide clinically and 
physiological useful information to guide MV therapy (Lauzon and Bates, 1991, 
Sundaresan et al., 2009, Ma and Bates, 2010, Sundaresan and Chase, 2011). Complex 
modelling of respiratory mechanics can be developed, to describe patient-specific 
condition (Tawhai et al., 2004, Burrowes et al., 2008, Tawhai et al., 2009, Choi et al., 
2010). However, these complex models are computationally intense and cannot be 
customised to a specific patient in clinically relevant time frames to guide decision 
making. Thus, their real time clinical application to guide MV is limited (Bates, 
2009b, Schranz et al., 2010). Furthermore, specific protocols are required to define 
patient-specific complex respiratory system models (Farre et al., 1998). These 
protocols may be invasive and not clinically feasible due to the heterogeneity and 
severity of the patient’s conditions. 
 
4.1 Single Compartment Linear Lung Model 
Recent studies revealed that simple respiratory models have the potential to guide MV 
(Lucangelo et al., 2007). Studies that dynamically monitored a model-based or 
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clinically derived elastance component dynamically during breathing cycle (Guttmann 
et al., 1994, Chiew et al., 2011, Zhao et al., 2012a, Chiew et al., 2012b) revealed 
similar outcomes with the benefit of minimising work of breathing. In particular, the 
most commonly used model in clinical practice is the lumped parameter model (single 
compartment linear lung model) (Mead and Whittenberger, 1953). The respiratory 
system is modelled as a combination of an elastic/compliance component with a 
resistance component. The elastic or compliance component represents the physical 
lung, whereas the resistive component models the airway. The schematic 
representation of the single compartment lung model is shown in Figure 4.1. 
 
        
Figure 4.1: Schematic drawing for single compartment linear lung model. (Left) 
Mechanical system. (Right) Electric circuit representation of the respiratory model. 
 
When the air enters the lung through the endotracheal tube (ETT) and patient’s 
airway, there is a pressure drop due to the resistance component (Rrs) of the combined 
conducting airway as shown in Equation 4.1. The lung is modelled as an expandable 
compartment connected by a spring with elastic property (Ers) as shown in Equation 
4.2). 
 
 ∆P(t) = Rrs ×  Q(t)       (4.1) 
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 Plung(t) = Ers ×  V(t)       (4.2) 
 
Where ∆P is the pressure drop, t is time, Rrs is the conducting airway resistance, Q is 
the air flow, Plung is the pressure build-up in the lung compartment, Ers is the elastic 
property of the lung and V is the lung volume. Thus, the equation of motion of the 
respiratory system can be derived by combining both Equations 4.1 and 4.2 to yield: 
  
Paw(t) = ∆P(t) + Plung(t)      (4.3) 
 Paw(t) = Rrs ×  Q(t) + Ers ×  V(t)     (4.4) 
 
Where Paw is the airway pressure. Equation 4.4 is augmented with an offset pressure, 
P0 to account for pressure equilibrium. P0 is normally zero at atmospheric pressure 
and will only change when PEEP is applied and accounts for Auto-PEEP (Bates, 
2009a). Thus, the respiratory system may be simply modelled as in this form using a 
model defined: 
 
 Paw(t) = Rrs ×  Q(t) + Ers ×  V(t) + P0     (4.5) 
 
4.2 Application of Compartment Model in Respiratory Mechanics 
Monitoring 
As briefly discussed in Chapter 2, monitoring respiratory mechanics in ARDS patients 
has been shown to be beneficial in clinical decision making, as the respiratory 
mechanics represents the patient-specific and condition-specific response to MV 
settings (Carvalho et al., 2007, Lucangelo et al., 2007, Suarez-Sipmann et al., 2007, 
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Lambermont et al., 2008). However, its application is limited and it is yet to be used 
continuously in regular clinical practice to guide therapy (Rousselot et al., 1992, 
Baconnier et al., 1995, Bersten, 1998, Muramatsu et al., 2001, Eberhard et al., 2003, 
Lucangelo et al., 2007, Brochard et al., 2012). 
 
In this chapter, the feasibility of continuously monitoring respiratory mechanics using 
single compartment respiratory model is studied extensively in experimental ARDS 
animal model. The respiratory mechanics in Equation 4.5 (Ers and Rrs) of the 
mechanically ventilated animal are estimated and monitored using model-based 
methods (Rousselot et al., 1992, Muramatsu et al., 2001). These estimated values are 
compared with conventional clinically derived respiratory mechanics. It is 
hypothesised that monitoring the model-based respiratory mechanics for ARDS 
animal, or patient, in real-time will provide unique descriptions of the subject’s 
disease progression, and response to MV different settings. Such data can provide 
guidelines to guide MV therapy and decision making in real-time. 
 
4.3 Methodology 
4.3.1 Experimental Data 
The recorded pressure, flow and volume profile from the experiment described in 
Chapter 3 were used to examine the hypothesis. Unlike the minimal model (Chiew et 
al., 2012a), where it can only compare 2 distinct state; the healthy state and ARDS 
state, the single compartment model can be used to monitor respiratory mechanics 
throughout the trial, including Phase 2 (Disease progression). An example of the 
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pressure profile during all 3 phases, as described in the methodologies presented in 
Chapter 3 is shown in Figure 4.2.  
 
Phase 
1 
 
 
Phase 
2 
 
Phase 
3 
 
Figure 4.2: Pressure profile during the 3 phase clinical trial. (Top) Phase 1 - Healthy 
state staircase RM, (Middle) Phase 2 - Progression to ARDS State and, (Bottom) 
Phase 3 - Disease State RM during ARDS. The single compartment model is used to 
estimate the respiratory mechanics continuously for all 3 phases. 
 
 
4.3.2 Respiratory Mechanics Estimation 
Respiratory mechanics of every breathing cycle from the 3 piglets that reached an 
ARDS state were estimated using 3 different methods: 1) model-based method using 
Equation 4.6; 2) a conventional method and 3) Automated end of inspiratory pause 
(EIP).  
 
a) Model-based Method 
The model-based method uses integral-based method (Hann et al., 2005)  to estimate 
ErsIB (Elastance) and RrsIB (Resistance) value that best fit Equation 4.5. Integral-based 
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parameter identification is similar to multiple linear regression, where using integrals 
significantly increases robustness to noise. Equation 4.6 defines the overall approach 
that yields a set of the expressions in terms of elastance and resistance when 
integrating 2 or more time frames within a breath (Chiew et al., 2011).  
 
 ∫Paw(t) = RrsIB ×  ∫Q(t) + ErsIB ×  ∫V(t) + ∫P0   (4.6) 
 
b) Conventional Method  
The conventional method (2-point calculation) calculates of respiratory elastance 
using the difference between clinically observed peak airway inspiratory pressure 
(PIP) and PEEP, divided by inspiratory tidal volume (Vt). This conventional elastance 
(ErsVent) is defined: 
 
 ErsVent = (PIP – PEEP)/ Vt      (4.7) 
 
The conventional method is comparatively simpler than the model-based method. 
However, ErsVent is often overestimated in this approach as the term ErsVent includes 
information of the airway resistance (Storstein et al., 1959, Barberis et al., 2003, 
Lucangelo et al., 2007). Thus, ErsVent can be associated with dynamic elastance (1/ 
dynamic compliance).  Airway resistance is not normally measured without an end 
inspiratory pause (EIP) (Storstein et al., 1959, Barberis et al., 2003, Lucangelo et al., 
2007). Thus, model-based methods should provide better resolution and identification 
of clinically relevant respiratory mechanics without additional clinical protocol.  
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c) Automated End of Inspiratory Pause (EIP) 
In this study, the experimental piglets were ventilated using Engström CareStation 
ventilator (Datex, General Electric Healthcare, Finland), volume control, square flow 
profile. The ventilation mode was set with an automated short end inspiratory pause 
(EIP) (Ingelstedt et al., 1972, Fuleihan et al., 1976, Pillet et al., 1993). The zero-flow 
phase during EIP omits the resistance component in Equation 4.3. The resulting end 
of inspiratory pressure after EIP (plateau pressure, Pplat) can be used to estimate the 
static ventilation elastance as shown in Equation 4.8 (Shiu and Rosen, 2006). Equally, 
the pressure difference between peak pressure (PIP) and Pplat can be used to calculate 
the airway resistance as shown in Equation 4.9.  
 
 EStatic= (Pplat – PEEP)/ Vt       (4.8) 
 RStatic= (PIP – Pplat)/ Q      (4.9) 
 
Both EStatic and RStatic can be derived directly from the modern ventilators with 
automated EIP feature. This feature allows the model-based estimated ErsIB and RrsIB 
to be compared with EStatic and RStatic, validating the model-based method.  
 
4.4 Results and Discussion 
4.4.1 Model Fitting 
The model-based method estimates the ErsIB and RrsIB values using the integral based 
method as fitted to the measured airway pressure. Median absolute percentage fitting 
errors of the model of Equation (4.6) to measured airway pressure are reported in 
Table 4.1. Overall, the median absolute percentage fitting error to the model is 2.42% 
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[IQR: 1.95-2.77] in every subject over all three phases. This result indicates that the 
single compartment lung model was able to identify the fundamental, subject-specific 
and clinically relevant respiratory mechanics (Marini, 1992, Lucangelo et al., 2007, 
Brochard et al., 2012).  
 
Table 4.1: Model fitting errors using ErsIB, RrsIB, median [IQR] using integral based 
method of (Hann et al., 2005) 
Subject 
Absolute Percentage Fitting Error (%) Overall 
Phase 1 Phase 2 Phase 3  
1 1.73 [0.98-3.17] 2.42 [1.83-3.06] 3.41 [2.58-4.44]  
2 2.22 [1.60-2.72] 2.01 [1.53-2.51] 2.55 [2.21-3.04]  
3 1.77 [1.32-2.17] 2.48 [1.49-4.26] 5.93 [3.48-7.70]  
    2.42 [1.95-2.77] 
 
4.4.2 Clinically Derived and Model-based Respiratory Mechanics 
Tables 4.2-4.4 reported and compared the identified respiratory mechanics during the 
healthy state (Phase 1) and during the ARDS state (Phase 3). Figures 4.3-4.5 show all 
respiratory mechanics estimated throughout the clinical trial in different subjects at 
every breathing cycle. Note that only the integral based method can also identify 
resistance (RrsIB) in Table 4.4, which the conventional method ignores. 
 
As expected, the elastance calculation in the conventional method is higher than 
model-based method due to the effect of respiratory system resistance (as noted in 
Equation 4.5). The linear definition of ventilator elastance (ErsVent) also means that it 
cannot capture any non-linearity compared to the physiologically realistic Equation 
(4.5), and this nonlinearity difference can vary within a subject.  
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Table 4.2: ErsVent for all 3 subjects in Phase 1 and Phase 3 (ARDS) using the 
conventional method of Equation of 4.7 
Subject 
ErsVent (cmH2O/l), Median [IQR] 
PEEP 5 PEEP 10 PEEP 15 PEEP 20 
5 73.61 [71.54-75.75] 77.55 [74.12-79.15] 90.14 [84.63-96.11] 
131.26 
 [126.73-133.01] 
6 73.11 [72.43-73.81] 75.19 [73.44-75.95] 84.56 [81.34-88.71] 
126.24 
 [125.93-127.22] 
9 90.94 [90.21-91.49] 91.11 [88.10-94.84] 88.57 [84.85-93.12] 
104.71  
[100.44-106.89] 
 ErsVent (cmH2O/l), Median [IQR] 
 PEEP 5 PEEP 10 PEEP 15 PEEP 20 
ARDS5 
127.50  
[126.60-127.73] 
142.71  
[133.29-152.59] 
129.25  
[121.23-150.26] 
146.11 
 [142.47-154.94] 
ARDS6 
121.16  
[120.86-121.40] 
121.11  
[117.50-123.40] 
114.57  
[112.57-118.11] 
124.15  
[121.20-126.88] 
ARDS9 
180.85  
[179.16-181.82] 
168.34  
[167.48-171.25] 
156.59  
[155.64-160.63] 
152.37  
[149.78-156.62] 
 
 
Table 4.3: ErsIB for all 3 subjects in Phase 1 and Phase 3 (ARDS) using the integral-
based method of (Hann et al., 2005) 
 
ErsIB (cmH2O/l), Median [IQR] 
PEEP 5 PEEP 10 PEEP 15 PEEP 20 
5 58.72 [56.43-60.23] 62.06 [59.50-63.91] 75.52 [71.07-84.70] 
106.89  
[104.61-113.49] 
6 52.50 [52.16-53.15] 58.57 [56.35-60.25] 68.78 [66.18-74.68] 
109.26  
[108.10-111.35] 
9 71.86 [71.42-72.12] 67.47 [65.68-70.53] 69.27 [66.27-74.49] 84.97 [81.36-88.76] 
 ErsIB (cmH2O/l), Median [IQR] 
 PEEP 5 PEEP 10 PEEP 15 PEEP 20 
ARDS5 
108.85  
[106.92-111.34] 
123.40  
[117.70-130.76] 
109.87  
[105.80-130.40] 
128.36  
[123.04-141.69] 
ARDS6 
113.46  
[112.26-114.57] 
114.71  
[113.85-116.69] 
112.95  
[109.38-117.03] 
119.71  
[117.17-122.98] 
ARDS9 
122.25  
[119.74-126.14] 
134.29  
[132.00-136.58] 
132.88  
[131.13-137.13] 
131.83  
[128.85-136.59] 
 
Table 4.4: RrsIB for all 3 subjects in Phase 1 and Phase 3 (ARDS) using the integral-
based method of (Hann et al., 2005) 
 
RrsIB (cmH2Os/l) Median [IQR] 
PEEP 5 PEEP 10 PEEP 15 PEEP 20 
5 10.99 [10.71-12.64] 8.17 [7.20-9.97] 5.73 [4.59-7.52] 7.88 [5.53-8.85] 
6 18.17 [17.87-18.52] 13.30 [12.71-13.53] 9.54 [9.26-9.67] 6.33 [6.29-6.55] 
9 16.89 [16.71-17.04] 14.96 [14.83-16.67] 12.53 [12.38-12.81] 10.21 [10.13-10.52] 
 RrsIB (cmH2Os/l) Median [IQR] 
 PEEP 5 PEEP 10 PEEP 15 PEEP 20 
ARDS5 13.64 [12.60-14.47] 7.24 [6.31-8.44] 6.30 [5.51-7.18] 6.13 [5.48-7.43] 
ARDS6 15.29 [14.13-15.95] 8.77 [6.81-10.56] 4.69 [2.92-4.99] 4.45 [2.18-4.66] 
ARDS9 53.11 [51.55-54.32] 36.88 [36.18-37.96] 27.02 [25.45-28.05] 19.92 [18.42-20.95] 
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In this study, the highest airway pressure (70 cmH2O) was observed at PEEP 20 
cmH2O. Theoretically, airway pressure that exceeds 45 cmH2O, potentially causes 
alveolar overdistension and ventilator induced lung injury (VILI) (Chiumello et al., 
2008, Caironi et al., 2010). However, recent studies by Borges et al using recruitment 
manoeuvres with airway pressures up to 60 cmH2O reversed ARDS lung collapse, 
without inducing lung injury (Borges et al., 2006, de Matos et al., 2012). This finding 
confirms that the airway pressure alone does not necessarily represent the alveolar 
pressure well, given high airway resistance. 
 
In this study, airway resistance (RrsIB) was subject-specific and high. Therefore, 
monitoring model-based respiratory mechanics which identifies a subject-specific 
airway resistance (RrsIB) can provide a better indication of alveolar condition, and thus 
better protection in overdistension. In contrast, the conventional approach of 
identifying ErsVent alone does not segregate this effect, resulting in potentially 
misleading results and less insight. 
 
4.4.3 Recruitment Manoeuvre - Phase 1 and Phase 3 
Figure 4.3 show the RM results in Phase 1. Increased respiratory elastance was 
observed at the start of every increase in PEEP. As the breathing pattern stabilises, 
respiratory elastance slowly decreases to a specific minimum at that PEEP level. 
Decrease of elastance over time can be described by the lung’s viscoelastic properties, 
which causes hysteresis (Ganzert et al., 2009, Andreassen et al., 2010). Equally, PEEP 
induced recruitment is time dependant, and will contribute to prolonging the 
stabilisation period (Albert et al., 2009).  
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In this animal trial, it was also found that decreasing PEEP titration resulted in lower 
overall respiratory elastance compared to increasing PEEP titration, as shown in 
Figures 4.3 and 4.4. When PEEP is increased to a higher level, recruitment, as well as 
potential lung overstretching, occurs. However, after PEEP is decreased from a higher 
PEEP value, the lung remained compliant. This observation is supported by several 
studies that showed PEEP titration should be performed after recruitment manoeuvres 
to keep the lung open (Lachmann, 1992, Halter et al., 2003, Huh et al., 2009, Suarez-
Sipmann and Bohm, 2009, Hodgson et al., 2011b, Hodgson et al., 2011a). Hence, the 
model is capturing clinically observed and relevant behaviours. 
 
During PEEP titration in Phase 3, subject-specific respiratory elastance drops to an 
overall minimum at specific PEEP (PEEP = 15 cmH2O for Subjects 5 and 6, and 
PEEP = 5 cmH2O for Subject 9). Setting PEEP at minimum elastance theoretically 
benefits ventilation by maximising recruitment, reducing work of breathing and 
avoiding overdistension, as shown in previous works (Carvalho et al., 2007, Suarez-
Sipmann et al., 2007, Lambermont et al., 2008, Zhao et al., 2010a).  It should also be 
noted that, the methods for PEEP titration between these works are different. Studies 
by Lambermont, Carvalho and Suarez-Sipmann (Lambermont et al., 2008, Carvalho 
et al., 2007, Suarez-Sipmann et al., 2007) used decreasing PEEP titration after a 
recruitment manoeuvre, whereas Zhao (Zhao et al., 2010a) used increasing PEEP 
titration to monitor respiratory elastance with shorter stabilisation period. However, 
the overall result and trends were consistent, and are captured by this model in these 
experiments. 
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Figure 4.3: Respiratory system mechanics monitoring of during Phase 1, healthy state 
recruitment manoeuvre. The recruitment manoeuvre is separated by increasing PEEP 
and decreasing PEEP changes. (Top) Subject 5, (Middle) Subject 6 and (Bottom) 
Subject 9.  
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Figure 4.4: Respiratory system mechanics monitoring of during Phase 3, ARDS 
recruitment manoeuvre. The recruitment manoeuvre is separated by increasing PEEP 
and decreasing PEEP changes. (Top) Subject 5, (Middle) Subject 6 and (Bottom) 
Subject 9. 
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Recruitment is a function of PEEP and time (Barbas et al., 2005, Albert et al., 2009), 
and, equally, the ARDS affected lung is prone to collapse due to the instability of 
ARDS affected lung units (Pelosi et al., 2001, Halter et al., 2003). That said, 
respiratory elastance during increasing PEEP titrations is expected to reduce as time 
progress to achieve stability and in contrast, elastance will increase with time during 
decreased PEEP to achieve stability, assuming that the severity of ARDS does not 
change during the process. However, this study found that minimum elastance occurs 
at a similar PEEP in both increasing and decreasing PEEP titration. Thus, the authors 
hypothesise that PEEP can be titrated to a minimum elastance either way, provided a 
stabilisation period is given at each PEEP level to obtain the true minimal elastance. 
Hence, these results provide first insight into how the model can be used to capture 
relevant dynamics and subsequently guide decision making. 
 
Identified airway resistance decreases were seen consistently in Subjects 5 and 6 with 
varying PEEP (Mols et al., 2001). However, in Subject 9 the airway resistance was 
lowest at higher PEEP, suggesting that increasing PEEP was opening up the 
respiratory system airways in this subject resulting in airway resistance drop. This 
finding coincides with several studies reporting lower airway resistance at high PEEP 
(Suarez-Sipmann et al., 2007, Mols et al., 2001, Carvalho et al., 2007). The results 
highlight both the patient/ subject-specificity of the model, as well as the significant 
inter-subject variability that defines MV patient in general. The change of airway 
resistance in Subject 9, Phase 3 indirectly affects the estimated model-based estimated 
elastance, resulting in different trend than ventilator calculated elastance. 
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4.4.4 Disease Progression - Phase 2 
The comparison for the model-based estimated respiratory mechanics and 
conventional method is presented in Figure 4.5. It was found that Subjects 6 and 9 
were diagnosed with ARDS after 60 ~70 minutes, whereas Subject 5 took more than 2 
hours to develop ARDS. The difference in ARDS progression over time indicates the 
inter-subject variability response to oleic acid, as well as variability to MV (Schuster, 
1994, Ware, 2008, Bastarache and Blackwell, 2009, Ballard-Croft et al., 2012). 
Disease progression was captured in this study by tracking the parameter of the single 
compartment model.  
 
After oleic acid injection, it was found that the respiratory elastance gradually 
increases in 2 basic steps in Figure 4.5 as ARDS develops. After being diagnosed with 
ARDS (with PF ratio < 200), the respiratory elastance is as high as two times (2X) the 
initial elastance. These two steps shows a slow and then rapid change. Hence, the 
ability to capture this subject-specific progression at this resolution indicates the 
ability of the model to track progression with high resolution and thus to potentially 
intervene in the process.  
 
 
  
71 
 
 
 
 
Figure 4.5: Respiratory system mechanics monitoring of during Phase 2, ARDS 
progression. (Top) Subject 5, (Middle) Subject 6 and (Bottom) Subject 9. 
 
  
72 
 
The single compartment lung model has demonstrated its robustness in monitoring 
subject’s respiratory mechanics continuously with fitting error less than 10%. The 
model is less descriptive compared to highly complex models (Tawhai et al., 2004, 
Tawhai et al., 2009, Bates, 2009b, Schranz et al., 2010), unable to determine the intra-
lung ventilation inhomogeneity, alveolar opening pressure (Sundaresan et al., 2009) 
or the viscoelastic properties of the lung (Schranz et al., 2011). However, comparing 
the trends of model-based elastance and examining identified airway resistances, it 
was able to provide sufficient and, importantly, clinically relevant physiological 
insight not readily available at the bedside to guide MV therapy in ICU. The model-
based method was also able to better define the observed dynamics than the 
conventional method (ErsVent), particularly in capturing the nonlinear effect of the 
respiratory mechanics. All these results show its potential to augment and aid clinical 
decision making.  
 
4.4.5 Validation of Model-Based Methods using Automated End of Inspiratory 
Pause 
The Engström CareStation ventilator (Datex, General Electric Healthcare, Finland) 
automates short end inspiratory pause (EIP) in MV patients (Ingelstedt et al., 1972, 
Fuleihan et al., 1976, Pillet et al., 1993). This finite pause at the end of inspiratory 
enables a zero-flow phase that prolongs inspiration, retaining the inspired tidal 
volume in the lung for a longer period. The prolonged inspiration time allows the 
inspired tidal volume to distribute evenly in the lung and have resulted in improved 
alveolar ventilation (Fuleihan et al., 1976, Lindahl, 1979, Baehrendtz, 1985, Pillet et 
al., 1993, Devaquet et al., 2008).  
  
73 
 
Table 4.5 and 4.6 show EStatic and RStatic derived directly from the ventilator using 
automated EIP. It was found that both elastance and resistance are different between 
model-based methods and measured ventilators values. The overall EStatic is higher 
than ErsIB whereas the ventilator RStatic is lower than RrsIB. However, ErsIB has similar 
trend to EStatic, and RrsIB showed similar trend to RStatic. An example of the trend 
comparison between EStatic and ErsIB, RStatic and RrsIB for Subject 6 Phase 1 is shown in 
Figure 4.6. The trend comparison in EStatic and ErsIB, RStatic and RrsIB for all other cases 
are included in Appendix 01 for further reference. 
 
Table 4.5: EStatic for all 3 subjects in Phase 1 and Phase 3 (ARDS) using automated 
EIP in modern ventilators 
Subject 
EStatic (cmH2O/l), Median [IQR] 
PEEP 5 PEEP 10 PEEP 15 PEEP 20 
5 59.50 [57.90-59.84] 65.25 [61.77-66.55] 77.39 [73.43-82.69] 
122.27  
[118.59-123.28] 
6 58.57 [57.99-59.28] 63.12 [61.37-63.69] 72.28 [70.92-75.44] 
117.21 
[116.86-118.19] 
9 70.33 [48.86-70.96] 74.94 [72.35-78.25] 74.64 [71.17-78.68] 91.42 [87.99-93.00] 
 EStatic(cmH2O/l), Median [IQR] 
 PEEP 5 PEEP 10 PEEP 15 PEEP 20 
ARDS5 
111.64 
[110.75-113.35] 
128.10 
[120.12-138.25] 
111.13 
[105.72-122.94] 
132.86 
[128.38-140.28] 
ARDS6 
108.37  
[107.70-109.27] 
110.35 
[107.20-113.16] 
105.56 
[103.80-108.28] 
117.19 
[114.99-119.86] 
ARDS9 
157.08 
[155.43-158.40] 
147.37 
[147.12-148.91] 
138.62 
[136.58-142.21] 
138.49 
[134.65-141.48] 
 
Table 4.6: RStatic for all 3 subjects in Phase 1 and Phase 3 (ARDS) using modern 
ventilators 
 
RStatic (cmH2Os/l) Median [IQR] 
PEEP 5 PEEP 10 PEEP 15 PEEP 20 
5 11.38 [10.16-12.43] 9.51 [9.35-9.81] 9.22 [8.17-10.20] 6.42 [5.90-7.24] 
6 11.19 [11.10-11.67] 9.32 [9.04-9.59] 8.61 [8.46-9.32] 6.34 [5.83-6.83] 
9 20.12 [19.27-42.49] 13.19 [12.30-13.66] 10.84 [10.47-11.05] 9.53 [8.98-10.05] 
 RStatic(cmH2Os/l) Median [IQR] 
 PEEP 5 PEEP 10 PEEP 15 PEEP 20 
ARDS5 11.42 [10.80-11.77] 10.31 [9.61-10.63] 10.23 [9.56-13.69] 9.57 [8.82-10.23] 
ARDS6 9.35 [9.08-9.59] 7.91 [7.68-8.44] 6.67 [6.29-7.07] 4.91 [4.40-5.15] 
ARDS9 16.02 [15.47-17.52] 14.79 [14.05-15.81] 12.64 [12.41-13.72] 10.55 [10.32-11.31] 
  
74 
 
 
Figure 4.6: Comparison between ventilator measured EStatic and RStatic with model-
based ErsIB and RrsIB for Subject 6, Phase 1. The elastance and resistance between two 
methods are different but have showed similar trend. 
 
 
While the automated EIP feature in ventilator provides a simpler way to measure 
‘static’ elastance and resistance, this mode of ventilation is not normally available in 
other ventilators. In addition, this method may be erroness in some cases because the 
automated end inspiratory pause is too short and does not allow peak pressure to drop 
to the true plateau pressure (Barberis et al., 2003). Figure 4.7 shows an example of 
further drop in plateau pressure to a true plateau pressure if a longer EIP is performed 
on an experimental subject (Barberis et al., 2003). The true plateau pressure will 
decrease EStatic and increase RStatic resulting in more similar values to model-based 
ErsIB and RrsIB. Nevertheless, the automated EIP method is comparatively less invasive 
which allows a surrogate of airway resistance and static elastance to be estimated. In 
summary, the model-based method was able to capture respiratory mechanics similar 
to the modern ventilators, thus further validates the model-based findings. 
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Figure 4.7: Pressure and flow profile with automated short end inspiratory pause 
(Area shaded grey). During end of inspiration pause, the airway pressure decreases 
from peak pressure to plateau pressure. This pressure difference is due to the airway 
resistance. A longer end of inspiratory pause enables true plateau pressure to be 
found. 
 
4.5 Study Limitations 
4.5.1 Variable ARDS 
In this study, it was found that 2 of 3 subjects showed similar respiratory mechanics 
trends. Subject 9 in particular, given a similar preparation method and similar 
protocol, resulted in different observed respiratory mechanics. The overall peak 
airway pressure of Subject 9 during ARDS state at baseline PEEP is much higher than 
in Subjects 5 and 6. The PEEP titration carried out in this work also does not show 
significant change in overall respiratory mechanics compared to Subject 5 and 6. 
Thus, we are unable to conclude the findings with statistical significance. However, 
the findings showed subject’s variable response to protocol and MV settings, and 
further encourages patient-specific MV treatment in ICU to optimise outcome. 
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4.5.2 Respiratory Mechanics Monitoring for Sedated Patients 
The application of single compartment lung model is limited to patients who are fully 
sedated and dependant on mechanical ventilation (Brochard et al., 2012). When a 
patients’ breathing effort is taken over by the ventilator, the mechanics of the patients 
breathing is similar to mechanics of the ventilator support, allowing the respiratory 
mechanics to be determined. However, this is not the case for spontaneously breathing 
patients. Spontaneous breathing patients have individual breathing efforts aside from 
ventilator support (Grinnan and Truwit, 2005), altering the respiratory mechanics. 
Hence additional equipment (e.g. oesophageal balloon catheters) may be required to 
best measure patient-specific mechanics and this overall approach thus requires 
further study to be extended to this cohort (Mead and Whittenberger, 1953, Benditt, 
2005, Talmor et al., 2006, Khirani et al., 2010). However, the methods presented are 
still viable for a large portion of the most ill and costly MV patients. 
 
4.6 Summary 
Respiratory system mechanics vary due to inter-subject variability in disease state 
development and in response to MV settings. A single compartment lung model with 
integral-based parameter identification was effective in capturing fundamental 
respiratory mechanics in all patients’ conditions (Healthy, Progression and ARDS). 
The trends match clinical expectation and provide better resolution commonly, 
clinically derived linear metrics, demonstrating the method’s robustness and potential 
to guide MV therapy. Overall, the results show the importance and potential of 
including continuous monitoring of respiratory mechanics in clinical practice to 
optimise mechanical ventilation. 
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ARDS animal models are more consistent where the methods of developing ARDS 
are known and controlled.  ICU patients, on the other hand, are comparatively more 
variable as the causes of disease are different and patients may be more inter-patient 
variable to treatment. Thus, the use of respiratory mechanics monitoring in actual 
patients needs to be tested in humans. In the next chapter, the investigation of the 
performance model-based method is further extended in clinical settings. It is a proof 
of concept study for the model’s applicability in actual ICU setting. A different 
clinical protocol which is used to examine patient’s respiratory mechanics is also 
developed to account for patient safety, feasibility and practicability. 
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Chapter 5 
Proof of Concept Study using Respiratory 
Mechanics Monitoring  
 
5.1 Implementation of Model-based Methods 
The fundamental of MV for ARDS patients remains in selecting an optimal positive 
end-expiratory pressure (PEEP) to maximise patient-specific lung recruitment, 
prevent alveoli collapse and avoid ventilator induced lung injury (VILI) (Slutsky, 
1999, Esteban et al., 2002, Gajic et al., 2004, Gullo et al., 2006, Desai and Deep, 2006, 
Girard and Bernard, 2007, Gattinoni et al., 2010).  Several attempts have been made 
to standardize MV, and in particular, PEEP selection (Levy, 2002, Meade et al., 2008, 
Mercat et al., 2008, Briel M and et al., 2010). However, due to inter-patient variability 
and intra-patient heterogeneity of ARDS, most have failed to deliver conclusive 
results on PEEP selection as discussed earlier in Chapter 2 (Ware and Matthay, 2000, 
Stenqvist, 2003, Suh et al., 2003, Esteban et al., 2005, Sundaresan and Chase, 2011). 
Thus, without a gold standard method for setting PEEP, clinicians rely on intuition 
and experience, leading to more variable care and outcomes. 
 
Model-based and patient-specific approaches offer the ability to identify intra- and 
inter-patient variability in real-time (breath-to-breath) and thus, potentially to guide 
MV therapy based on patient-specific conditions and needs (Sundaresan and Chase, 
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2011, Chase et al., 2011). This approach provides the opportunity to balance risk of 
lung injury and lung function support, and to reduce the work of breathing during MV 
(MacIntyre, 2008). However, to date, only a few such methods have been tested 
(Quaglini et al., 2001, Carvalho et al., 2007, Badet et al., 2009, Sundaresan et al., 
2011a, Kostic et al., 2011, Zannin et al., 2012) and their potential in critical care is not 
yet validated. 
 
This chapter further extends the studies of model-based approaches to identify 
patient-specific disease state and patient-specific response to MV therapy using 
patient-specific constant lung elastance (Ers = 1/ Compliance) as presented in Chapter 
4 (Suarez-Sipmann et al., 2007, Carvalho et al., 2007, Lambermont et al., 2008). In 
addition, the Equation 4.5 is further modified to calculate dynamic (sample-to-sample) 
lung elastance (Edrs) in ARDS within a breathing cycle.  The dynamic lung elastance 
(Edrs) is a time-variant lung elastance at each breath during MV. A metric that 
compares Ers and Edrs during PEEP change are thus proposed for guiding PEEP 
selection. By monitoring both the identified parameters (Elastance = 1/ Compliance) 
through limited PEEP titration, it is possible to identify PEEP settings that safely 
maximize recruitment, minimize elastance, and thus minimize the work of breathing 
without inducing lung injury. 
 
5.2 Study Design in Christchurch Hospital 
5.2.1 Patients 
Patients in the Intensive Care Unit (ICU), Christchurch Hospital, New Zealand, 
diagnosed with ARDS (Acute onset, findings of bilateral infiltrates on chest 
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radiograph, absence of left side heart failure and PaO2/FiO2 (PF ratio) between 150-
300 mmHg), are eligible for the study. The exclusion criteria for the study are: 1) 
Patients who were likely to be discontinued from MV in 24 hours; 2) Age < 16 years 
old; 3) Moribund and/ or not expected to survive for greater than 72 hours; and 4) 
Patient who are minimally sedated. 10 patients who were eligible for study underwent 
a modified recruitment manoeuvre (RM). 
 
Prior to the study, written informed consent was obtained from the patient, immediate 
family members or relatives. These trials and the use of the data were approved by the 
New Zealand, South Island Regional Ethics Committee (U1111-1125-7363). The trial 
is registered with Australian New Zealand Clinical Trials Registry (ACTRN 
12611001179921). 
 
5.2.2 Mechanical Ventilation and Data Acquisition 
All patients recruited for the study were intubated and ventilated using Puritan 
Bennett, PB840 ventilator (Covidien, Boulder, CO, USA). They are ventilated with 
volume control (tidal volume, Vt = 6~8 ml/kg), synchronized intermittent mandatory 
ventilation (SIMV) mode, throughout the trial. Patients were sedated and paralyzed 
with muscle relaxants to prevent spontaneous breathing efforts. Arterial blood gas 
(PaO2) was recorded at each clinically selected PEEP. This PEEP was selected by the 
attending doctor as they see fit. One arterial blood gas was taken before the RM and a 
second arterial blood gas sample is taken 30 minutes after the RM for comparison. 
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A pneumotachometer with Hamilton Medical flow sensor (Hamilton Medical, 
Switzerland) connected to the ventilator circuit Y-piece is used to record patient’s 
airway pressure and flow data. A Dell
TM
 (Dell, Austin, TX, USA) laptop was used in 
conjunction with National Instruments USB6009 and Labview Signal Express 
(National Instruments, Austin, TX, USA) to obtain measurements at a sampling rate 
of 100Hz. Analysis was performed using MATLAB (The Mathworks, Natick, 
Massachusetts, USA). 
 
5.2.3 Clinical Protocol - Modified Recruitment Manoeuvre (RM) 
At the start of the RM, the clinically selected PEEP is decreased to zero PEEP for 5 
breathing cycles. The clinically selected PEEP is determined by the attending 
clinicians as they see fit. At the end of the 5
th
 breath, an end expiratory hold is 
performed to obtain the alveolar intrinsic PEEP (Auto-PEEP) (Rossi et al., 1995). An 
end inspiratory pause is also performed to obtain plateau pressure for resistance 
calculations (Barberis et al., 2003). PEEP is then increased with increments of 5 
cmH2O from PEEP = 0 cmH2O (ZEEP) until peak airway pressure (PIP) reaches a 
limit of 45 cmH2O (Gattinoni et al., 2006a). Every subsequent PEEP level was 
maintained for 5 breathing cycle before increasing to a higher PEEP. PIP of 45 
cmH2O is set as a threshold safety to avoid any possible overdistension. After 
reaching PIP 45 cmH2O, PEEP is reduced by steps of 5 cmH2O to the clinically 
selected PEEP. Throughout the trial, other ventilator settings were not changed. 
 
Through continuous monitoring of airway pressure and flow data, the volume of air 
entering the lung can be calculated by integrating flow with time. Thus, the patient-
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specific lung volume increase corresponding to PEEP increase can be calculated. The 
minimum lung volume at the beginning of a breathing cycle at different PEEP level 
with reference to atmospheric pressure is denoted as dynamic functional residual 
capacity (dFRC) (Desaive et al., 2009, Sundaresan et al., 2011b).  
 
5.2.4 Single Compartment Model 
The model-based approach presented in Chapter 4 in Equations 4.4-4.5 is used to 
estimate patient-specific respiratory elastance and resistance. These two equations are 
renumbered as Equation 5.1 and 5.2. Patient-specific respiratory elastance denoted Ers 
reflects the lung stiffness (1/Compliance). Therefore, a lower Ers indicates a more 
compliant lung. Airway resistance is denoted as Rrs. 
 
 Paw(t) = Rrs ×  Q(t) + Ers ×  V(t)     (5.1) 
 Paw(t) = Rrs ×  Q(t) + Ers ×  V(t) + P0     (5.2) 
 
Next, Ers in Equation 5.2 can be replaced with time-variant dynamic respiratory 
elastance, Edrs(t). Thus, Equation 5.2 can be modified into: 
  
 Paw(t) = Rrs ×  Q(t) + Edrs(t) ×  V(t)+ P0    (5.3) 
 
Compared to a single, constant Ers value at each PEEP, identifying time-variant Edrs 
allows this change to be seen dynamically within each breath as pressure increases. 
This approach enables a more detailed view of patient-specific lung physiological 
condition and response to MV. To ensure that the identified parameters of constant Ers 
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and time-variant Edrs are valid, the absolute percentage error (APE) between the 
identified model and measured clinical pressure data is reported.  
 
5.2.5 PEEP Selection Metric 
During each breathing cycle, as PEEP rises, lung elastance (Ers) falls as new lung 
volume is recruited faster than the pressure build-ups in the lung. If little or no 
recruitment occurs, Ers rises with PEEP, indicating that pressure above that PEEP 
level was unable to recruit significant new lung volume and is, instead, beginning to 
stretch already recruited lung units (Vieira et al., 1998). Hence, recruitment and 
potential lung injury can be balanced by selecting PEEP at minimum Ers or Edrs 
(Carvalho et al., 2007). Three model-based approaches based on patient-specific Ers 
and Edrs trajectory in a patient’s breath at different PEEP levels are used to optimize 
PEEP selection. 
  
a) Minimum Edrs and Ers - Locates the point where minimum time-varying Edrs or 
constant Ers occurs over all PEEP values (and pressure for Edrs) during the recruitment 
manoeuvre.  
b) Minimum Edrs Area - Edrs Area is obtained by integrating time-varying Edrs over 
time during the patient’s breathing cycle at each PEEP. Edrs Area is more clinically 
relevant than median or mean Edrs throughout each breath and can be shown to be 
proportional to patient-specific work of breathing. 
c) Inflection Method - This method detects the inflection in the Edrs Area-PEEP and 
Ers-PEEP curves. Inflection is defined here at the PEEP value with Edrs value 5-10% 
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above (before) minimum Edrs Area or Ers (105~110% of minimum Edrs Area or Ers). 
PEEP is selected where inflection occurs, as a point of diminishing returns. 
 
The overall approach implies that as long as Ers or Edrs falls during each breath, as 
PEEP level increases, that recruitment of new volume outweighs lung stretching as 
flow and volume follow a path of lesser or least resistance. These methods are thus 
attempts to maximize recruitment (Minimum Edrs and Minimum Edrs Area) and also 
ensure safety from excessive pressure (Inflection Method). These metrics are three of 
many possibilities which can be defined here to demonstrate the concept in a 
clinically relevant fashion. The PEEP selected is compared to the clinically selected 
PEEP value to assess the opportunity for improvement in this non-intervention trial. 
 
5.2.6 Edrs Area and Work of Breathing 
These approaches were also compared with selecting PEEP using the identified 
minimum or inflection of constant Ers, for comparison to other similar work (Carvalho 
et al., 2007). Patient-specific Ers and Edrs are only analyzed during inspiration and not 
during the expiratory cycle. This choice was made because increases in pressure 
induce both recruitment and lung damage as it passes a limit, and thus expiration 
(decreasing pressure) should not be used to guide PEEP selection in respect. 
 
A higher resolution of the trend changes in Edrs can be observed using Edrs Area. Edrs 
Area is obtained through integration of Edrs with time. It is also known that the work 
of breathing (WOB) (Otis et al., 1950, Marini et al., 1985) for a patient is proportional 
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to lung elastance. In general, more work is required to fill a given lung volume with 
higher elastance. WOB is defined:  
 
 WOB = Paw ×  V       (5.4) 
 
Substituting Paw from Equation (5.3) into Equation (5.4) and using P0 = 0, 
(atmospheric). The work of breathing can be defined as: 
 
 WOB= (ErsV + RrsQ) ×  V = ErsV
2
 + RrsQ V    (5.5) 
 
From Equation (5.5), work of breathing can be divided into work to overcome lung 
elastance (WOBE = ErsV
2
) (Grinnan and Truwit, 2005, Kallet et al., 2007) and work to 
overcome airway resistance (WOBR = RrsQV). Substitution of dynamic lung elastance, 
Edrs, for constant Ers enables a derivation for WOBE: 
 
 Edrs = WOBE(t) / V(t)
2
       (5.6) 
 
Edrs Area in Equation 5.7 is the integral of Equation 5.6, yielding the relation of Edrs to 
WOB required to overcome lung elastance at a given level of PEEP and mode of MV. 
  
Edrs Area = ʃEdrs(t) dt       (5.7) 
 
Equation 5.7 clearly relates WOBE and Edrs, thus showing the relation of Edrs to a 
clinically relevant metric that is commonly used. 
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5.2.7  Analysis and Comparisons 
Ers and median Edrs are compared using Pearson’s linear correlation coefficients to 
relate these metrics. Ers and Edrs Area (ʃEdrs) are also compared to median Edrs and 
WOBE to ensure there was no loss of information for each patient at different PEEP 
values, and to show the validity of Equation 5.6 and using Edrs Area. Finally, 
clinically selected PEEP is compared to the value determined by proposed model-
based metrics.  
 
5.3 Results and Discussion 
5.3.1 PaO2 Before and After RM 
The patient demography with their clinical diagnosis, including PaO2 before and after 
the RM are shown in Table 5.1. It was found that PaO2 for 7 out of 10 patient 
decreased from 84.0 mmHg [IQR: 73.0-114.0] to 77.5 mmHg [IQR: 68.0-86.0], 30 
minutes after recruitment manoeuvre (p > 0.005). While not statistically significant, 
this result contradicts other reports (Tusman et al., 1999, Gattinoni et al., 2006a, 
Hodgson et al., 2011a) that showed significant increase in PaO2 after RM. It is 
hypothesised that 30 minutes after the RM were insufficient for perfusion to occur 
fully. Similarly, this result can be an indication of the level of lung injury, in which 
some patients are not responsive to RM (Gattinoni et al., 2006a, Caironi et al., 2010). 
This issue should be considered in future clinical trials when monitoring arterial blood 
gas information. In particular, arterial blood gas should be monitored over a longer 
period with additional time steps (15, 30, 45, 60, 90, 120 minutes after a RM (Tusman 
et al., 1999)), to verify and confirm the hypothesis. 
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Table 5.1: Patient demography 
P
a
ti
en
t Sex Age 
(year) 
Clinical Diagnostic PF Ratio 
(mmHg) 
FiO2 PaO2 
Before RM 
(mmHg) 
PaO2,  
30 minutes  
After RM 
 
1 F 61 Peritonitis, COPD* 209 0.35 73 60 
2 M 22 Trauma 170  0.50 85 73 
3 M 55 Aspiration 223 0.35 78 76 
4 M 88 Pneumonia, COPD* 165 0.40 66 56 
5 M 59 Pneumonia, COPD* 285 0.40 114 79 
6 M 69 Trauma (Abdominal 
Sepsis) 
280 0.35 98 118 
7 M 56 Legionnaires 265 0.55 146 68 
8 F 54 Aspiration 303 0.40 121 106 
9 M 37 H1N1, COPD* 183 0.40 73 86 
10 M 56 Legionnaires, COPD* 237 0.35 83 83 
Median 
[IQR] 
    84.0  
[73.0-114.0] 
77.5 
[68.0-86.0] 
*COPD - Chronic obstructive pulmonary disease; PF Ratio - Partial pressure of oxygen in arterial 
blood/ fraction of inspired oxygen; FiO2 - Fraction of inspired oxygen; PaO2 - Partial pressure of 
oxygen in arterial blood; RM - Recruitment manoeuvre, H1N1 - Swine flu 
 
5.3.2 Model Fitting 
Table 5.2-5.4 shows the median [Inter-quartile Range (IQR)] Edrs, Ers and Edrs Area 
for each patient and PEEP, and absolute percentage fitting error (APE). Median 
absolute percentage fitting error (APEEdrs(t)) across all patients and PEEP is 0.9% 
[IQR: 0.5-2.4]. Median fitting error for time-variant Edrs is less than 1%, showing that 
a single compartment lung model can be used for time-varying Edrs estimation. 
Compared to the estimation of Ers in Table 5.3, median fitting error is 5.6% [IQR: 1.8-
11.3] and in specific cases, fitting error can be as high as 15.7-17.7% (Patients 4 and 
5). This latter result indicates that a first order model can be used to estimate most 
patient-specific constant Ers, but, in several cases, the model may not accurately 
represent patients’ physiological dynamic and condition. Time-varying Edrs provides a 
better model fit across all patients and also provides a clearer insight into the patient’s 
physiological condition, and is thus the better model-based metric.  
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Table 5.2: Patient-specific dynamic lung elastance (Edrs) at each PEEP level 
Patient 
Dynamic Lung Elastance, Edrs (cmH2O/l) Median [IQR]  Edrs 
(cmH2O/l) 
Median 
[IQR] 
APE+ 
(%) 
Median 
[IQR] 
PEEP (cmH2O) 
0 5 10 15 20 25 30 
1 
63.1 
[46.9-114.9] 
53.8 
[43.0-80.2] 
43.6 
[38.4-54.5] 
35.0 
[33.3-39.4] 
33.4 
[32.0-34.2] 
31.1 
[32.0-32.4] 
PEEP 27 
32.2 
[31.9-32.6] 
35.0 
[32.5-51.2] 
1.1 
[0.5-4.1] 
2 
30.8 
[26.3-45.1] 
26.4 
[23.7-31.4] 
23.1 
[22.0-24.3] 
22.1 
[22.0-22.6] 
22.5 
[22.4-22.6] 
PEEP 22 
23.1 
[22.9-23.2] 
 
23.1 
[22.5-26.4] 
0.7 
[0.6-2.4] 
3 
26.9 
[22.6-36.9] 
22.1 
[20.2-25.6] 
18.3 
[18.0-19.0] 
17.3 
[17.2-17.4] 
17.5 
[17.1-17.5] 
17.8 
[17.4-18.7] 
PEEP 28 
19.2 
[17.9-19.7] 
18.3 
[17.6-21.4] 
0.6 
[0.5-1.3] 
4 
73.2 
[50.4-144.4] 
70.4 
[49.9-126.9] 
54.5 
[41.7-82.3] 
36.8 
[30.6-43.9] 
28.5 
[25.6-31.4] 
25.9 
[21.6-28.4] 
23.1 
[19.4-25.5] 
36.8 
[26.6-66.4] 
3.4 
[0.9-5.4] 
5 
105.7 
[80.6-199.8] 
97.8 
[77.5-166.8] 
89.3 
[74.3-143.4] 
79.4 
[68.6-107.3] 
67.3 
[61.4-79.4] 
52.3 
[52.0-55.8] 
 
84.4 
[67.3-97.8] 
3.2 
[0.9-6.0] 
6 
30.4 
[25.9-39.1] 
26.2 
[25.5-27.2] 
23.3 
[22.4-23.5] 
21.6 
[21.5-21.8] 
21.8 
[21.3-22.5] 
23.3 
[22.6-23.9] 
 
23.3 
[21.8-26.2] 
0.8 
[0.6-1.2] 
7 
49.3 
[46.1-62.4] 
42.2 
[41.5-43.1] 
44.3 
[41.8-47.7] 
53.6 
[48.8-59.7] 
PEEP 16 
52.4 
[50.3-57.6] 
  
49.3 
[43.8-52.7] 
1.6 
[1.3-2.0] 
8 
45.7 
[37.9-67.8] 
37.2 
[32.9-43.0] 
31.8 
[29.9-33.5] 
28.8 
[28.0-29.8] 
27.4 
[27.1-27.9] 
26.8 
[26.3-27.0] 
27.0 
[26.8-27.5] 
28.8 
[27.1-35.9] 
0.8 
[0.5-2.2] 
9 
58.1 
[47.1-100.8] 
40.5 
[36.4-52.8] 
39.9 
[35.8-48.7] 
31.2 
[30.2-33.6] 
28.3 
[27.9-29.0] 
26.3 
[26.3-26.5] 
26.2 
[25.8-26.5] 
31.2 
[26.8-40.4] 
0.8 
[0.4-2.1] 
10 
54.4 
[48.1-76.2] 
45.2 
[41.9-51.8] 
39.4 
[38.4-41.7] 
35.9 
[35.7-36.0] 
33.9 
[33.7-34.1] 
33.9 
[33.4-34.6] 
PEEP 27 
33.9 
[33.2-34.8] 
35.9 
[33.9-43.8] 
0.4 
[0.4-0.9] 
Median 
[IQR] 
51.9 
[30.8-63.1] 
41.4 
[26.4-53.8] 
39.7 
[23.3-44.3] 
33.1 
[22.1-36.8] 
28.4* 
[22.5-33.9] 
26.3* 
[23.1-32.2] 
26.6* 
[23.1-32.2] 
32.2 
[26.1-46.6] 
0.9 
[0.5-2.4] 
+APE - Absolute percentage fitting error, *Values presented include value from different PEEP. Eg. PEEP 16 is included in PEEP 20 Median [IQR] 
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Table 5.3: Patient-specific constant lung elastance (Ers) at different PEEP 
Patient 
Constant Lung Elastance, Ers (cmH2O/l) Ers 
(cmH2O/l) 
Median 
[IQR] 
APE  
(%) 
Median 
[IQR] 
PEEP (cmH2O) 
0 5 10 15 20 25 30 
1 53.8 47.0 41.2 32.8 32.8 32.1 
PEEP 27 
32.2 
34.7 
[32.4-45.5] 
7.2 
[1.7-19.0] 
2 27.7 25.3 22.8 22.3 22.6 
PEEP 22 
23.1 
 
23.0 
[22.6-25.3] 
2.5  
[1.1-7.7] 
3 24.0 21.6 18.3 17.3 17.4 18.1 
PEEP 28 
19.1 
18.3 
 [17.6-20.9] 
4.2  
[1.6-6.6] 
4 60.2 59.7 50.1 35.1 27.8 25.3 22.5 
35.1 
 [25.9-57.3] 
17.7  
[15.4-32.1] 
5 87.4 84.0 81.2 74.3 65.7 53.1  
77.8 
 [65.7-84.0] 
15.7 
[9.2-19.8] 
6 27.1 25.5 22.8 21.6 21.8 23.4  
23.1 
[21.8-25.5] 
2.7 
[2.2-4.2] 
7 47.7 42.5 45.5 55.7 
PEEP 16 
55.3 
  
47.7 
 [44.8-55.4] 
6.2 
[5.0-7.7] 
8 41.7 35.5 31.2 28.7 27.5 26.6 27.0 
28.7  
[27.2-34.4] 
2.9 
[1.3-8.7] 
9 51.3 39.1 38.2 31.1 28.2 26.2 26.1 
29.7 
[26.2-38.7] 
3.1 
[1.0-10.8] 
10 51.0 44.1 39.2 35.8 33.9 34.0 
PEEP 27 
34.2 
35.8  
[34.1-42.9] 
2.0 
[1.0-5.6] 
Median 
[IQR] 
49.4 
[27.7-53.8] 
40.8  
[25.5-47.0] 
38.7 
[22.8-45.5] 
31.9 
[22.3-35.5] 
28.0* 
[22.6-33.9] 
26.2* 
[23.3-32.6] 
26.6*  
[22.5-32.2] 
32.2  
[25.0-45.9] 
5.6 
[1.8-11.3] 
*Values presented include value from different PEEP. Eg. PEEP 16 is included in PEEP 20 Median [IQR] 
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Table 5.4: Patient-specific Edrs Area at different PEEP 
Patient 
Edrs Area (cmH2Os/l) Edrs Area 
(cmH2Os/l) 
Median [IQR] 
PEEP (cmH2O) 
0 5 10 15 20 25 30 
1 84.6 49.5 37.1 28.9 26.6 25.7 
PEEP 27 
25.7 
28.9 
[25.9-46.4] 
2 34.0 24.8 21.0 20.2 20.3 
PEEP 22 
20.7 
 
20.9 
[20.3-24.8] 
3 37.7 27.6 22.2 20.8 19.1 19.7 
PEEP 28 
18.9 
20.8 
[19.3-26.3] 
4 102.2 91.2 61.7 37.9 31.7 48.1 47.5 
48.1 
[40.3-83.8] 
5 118.7 99.9 89.1 70.6 75.7 42.9  
82.4 
[70.6-99.9] 
6 29.4 23.8 20.8 21.6 19.5 20.8  
21.2 
[20.8-23.8] 
7 37.6 33.8 31.3 37.9 
PEEP 16 
32.1 
  
33.8 
[31.9-37.7] 
8 55.1 38.5 32.0 29.0 27.5 24.1 24.3 
29.0 
[25.1-36.9] 
9 106.5 55.2 51.3 38.3 34.1 31.6 31.3 
38.4 
[32.2-54.2] 
10 74.7 52.6 44.0 39.5 37.3 37.2 
PEEP 27 
37.3 
39.5 
[37.3-50.5] 
Median 
[IQR] 
64.9 
[37.6-102.2] 
44.0 
[27.6-55.2] 
34.6 
[22.2-51.3] 
33.5 
[21.6-38.4] 
29.6* 
[20.3-34.1] 
25.7* 
[20.8-38.6] 
28.5*  
[24.3-37.3] 
34.0 
[24.7-48.5] 
*Values presented include value from different PEEP. Eg. PEEP 16 is included in PEEP 20 Median [IQR]  
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5.3.3 Model-based Estimated Ers and Edrs 
The median Edrs is 32.2 cmH2O/l [IQR: 26.1-46.6].  Patients who suffer from COPD 
(Patients 1, 4, 5, 9 and 10) have significantly higher Edrs than others (p < 0.005), as 
expected clinically.  Similar to Edrs trend the constant Ers at each PEEP is 32.2 
cmH2O/l [IQR: 25.0-45.9] and Edrs Area at each PEEP is 34.0 cmH2Os/l [IQR: 24.7-
48.5]. The wide range of patient-specific Edrs across all patients and PEEP shown in 
Table 5.2 reflects the heterogeneity of ARDS patient condition and response to PEEP 
that makes standardising and PEEP selection difficult (Mercat et al., 2008).  
 
5.3.4 Effect of PEEP towards Patient-Specific Ers, Edrs and dFRC 
5.3.4.1 Overall  
Figure 5.1 shows the changes of Ers comparing to peak inspiratory pressure, dynamic 
functional residual capacity (dFRC) with PEEP increase. In the beginning of the 
recruitment manoeuvre, Figure 5.1 (Top), at ZEEP, Ers is relatively very high for all 
patients. As PEEP rises, it is observed that Ers drops, but at patient-specific rates. This 
Ers drop with PEEP increase trend coincides with previous PEEP titration studies in 
animal subjects (Carvalho et al., 2007, Suarez-Sipmann et al., 2007, Lambermont et 
al., 2008). It is observed that PIP did not increase significantly with PEEP increase. 
Both Ers and PIP trends suggest recruitment, with increase of lung volume, and thus 
relatively little peak pressure increase. The dFRC shown in Figure 5.1 (Bottom) 
increases with PEEP and follows a sigmoidal curve that is similar to the static 
compliance curve (Venegas et al., 1998). dFRC is the lung volume at PEEP where 
zero flow occurs, and thus, it is a surrogate for patient-specific static compliance. The 
dFRC trends in this study suggested overstretching of the lung at high PEEP. This 
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result is similar to the results presented by Lambermont et al, where the changes in 
functional residual capacity decreased after a certain PEEP level is reached 
(Lambermont et al., 2008). 
 
 
 
 
Figure 5.1: Ers-PEEP, PIP-PEEP and dFRC-PEEP plot. (Top) Ers range for the 10 
patients with PEEP increase. (Middle) PIP range for the 10 patients with PEEP 
increase. (Bottom) dFRC range for the 10 patients with PEEP increase. 
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Table 5.2 shows median [IQR] Edrs for every patient and PEEP. The IQR range drops 
significantly for every patient as PEEP increases. This range is an indication of the 
lung response to pressure. A small IQR range indicates that the lung is ventilated at a 
PEEP level where maximal lung recruitment occurs over a narrow pressure range as 
tidal volume, Vt is fixed in the MV mode used. A high IQR range shows the opposite, 
indicating a more variable change in overall lung recruitment within a breath. 
 
5.3.4.2 Patient-Specific Finding 
Figure 5.2 shows patient-specific time-varying Edrs at each PEEP level for Patients 2, 
6, 8 and 10. Edrs decreases as pressure increases at each PEEP. However, at higher 
PEEP, this trend can reverse, indicating stretching exceeding recruitment of new lung 
volume. The optimal PEEP derived by minimum Edrs is indicated. Similar to Figure 
5.2, Figure 5.3-5.4 shows patient-specific Edrs Area and Ers for Patients 2, 6, 8 and 10 
with PEEP. The optimal PEEP is derived using minimum Edrs Area or minimum Ers 
and Inflection method with the band of 5-10% above minimum Edrs Area or minimum 
Ers shown by the dashed-lines. 
 
Edrs-Pressure-PEEP curves and Edrs Area decrease with increasing PEEP, lung 
pressure, and volume over each breath. In the beginning of the recruitment manoeuvre, 
at zero end-expiratory pressure (ZEEP), Edrs is relatively very high for all patients 
with median 51.9 cmH2O/l [IQR: 30.8-63.1]. In particular, chronic obstructive 
pulmonary disease (COPD) patients or patients with similar clinical features (Hoare 
and Lim, 2006) (Patients  1, 4, 5, 9 and 10) have initially the highest Edrs median, as 
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expected, from 63.1 cmH2O/l [IQR: 57.2-81.3] versus 30.8 cmH2O/l [IQR: 29.5-46.6] 
for the other patients  (p < 0.005).  
 
  
  
 
Figure 5.2: Dynamic lung elastance (Edrs)-Pressure-PEEP plot. (Top Left) Patient 2, 
(Top Right) Patient 6. Both patients show significant Edrs drop from lower zero PEEP 
to PEEP 15 cmH2O. Further increase of PEEP to 20 cmH2O shows increase of overall 
Edrs. (Bottom Left) Patient 8,  (Bottom Right) Patient 10. Both patients show a 
consistent drop in overall Edrs with increasing of PEEP and overall Edrs did not rise 
with PEEP for the entire ranged considered.  
 
As PEEP rises, it is observed that Edrs curves drop at patient-specific rates. High 
constant lung elastance, Ers at ZEEP and decreasing elastance as PEEP increments are 
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also observed in Figure 5.4 for Patient 10. COPD patient show the greatest drop as 
PEEP exceeds the pressure that opens their obstruction. Thus, the model detects this 
dynamic and can diagnose a suitable PEEP to reduce the obstruction effect.  
 
 
  
  
Figure 5.3: Edrs Area-PEEP plot. (Top Left) Patient 2, (Top Right) Patient 6. (Bottom 
Left) Patient 8,  (Bottom Right) Patient 10. Severe COPD or patients with similar 
clinical features (e.g. Patient 10) showed significantly higher Edrs Area compared to 
other patients. PEEP selection is based on minimum Edrs-Area and the inflection 
method with PEEP increase. 
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Figure 5.4: Ers-PEEP plot. (Top Left) Patient 2, (Top Right) Patient 6. (Bottom Left) 
Patient 8,  (Bottom Right) Patient 10. PEEP derived from Minimum Ers and Inflection 
method are as indicated. 
 
In all cases, patient-specific Edrs and Ers decrease to a patient-specific minimum 
before increasing at higher PEEP. Minimum Edrs and Ers suggest the point where the 
lung is most compliant, if ventilated at that PEEP level. Further increases in PEEP and 
pressure thus lead to increased Ers or Edrs, and thus increase detrimental effects. In 
particular, increases in Ers or Edrs can be associated with overstretching of the 
patient’s lung (Carvalho et al., 2006, Carvalho et al., 2007). However, the 
heterogeneity of ARDS means there is a possibility of overstretching of healthy lung 
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units even at low PEEP and airway pressures (Stenqvist, 2003). Thus, Minimum or, 
perhaps preferably, Inflection Edrs and Ers can provide a potentially higher resolution 
metric. 
 
Patients 2 and 6 (Figure 5.2-5.4: Top panels) are examples where patient-specific Edrs, 
Edrs Area and Ers increase after descending to a minimum. Results suggest that further 
increases of PEEP and inflation pressures will stretch lung units causing possible 
damage, as seen by increasing Edrs at higher PEEP. The rise of Edrs occurs at relatively 
low PEEP and pressure 15-20 cmH2O in these two patients.  
 
In contrast, Patients 8 and 10 (Figure 5.2-5.4: Bottom panels) never see Edrs or Ers 
rising even at the maximum PEEP used in this study. However, the Edrs range at 
higher PEEP for Patients 8 and 10 (PEEP 15~30 cmH2O) is relatively small with 
median Edrs = 31.3 cmH2O/l, [IQR = 27.2-33.9]. This outcome indicates that further 
increases of PEEP from 15 to 30 cmH2O has no added advantage in reducing Edrs, 
suggesting PEEP selection should be made at using the Inflection method.  
 
5.3.5 Relation of Patient-Specific Edrs Area, Edrs and Work of Breathing 
Across all 10 patients, patient-specific constant lung elastance (Ers) can be represented 
by the median of dynamic lung elastance (Edrs) with correlation R = 0.987. 
Correlation of Ers and WOBE is R = 0.815. Edrs Area and median Edrs are also closely 
correlated with R = 0.896. Hence, Edrs can be represented with Edrs Area, where Edrs 
Area captures all Edrs values in a given breath and thus, is a more physiologically 
representative metric. Finally, validating Equation (2), Edrs Area is correlated to the 
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work to overcome lung elastance, WOBE, as expected, with R = 0.936. The 
correlations are shown in Figure 5.5. 
 
  
  
Figure 5.5: Pearson’s Correlation. (Top Left) Ers-Median Edrs, R = 0.987. (Top Right) 
Ers-WOBE, R = 0.815. (Bottom Left) Edrs Area-Median Edrs, R = 0.896. (Bottom Right) 
Edrs Area-WOBE, R = 0.936. 
 
It is found that Edrs Area is closely related to median Edrs, as shown in Figure 5.5. Edrs 
Area at lower PEEP with median 64.9 cmH2Os/l [IQR: 37.6-102.2] is observed and as 
PEEP increases, Edrs Area decreases. Upon reaching minimum Edrs Area, patient-
specific Edrs Area increase with PEEP (Patients 2, 4, 6, 7 and 10). This trend is similar 
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to the trend observed in patient-specific time-variant Edrs (Table 5.2) and constant Ers 
(Table 5.3). Optimal PEEP derived using minimum or inflection method in Edrs Area 
is similar to minimum patient-specific Edrs but different as Edrs Area considers the 
whole inspiration and the effect of WOBE. It is also found that Edrs Area is closely 
correlated to work in overcoming the lung elastic properties (WOBE). This means that 
Edrs Area provides combined information of patients-specific lung physiological 
conditions as well as work of breathing, In this study, Patient 10 who is diagnosed 
with legionnaires and COPD, had significant Edrs Area drop when PEEP increases 
from 0 to 10 cmH2O (Figure 5.3 Bottom right). Patient with COPD requires higher 
work of breathing to ventilate the lung, and this information is clearly shown in 
Patient 10’s Edrs Area-PEEP curve, and thus Edrs Area is a better metric for decision 
making. 
 
5.3.6 Clinically Selected PEEP vs Model-based PEEP Selection. 
Table 5.5 compares clinically selected PEEP during MV therapy with PEEP selected 
using Minimum Edrs, and Minimum Edrs Area and the Inflection method. The clinical 
values are set over a much narrower range, both higher and lower than those selected 
using model-based methods. Minimum Edrs Area always selects a higher PEEP, by 
definition, than the Inflection method. However, Minimum Edrs Area selects PEEP 
similar to or higher than Minimum Edrs, where it also adds in the consideration of the 
reduction in overall WOBE in selecting PEEP. PEEP derived from minimum Ers and 
Inflection Ers are also indicated. 
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Table 5.5: PEEP (cmH2O) selection in clinical and model-based approach 
 Patients 
Selection 
Method 
1 2 3 4 5 6 7 8 9 10 
Clinical  10 12 10 10 12 11 7.5 12 10 10 
Minimum 
Edrs  
20 15 15 25 25 15 5 20 15 20 
Minimum 
Edrs Area  
25 15 20 20 25 20 10 25 25 20 
Inflection 
Edrs Area 
14~16 6~9 15~17 16~18 22~24 
7.5~ 
12 
5~7.5 21~23 20~23 12~16 
Minimum 
Ers 
25 15 15 30 25 15 5 25 30 20 
Inflection 
Ers 
13~17 6~9 8~10 26~27 21~24 
7.5~ 
10 
5 12~18 19~22 12~15 
 
For 9 of 10 patients, the PEEP selected using Minimum Edrs and Edrs Area results in a 
value higher than the clinically selected PEEP. This latter result suggests that these 
patients could be treated at PEEP levels higher than clinically selected PEEP. When 
Minimum Edrs or Edrs Area metrics are compared with Minimum Ers (Carvalho et al., 
2007), they result in selecting similar PEEP. However, selecting PEEP is a trade off in 
minimizing lung pressure and potential damage, versus maximizing recruitment. 
Hence, the Inflection method offers similar recruitment at a lower PEEP and may be a 
safer choice, although its selected values are still higher than clinically selected values 
in 7 of 10 cases. Overall, these results reflect the heterogeneity of the ARDS lung and 
the need for patient-specific approaches to select PEEP, perhaps allowing also for 
more regular changes over time to optimize care. 
 
5.3.7 Individual Case Finding 
Patient 9 is an interesting case that illustrates the model’s potential to capture unique 
patient-specific lung recruitment and condition as it occurs in a clinically and 
physiologically relevant manner. When the patient is ventilated from PEEP of 5 to 10 
cmH2O, Ers only decreases by less than 1.0 cmH2O/l. However, when PEEP is 
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increased to 15 cmH2O, the Ers drops significantly, as shown in Figure 5.6 (Left). This 
Ers drop suggests that only minimal lung volume is recruited from PEEP of 5 to 10 
cmH2O. The significant drop in Ers at PEEP 15cmH2O indicates that PEEP 15 cmH2O 
has overcome recruitment resistance and additional new lung volume is recruited. The 
recruitment that causes the significant drop in Ers is shown the rapid increase of lung 
volume in Figure 5.6 (Right). Patient 9 was diagnosed with H1N1 and high PEEP for 
lung recruitment has proven to be beneficial for these patients (Ramsey et al., 2010, 
Peris et al., 2010, Briel M and et al., 2010). Similar trends can be observed with the 
Edrs and Edrs Area as shown in Table 5.2 and 5.4.  
 
  
Figure 5.6: Patient 9’s Ers-PEEP (Left) and dFRC-PEEP (Right) curve. The 
significant increase in dFRC result in Ers drop when PEEP is increased from 10 to 15 
cmH2O. 
 
5.4 Study Limitations 
5.4.1 Simple Compartment Model and Offset Pressure 
In this research, the lung model used to identify patient-specific Edrs comprised a 
single compartment lung model. It was initially proposed for simple computational 
Significant 
Drop 
Significant 
Increase 
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analysis and neglects the effect of nonlinear flow (Bates, 2009a). However, this 
analysis is based predominantly on trend comparisons, where the patient is their own 
reference. In addition, the model is simple and capable of capturing the fundamental 
lung mechanics, which varies intra- and inter- patients. Hence, this limitation should 
be minimal in this case, but should be confirmed with direct prospective clinical 
studies. 
 
Compared to Equation 5.1, Equation 5.2 is extended with an offset pressure (P0) to 
equilibrate Equation 5.2 because the total lung volume is not known (Bates, 2009a). 
In this study, the pneumotachometer allows the air entering the lung to be calculated 
continuously without interruption. Thus, the V(t) term used in Equation 5.1 is the 
change of total lung volume instead of change of tidal volume. Equally, using the 
information on the change of total lung volume takes into account of Auto-PEEP and 
external PEEP, allowing easier implementation of the model-based method in this 
study. Equation 5.1 can be replaced with Equation 5.2, if information on the change of 
total lung volume is not available. 
 
5.4.2 Sedation and Patient Effort 
During the clinical trials, the patients were sedated and paralyzed using muscle 
relaxants. It is assumed that after sedation, the patient will be fully dependant on 
mechanical ventilation and not have spontaneous breathing effort. This assumption 
thus assumes the patient’s pleural pressure (Ppl) after sedation is zero or constant 
allowing Ppl to be omitted from Equation 5.1, and 5.2, which may not be entirely valid 
(Fernandes, 2006, Bates, 2009a) . However, this assumption is made for the first step 
  
103 
 
study to prove the concept within a simpler situation. Given the low fitting errors 
observed, this issue should have little impact in this research. 
 
5.4.3 Is Airway Resistance Constant? 
During the course of estimating patient-specific Ers or Edrs, respiratory system 
resistance, R, is assumed overall constant within a physiological range (Mols et al., 
2001) as PEEP increases. This assumption may not be entirely valid in some cases 
(Mols et al., 2001, Guérin et al., 2001). The airway resistance decreases with PEEP 
increase (Also shown in Chapter 4.0, Subject 9, Phase 3 - airway resistance decrease 
with PEEP). This can be explained by higher PEEP opened up the airway, resulting 
and overall drop in resistance. Continuous measurements of respiratory resistance are 
not typically available without additional invasive protocols, for example, using end 
inspiratory hold, that takes time, interrupt care and are thus not practical in regular 
care. In this clinical trial, the effect of this resistive term is limited mathematically in 
its impact. Equally, trend comparison, as used here, across PEEP values will reduce 
the impact.  
 
5.4.4 Validity of PEEP Selection Metric 
The identification of Ers, Edrs and Edrs Area during MV is presented as a method to 
select PEEP, but there is currently no conclusive, optimum overall Edrs or Edrs Area in 
patients. Edrs range varies depending on patient disease state and thus will also change 
over time. However, this trial includes only 10 patients, and there is not yet enough 
clinical data to indicate an optimum Ers, Edrs or Edrs Area value for a specific patient 
or group. On-going, prospective trials with more specific patient groups should 
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develop more conclusive outcomes, relating specific set values of Edrs metrics to 
effective patient-specific treatments and clinical outcome. 
 
In particular, the time-varying Edrs value and its changes over a given breathing cycle, 
provides additional insight to guide ventilation that is not investigated here. For 
example, changes in ventilator pattern or mode to modify the Edrs trajectory could also 
be used with this data to guide therapy choice. However, this study does not have the 
numbers or design to provide that advice, or specific Edrs values associated with 
specific decrease state or lung damage. 
 
5.5 Summary 
This study presents the first clinical trial carried out in ARDS patients that monitors 
patient-specific respiratory system elastance for PEEP selection. The patient-specific 
elastance was shown to be correlated with clinically significant work of breathing and 
lung volume metrics, and further validating its relevance and potential.  
 
The model-based approach is capable of providing patient-specific, physiological 
insight not directly measurable without additional invasive, disruptive and clinically 
intensive test manoeuvres. This method can be directly implemented using modern 
ventilators with minimal, limited PEEP titrations, and thus without significant 
interruption to ongoing therapy. In particular, the full manoeuvres used here would 
not be required for clinical use, and only modest PEEP changes (3-8 cmH2O) would 
be required to determine if Edrs was decreasing at a different PEEP. Edrs offers higher 
resolution in patients’ response to change of pressure and PEEP, which is potentially, 
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a better metric compared to existing constant lung elastance estimation. Thus, the 
overall method is readily generalisable and clinical practicable. It is able to capture 
patient-specific condition, responsiveness to PEEP and recruitment accurately as 
clinically expected. Hence, the approach presented offers significant potential to 
improve clinical insight and delivery of mechanical ventilation, and should be 
prospectively tested.  
 
In the next chapter, mechanical ventilation of spontaneously breathing patients is 
presented. The patients’ fundamental breathing pattern is greatly altered by patient-
specific breathing effort and thus, Equation 5.1 and 5.2 is not suitable for respiratory 
mechanics monitoring without additional information or invasive measurements. Thus, 
different decision metrics are needed and their performance is tested. 
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Chapter 6 
Spontaneous Breathing and Assisted 
Ventilation: Pressure Support (PS) and 
Neurally Adjusted Ventilatory Assist 
(NAVA) 
 
6.1 Background 
Assisted ventilation modes were initially designed for spontaneously breathing 
patients with the aim to facilitate the weaning process of mechanically ventilated 
patients. Weaning is the discontinuation process from mechanical ventilation and is a 
critical phase in respiratory therapy.  In addition, studies by Kuhlen et al., Putensen et 
al. and Slutsky et al. have indicated that promoting patients to breathe spontaneously 
with the ventilator during the course of treatment will result in better outcome 
(Kuhlen and Putensen, 1999, Putensen et al., 1999, Putensen et al., 2001, Slutsky et 
al., 2005b).  
 
In particular, spontaneous breathing patients benefit from improving arterial 
oxygenation, recruitment, increase of cardiac output, ventilation-perfusion matching, 
reduction of the use of analgesia and sedation, prevention of respiratory muscle 
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dysfunction, indirectly reduced length of MV, improved weaning and recovery 
(Burchardi, 2004, Wrigge et al., 2005, Brander and Slutsky, 2006, Kogler, 2009). 
Thus, there is increasing interest in providing optimal MV therapy through 
spontaneous breathing ventilation, and promoting patients who are sedated in MV to 
spontaneous breathing MV modes as rapidly as possible. 
 
6.2 Pressure Support (PS) and Neurally Adjusted Ventilatory Assist (NAVA)  
One of the most used partial assist ventilation modes is the pressure support 
ventilation (PS or PSV) (Esteban et al., 2000, Rose et al., 2009). In PS, each 
supported ventilation cycle is initiated by a pneumatic signal (flow or pressure), 
detected at the airway as produced by the patient’s inspiratory effort (Tutuncu et al., 
1997, Goulet et al., 1997, Correa et al., 2007). The ventilator sensor detects a drop in 
airway pressure signalling the start of a breath and adds pressure, like PEEP, to assist 
breathing. The amount of pressure support delivered to the patient is set by the 
clinician, and the transition of the breath from inspiration to expiration occurs when 
the inspiratory flow decreases to a predetermined level (MacIntyre et al., 1990, 
Tassaux et al., 2004, Tassaux et al., 2005).  However, under PS, a constant pressure is 
delivered by the ventilator regardless of the patient’s relative inspiratory effort. As 
this constant pressure produces the majority of resulting tidal volume (Vt) supply, PS 
is expected to reduce Vt variability.  
 
Neurally Adjusted Ventilatory Assist (NAVA) is an assisted ventilation mode that 
uses electrical activity of the diaphragm (Eadi), an expression of the patient’s 
inspiratory demand, to trigger and cycle the ventilator (Sinderby et al., 1999, 
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Sinderby, 2002, Slutsky et al., 2005a). The amount of pressure support delivered is in 
direct proportion to the patient’s Eadi (Sinderby et al., 1999, Terzi et al., 2012). A 
description on the difference between the triggering of NAVA ventilation and to other 
assisted ventilation modes (In this study, Pressure Support) is shown in Figure 6.1. 
 
Compared to PS, NAVA was found to improve patient-ventilator interaction by 
reducing trigger delay, improving expiratory cycling and reducing the number of 
asynchrony events (Colombo et al., 2008, Piquilloud et al., 2011b, Spahija et al., 
2010, Piquilloud et al., 2012). NAVA also increases respiratory variability in Vt and 
flow compared to PS (Colombo et al., 2008, Schmidt et al., 2010). Improved 
variability has been associated with improved ventilation perfusion and oxygenation 
(Boker et al., 2004, Gama de Abreu et al., 2008, Spieth et al., 2009a, Spieth et al., 
2009b). 
 
 
 
Figure 6.1: Difference between NAVA ventilation and other conventional assisted 
ventilation mode (Sinderby et al., 1999). NAVA triggers ventilation cycle using 
neural signal from diaphragm excitation whereas conventional assist ventilation 
modes triggers the ventilator using pneumatic signal from the airway. 
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However, no studies make these comparisons in relative to the inspiratory demand 
(Eadi), which may vary between modes and patients. Thus, to determine the true 
impact of NAVA on Vt variability, Eadi must be accounted for in the analysis. Such 
an analysis would validate whether these improvements associated with NAVA are 
real. 
 
It is hypothesized that the magnitude of Vt under NAVA mode would show better 
correlation with the magnitude of Eadi, better matching between Vt with Eadi and 
greater variability, compared to PS. This chapter presents the study and data used to 
confirm these hypotheses by analysing the flow and Eadi-time curves for PS and 
NAVA using a simple, new metric (Range90), that quantifies the matching of  
patient’s demand (Eadi) and ventilator supply (Vt). The result will clearly shows 
which mode provided better matching for each patient. 
 
6.3  Methodology 
This study analyses recorded Eadi-time and flow-time curves, as well as derived 
parameters, from a study exploring patient-ventilator synchrony on clinically based 
criteria (Piquilloud et al., 2011b). The data were obtained at the University Hospital of 
Geneva (Switzerland) and Cliniques Universitaires St-Luc (Brussels, Belgium). The 
study protocol was approved by the Ethics Committee of the University Hospital of 
Geneva (Commission centrale d'éthique hôpitaux universitaires de Genève) and the 
Ethics Committee at Cliniques Universitaires Saint-Luc (Commission d'Ethique 
biomédicale hospitalo-facultaire, université catholique de Louvain, faculté de 
médecine). 
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6.3.1 Patients and Ventilator Settings 
22 patients admitted to the ICU, intubated because of acute respiratory failure, and 
ventilated with PS mode were included for the study. The exclusion criteria are: 1) 
severe hypoxemia requiring FiO2 ≥ 50%; 2) Hemodynamic instability; 3) Known 
oesophageal problem (hiatal hernia, oesophageal varicosities); 4) Active upper gastro-
intestinal bleeding or any other contraindication to the insertion of a naso-gastric tube; 
5) Age ≤ 16 years old; 6) Poor short term prognosis (defined as a high risk of death in 
the next seven days); or 7) Neuromuscular disease. All included patients were 
ventilated with a Servo-I ventilator (Maquet, Solna, Sweden) equipped with the 
commercially available NAVA module and software, which delivers both PS and 
NAVA. The patients’ clinical characteristic and ventilator settings are summarised in 
Table 6.1. 
 
6.3.2 Clinical Protocol 
After written informed consent was obtained, the patient’s standard nasogastric tube 
was replaced with NAVA tube to measure Eadi signal and perform NAVA 
ventilation. Airway suctioning was performed before the beginning of the protocol. A 
20 minute continuous recording of patients airway pressure, Eadi and flow profile 
(~300-500 breaths) was first carried out during PS mode with the clinician 
predetermined ventilator settings. PS mode was then changed to NAVA mode with 
the NAVA gain (or NAVA level) (the proportionality factor between recorded Eadi 
and ventilator delivered pressure), set to obtain similar peak airway pressure during 
PS for that patient using a previsualisation system provided with the ventilator. 
During NAVA ventilation, further 20 minutes of recording is taken. 
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Table 6.1: Patients main clinical characteristics for both PS and NAVA and their 
main ventilator settings in each mode 
Patients   
Age (years) 66 ± 12 years 
Body Mass Index (BMI) 23.4 ± 3.1 kg/m
2 
PaO2/FiO2 194.8 ± 58.1 mmHg 
Pulmonary restrictive disease 1 of 22 patient 
Pulmonary obstructive disease 8 of 22 patients 
  
Ventilator Settings PS NAVA 
FiO2 0.43 ± 0.17 0.43 ± 0.17 
PEEP 7 ± 2 cmH2O 7 ± 2 cmH2O 
Inspiratory Trigger 
Flow Trigger: 1.2 l/min  
(20/22 patients) 
Pressure Trigger: -4 to -5 cmH2O 
(2/22 patients) 
0.5 uV 
Expiratory Trigger Sensitivity 
(ETS) 
25-30% - 
PS Level 13 ± 3 cmH2O - 
Pressurization Slope 100-150 ms - 
NAVA Gain Level - 
2.2 ± 1.8 
cmH2O/µV 
 
Airway pressure, Eadi and flow profile were acquired from the Servo-I ventilator and 
recorded at a frequency of 100 Hz by Servo-tracker V 4.0 (Maquet, Solna, Sweden). 
During the entire period, the pressure support level in PS and NAVA gain in NAVA 
were kept constant. Equally, other ventilator settings such as positive end expiratory 
pressure (PEEP), FiO2, inspiratory trigger, and cycling off settings were maintained at 
the same level. 
 
6.3.3 Data Processing and Analysis 
Flow and Eadi-time signal obtained from the Servo-tracker were used to perform the 
analysis using MATLAB software (The Mathworks, Natick, Massachusetts, USA). 
An inspiratory breath was determined by the flow signal, and was defined to 
commence when the flow signal became positive, and terminate when the flow signal 
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became negative. The flow-time signal was integrated to obtain tidal volume, Vt. 
Breaths with Vt < 50 ml were discarded from analysis as being very small and 
potentially artefacts. 
 
The Eadi signal was integrated between the same two time points to obtain the 
corresponding integrated Eadi value (ʃEadi), to represent total inspiratory demand 
(Schmidt et al., 2010). Peak Eadi value was captured and compared with the 
corresponding ʃEadi to ensure that there is no loss of information. ʃEadi is the time 
integral of Eadi signal and this parameter carries the information on the change of 
Eadi with time, while retaining information on peak Eadi. Thus, ʃEadi is used to 
represent patient inspiratory demand rather than the Peak Eadi value. Finally, the 
inspiratory time, Ti, is defined as the time when flow becomes positive until the time 
when flow became negative; and neural inspiratory time Ti_Neural, is defined as the 
time when flow became positive until the time when peak Eadi occurs. Figure 6.2 
shows the location of ʃEadi, Vt, Ti and Ti_Neural in a patient flow and Eadi-time curve. 
 
6.3.3.1 Correlation Analysis 
Pearson's linear correlation coefficients were calculated for each patient between peak 
Eadi value and ʃEadi, and also between Vt and ʃEadi. Two-sample non parametric 
Kolmogorov-Smirnov hypothesis tests were then used to compare variability 
(Coefficient of variation, CV) at each variable between the PS and NAVA groups.  
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Figure 6.2: Example of a patient’s flow and Eadi curve. Inspiratory time Ti is the 
time when flow becomes positive until the time when flow became negative. Tidal 
volume, Vt is the area under the flow curve. ʃEadi is the corresponding area under 
Eadi curve. Neural inspiratory time, Ti_Neural is the time when flow became positive 
until the time when peak Eadi occurs. 
 
6.3.3.2 Variation Analysis - Robust Coefficient of Variation 
Coefficient of variation (CV = standard deviation/mean) were calculated for Vt, ʃEadi 
and Ti over all breaths for each patient in each ventilator mode for variation analysis 
(MacIntyre et al., 1990, Schmidt et al., 2010). A lower CV value indicates lower 
variability (Wysocki et al., 2006).  However, normality was assessed using a one-
sample Kolmogorov-Smirnov goodness to fit test, which showed that some 
parameters were not normally distributed. Hence, a non-normal alternative variation 
test is used (Robust Coefficient of Variation, CVR = median absolute deviation/ 
median). CVRs for the PS and NAVA group are compared using a two-sample non 
parametric Kolmogorov-Smirnov hypothesis test. 
 
 
 
  
114 
 
6.3.3.3 A Metric for Matching Analysis – Range90 Supply over Demand 
Vt and ʃEadi were determined, and the ratio Vt/ʃEadi was assessed for each breath in 
both ventilation mode. Vt is the tidal volume supply given to patient and ʃEadi is 
defined as an expression for patient’s ventilatory demand. The ratio of Vt/ʃEadi 
represents an output over input ratio and it is also defined as the Neuroventilatory 
efficiency (Passath et al., 2010). This ratio thus carries the information of the 
matching of ventilator supply over patient demand, which thus captures a form or a 
level of patients-ventilator interaction.  
 
To calculate Range90 for a patient, the empirical cumulative distribution function 
(CDF) of Vt/ʃEadi ratio for each breath in each ventilation mode was plotted. 
Range90 is calculated as the 5
th
 to 95
th
 range of Vt/ʃEadi ratio as shown in Equation 
6.1. 
 
 Range90 = 95
th
 Vt/ʃEadi – 5th Vt/ʃEadi    (6.1) 
 
A smaller Range90 indicates better matching of the response Vt to the variable 
inspiratory ʃEadi demand resulting in a more constant ratio. A larger Range90 
indicates a lesser ability to match Vt and ʃEadi for each breath regardless of the 
underlying patient-specific variability in ʃEadi. Thus, if Vt variability were equally 
matched to variability in ʃEadi, then the ratio would be more consistent and Range90 
would be smaller. Equally, a larger Range90 thus indicates an inability to consistently 
match Vt to ʃEadi demand. Detailed description of Range90 and several case 
  
115 
 
examples beyond these presented in this chapter can be found in Appendix 02 at the 
end of the thesis. 
 
The Range90 metric normalizes differences in Eadi demand within and between 
patients and-or ventilatory modes in analysing the resulting Vt variability. The ratio of 
Vt/ʃEadi for each breath and the analysis of its variability (Range90) over a given 
mode thus allows fair comparison between modes (for a patient) and between patients, 
where Eadi demand may vary significantly.  
 
In this study, the range of 5
th
-95
th
 percentile of Vt/ʃEadi is used for matching analysis 
rather than other ranges, for example, the interquartile range, 25
th
-75
th
 percentile of 
Vt/ʃEadi (Range50). Range90 captures 90% of the patients breathing pattern whereas, 
a smaller range such as Range50 only capture the central tendency and spread of the 
patients breathing pattern.  
 
6.4 Results and Discussion  
For the 22 patients, the median [IQR)] for ʃEadi were not different between PS and 
NAVA: 4.10 µVs [IQR: 2.55-5.99] vs 3.97 µVs [IQR: 2.59-6.64]. Ti was 0.97 s [IQR: 
0.70-1.15] in PS and 0.80 s [IQR: 0.65-0.92] in NAVA. Median Vt was 468 ml [IQR: 
418-514] in PS and 431 ml [IQR: 378-472] in NAVA. Peak inspiratory pressure (PIP) 
was 21.44 cmH2O [IQR: 18.57-24.11] in PS and 21.63 cmH2O [IQR: 19.61-24.56] in 
NAVA. No significant difference (p > 0.005 using Wilcoxon ranksum test) was found 
between these median values for PS and NAVA. Table 6.2 shows the details and 
median [IQR] values for ʃEadi, Vt, Ti_Neural, Ti and PIP for all 22 patients for PS 
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and NAVA. The summary of Table 6.2 is shown in Table 6.3 and as a box-whisker in 
Figure 6.3. 
 
Table 6.2: ʃEadi, Vt, Ti_Neural, Ti and PIP of the 22 patients  
Patients ʃEadi (µVs) Vt (ml) Ti_Neural (s) Ti (s) PIP (cmH2O) 
1 PS 3.01 [2.71-3.36] 671 [653-687] 0.94 [0.90-1.02] 1.20 [1.18-1.23] 20.40 [20.33-20.46] 
NAVA 3.80 [3.37-4.46] 626 [584-671] 1.02 [0.95-1.09] 1.20 [1.14-1.29] 21.89 [20.56-23.43] 
2 PS 1.02 [0.71-1.96] 449 [394-517] 0.79 [0.63-0.92]
  1.05 [0.99-1.13]  15.25 [14.99-15.64] 
NAVA 2.06 [1.21-4.13] 303 [180-529] 0.76 [0.55-0.93]
  0.92 [0.76-1.06]  12.26 [9.85-17.97] 
3 PS 1.90 [1.42-2.64] 463 [454-472] 0.86 [0.79-0.94] 1.00 [0.97-1.03]  24.56 [24.50-24.69] 
NAVA 1.71 [1.39-1.97] 472 [382-520] 0.86 [0.68-0.98] 1.05 [0.89-1.14]  31.33 [27.62-35.37] 
4 PS 12.28 [10.67-
13.90] 
418 [400-435]  0.50 [0.45-0.54] 0.65 [0.63-0.68] 21.57 [21.50-21.63] 
NAVA 13.08 [11.39-
15.05] 
412 [387-442] 0.53 [0.49-0.59] 0.71 [0.67-0.77] 21.89 [20.59-23.36] 
5 PS 4.35 [3.81-5.03] 510 [495-525] 0.57 [0.52-0.62] 0.80 [0.76-0.82] 25.21 [25.08-25.41] 
NAVA 3.11 [2.68-3.74] 423 [384-475] 0.54 [0.49-0.60] 0.65 [0.61-0.71] 24.56 [22.46-27.06] 
6 PS 7.33 [4.88-9.59] 336 [318-353] 0.47 [0.39-0.55] 0.81 [0.77-0.84] 19.42 [19.29-19.48] 
NAVA 6.64 [5.62-7.63] 293 [257-325] 0.56 [0.52-0.65] 0.79 [0.70-0.87] 18.12 [16.23-19.48] 
7 PS 3.18 [1.70-4.17] 528 [486-555] 0.43 [0.36-0.49] 0.68 [0.61-0.71] 25.54 [25.47-25.60] 
NAVA 4.20 [2.73-4.83] 476 [434-513] 0.44 [0.38-0.49] 0.56 [0.51-0.60] 24.43 [21.76-26.06] 
8 PS 3.94 [2.68-4.98] 460 [432-479] 0.51 [0.46-0.57] 0.57 [0.55-0.61] 20.46 [20.40-20.53] 
NAVA 2.10 [1.81-2.43] 462 [429-498] 0.70 [0.61-0.77] 0.81 [0.74-0.87] 21.37 [19.09-23.85] 
9 PS 5.27 [4.72-5.96] 411 [396-423] 0.60 [0.57-0.63] 0.70 [0.68-0.72]
  21.50 [21.44-21.57] 
NAVA 5.97 [5.36-6.86] 393 [361-426] 0.60 [0.57-0.64] 0.72 [0.69-0.75]
  23.91 [21.78-25.91] 
10 PS 2.46 [2.06-2.87] 382 [352-407] 1.07 [0.96-1.20] 1.45 [1.39-1.52] 14.15 [14.02-14.34] 
NAVA 2.88 [2.41-3.38] 319 [282-342] 1.02 [0.82-1.14] 1.24 [1.10-1.34] 10.76 [10.05-11.54] 
11 PS 7.31 [6.53-8.16] 397 [389-406] 0.48 [0.44-0.52] 0.54 [0.53-0.55] 28.79 [28.66-29.12] 
NAVA 7.75 [6.60-9.17] 378 [350-408] 0.44 [0.40-0.49] 0.59 [0.55-0.64] 31.98 [29.77-35.47] 
12 PS 11.97 [8.14-
17.64]  
474 [437-501] 0.69 [0.61-0.76] 0.93 [0.89-0.99]  14.73 [14.60-14.86] 
NAVA 12.00 [9.91-
14.90]  
456 [418-486] 0.66 [0.60-0.75] 0.84 [0.78-0.91]  13.50 [12.06-15.32] 
13 PS 2.90 [1.71-5.59] 345 [317-384] 0.45 [0.28-0.67] 1.14 [1.05-1.27] 17.21 [17.08-17.53] 
NAVA 3.14 [1.66-5.94] 220 [124-397] 0.54 [0.36-0.69] 0.70 [0.54-0.83] 16.98 [13.01-25.57] 
14 PS 1.86 [1.25-2.38] 473 [417-516]  0.62 [0.47-0.72] 0.73 [0.68-0.80] 23.07 [22.87-23.20] 
NAVA 3.13 [0.96-5.32] 394 [108-560]  0.58 [0.38-0.71] 0.79 [0.60-0.89] 19.78 [10.89-24.17] 
15 PS 5.66 [4.67-8.41] 507 [459-538] 0.61 [0.53-0.69] 1.15 [0.96-1.26] 24.11 [23.98-24.24] 
NAVA 5.91 [4.90-6.91] 544 [475-613] 0.74 [0.65-0.82] 0.92 [0.84-0.99] 32.63 [28.17-38.82] 
16 PS 5.99 [5.25-6.97] 622 [608-634] 0.79 [0.73-0.85] 0.93 [0.90-0.96] 18.77 [18.70-18.90] 
NAVA 6.77 [6.04-7.68] 615 [583-644] 0.84 [0.75-0.87] 0.96 [0.90-1.03] 20.53 [18.90-22.67] 
17 PS 4.42 [3.24-5.61] 633 [579-727] 0.32 [0.18-0.44] 1.19 [1.07-1.35] 21.37 [21.31-21.50] 
NAVA 5.79 [3.83-7.77] 453 [341-568] 0.44 [0.34-0.54] 0.64 [0.51-0.79] 19.68 [16.84-22.94] 
18 PS 4.26 [3.51-5.09] 476 [465-489] 0.63 [0.53-0.77] 1.05 [1.01-1.10] 23.52 [23.39-23.59] 
NAVA 4.13 [3.11-5.40] 429 [326-514] 0.65 [0.50-0.78] 0.87 [0.73-0.96] 24.63 [21.11-28.39] 
19 PS 2.74 [1.46-4.56] 514 [406-586] 0.32 [0.20-0.48] 1.15 [0.80-1.43] 22.64 [22.41-23.33] 
NAVA 1.83 [1.49-2.24] 292 [241-336] 0.40 [0.32-0.47] 0.54 [0.48-0.61] 24.11 [21.57-27.75] 
20 PS 1.73 [1.50-1.97] 445 [430-462] 0.54 [0.42-0.64] 1.03 [0.99-1.06] 18.57 [18.51-18.64] 
NAVA 2.31 [2.01-2.73] 432 [380-488] 0.67[0.58-0.75] 0.87 [0.79-0.98] 20.04 [18.12-21.96] 
21 PS 2.55 [2.21-2.96] 836 [800-854] 0.87 [0.73-1.08] 1.16 [1.06-1.32] 14.99 [14.86-15.06] 
NAVA 2.59 [1.56-3.29] 758 [586-848] 0.71 [0.55-0.84] 0.92 [0.69-1.04] 19.61 [15.79-23.41] 
22 PS 22.51 [17.90-
25.43] 
431 [399-460] 0.38 [0.32-0.45] 0.58 [0.53-0.62] 26.84 [26.78-26.91] 
NAVA 19.96 [17.25-
22.44] 
440 [394-478] 0.46 [0.40-0.52] 0.60 [0.54-0.63] 35.50 [33.09-37.84] 
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Table 6.3: Summary of ʃEadi, Vt, Ti_Neural, Ti and PIP median [IQR] 
 ʃEadi (µVs) Vt (ml) Ti_Neural (s) Ti (s) PIP (cmH2O) 
Summary 
Median 
[IQR] 
PS 
 
4.10 
[2.55 - 5.99] 
468 
[418 - 514] 
0.97 
[0.70 - 1.15] 
0.97 
[0.70 - 1.15] 
21.44 
[18.57 - 24.11] 
NAVA 3.97 
[2.59 - 6.64] 
431 
[378 - 472] 
0.80 
[0.65 - 0.92] 
0.80 
[0.65 - 0.92] 
21.63 
[19.61 - 24.56] 
p-value >0.005 >0.005 >0.005 >0.005 >0.005 
 
 
  
  
Figure 6.3: Summary of ʃEadi, Vt, Ti and PIP for all 22 patients in PS and NAVA. 
 
6.4.1  Correlation Analysis 
Across all 22 patients, peak Eadi and ʃEadi are correlated (median [IQR]) with R = 
0.93 [IQR: 0.88-0.96] for PS and R = 0.87 [IQR: 0.78-0.90] for NAVA. The 
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correlation of ʃEadi and Vt (median [IQR]) for PS is R = 0.50 [IQR: 0.05-0.65]. For 
NAVA, R = 0.85 [IQR: 0.78-0.90]. Peak Eadi and ʃEadi were well correlated under 
both PS and NAVA ventilation modes. Hence, peak Eadi and ʃEadi are essentially 
identical and could be used to characterize Eadi in future studies. ʃEadi is used in this 
study instead of Eadi value in this study as it is more physiologically relevant as total 
inspiratory demand and readily calculated. Similarly, ʃEadi and Vt were only 
moderately correlated for PS, whereas these parameters were strongly correlated 
under NAVA mode. 
 
A two sample Kolmogorov-Smirnov hypothesis test shows that the NAVA and PS 
correlation datasets for ʃEadi and Vt are significantly different (p < 0.005), 
illustrating the much better correlation seen for NAVA, which thus better matches 
these two variables than PS. Significantly better correlation between Vt and ʃEadi 
under NAVA than PS, suggested that the delivered ventilation is possibly more 
physiological to the patient under NAVA than PS by better matching the patient’s 
demand and its variability.  
 
6.4.2 Variability Analysis  
The non-parametric coefficients of variation (CVRs) in Vt, ʃEadi, Ti, Ti_Neural and 
PIP for the 22 patients are shown in Table 6.4. The PS and NAVA CVR in Vt, Ti and 
PIP are significantly different (p < 0.005), with the NAVA being more variable. 
Conversely, no significant difference was observed between ʃEadi or Ti_Neural CVR, 
with p = 0.563 and p = 0.332, respectively. More importantly, it should be noted that 
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these results are reported for the whole population of 22 patients. Individual patients 
could exhibit a very different variability between PS and NAVA, and the specific 
variables reported.  
 
Table 6.4:  Robust Coefficient of Variation (CVR) in Vt, ʃEadi, Ti_Neural, Ti and PIP 
(Median [IQR])  
 Median [IQR] 
 PS NAVA 
ʃEadi  0.211 [0.140 - 0.326]  0.167 [0.153 - 0.272]  
Vt 0.050 [0.029 - 0.077]*  0.111 [0.076 - 0.163]* 
Ti_Neural 0.135 [0.093 - 0.203]
  0.126 [0.094 - 0.200]  
Ti 0.046 [0.031 - 0.082]* 0.093 [0.074 - 0.138]* 
PIP 0.006 [0.003 - 0.008]*  0.103 [0.083 - 0.156]* 
*
 
p-value < 0.005 
 
As increased in variability has previously been associated with improved ventilation-
perfusion ratio and improved oxygenation both in animal models (Gama de Abreu et 
al., 2008, Spieth et al., 2009a, Spieth et al., 2009b) and humans (Boker et al., 2004), 
the ability of NAVA in maintaining higher variability in tidal volume compared to PS 
could be of potential clinical interest and will require further investigation. Moreover, 
overall, it is hypothesized that greater variability in breathing pattern is a healthier 
patient condition. Thus, it is thought that better patient outcomes could be expected 
for those patients with a higher variability in ʃEadi when it is equally matched by a 
high variability in Vt. The results presented show that such a result is significantly 
more likely under NAVA than PS.  
 
6.4.3 Patient Range90 Matching Analysis 
For NAVA, the median [IQR; 5
th
-95
th
 percentile] Range90 = 71.0 ml/µVs [IQR: 36.5-
153.6; 15.0-531.3]. For PS, Range90 = 129.9 ml/µVs [IQR: 64.0-341.5; 19.2-645.2]. 
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These results indicate significant variability in the matching of Vt and ʃEadi for both 
modes, but a consistently lower range for NAVA. The Range90 for both PS and 
NAVA in all patients are shown in Table 6.5. 
 
Table 6.5: PS and NAVA Range90 (ml/µVs) for all patients 
Patients PS NAVA Range90 Ratio for 
PS/NAVA 
1 111.3 76.0 1.47 
2 644.4 153.6 4.20 
3 330.6 219.0 1.51 
4 21.2 17.1 1.24 
5 78.2 55.6 1.41 
6 64.0 19.9 3.22 
7 593.3 515.5 1.16 
8 285.2 183.9 1.56 
9 42.1 23.2 1.82 
10 124.9 103.1 1.22 
11 36.0 26.4 1.37 
12 62.5 36.5 1.72 
13 323.2 50.9 6.35 
14 523.1 154.8 3.38 
15 125.4 55.8 2.25 
16 77.5 44.4 1.75 
17 341.5 108.8 3.14 
18 134.1 78.4 1.72 
19 646.0 76.8 8.42 
20 187.8 66.0 2.85 
21 375.7 554.9 0.68 
22 16.4 11.8 1.39 
Median [IQR] 
5
th
-95
th
  
129.8 [64.0 - 341.5] 
[19.2 - 645.2] 
71.0 [36.5 - 153.6] 
[15.0 - 531.3] 
1.72 [1.39 - 3.14] 
[0.97 - 7.18] 
 
The CDFs for the Vt/ʃEadi ratio for 3 specific patients, along with dashed lines 
indicating the Range90 value (5
th
 and 95
th
 percentile of Vt/ʃEadi) are shown in Figure 
6.4. These three patients show a typical case where NAVA better matches Vt and 
ʃEadi than PS, the one case where PS better matches these variables than NAVA, and 
one case where they are similar showing the patient with ratio of Range90 values 
(PS/NAVA = 1.24) that is close to 1.0. 
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Figure 6.4: Cumulative distribution function (CDF) plots of Vt/ʃEadi for both NAVA 
and PS for three patients. The CDFs show the ~300-500 such values per patient and 
mode. The dashed lines show the variability (along x-axis) in this ratio or matching, 
where a narrower band is a smaller Range90 value and thus better matching of Vt and 
ʃEadi. Panels: (Top) Patient 3: NAVA is better than PS; (Middle) Patient 4: NAVA 
and PS are similar; (Bottom) Patient 21: PS is better than NAVA. 
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Figure 6.5 shows the Vt-ʃEadi scatter plot for two patients, who are also shown in 
Figure 6.4. The results from these two patients highlight the differences in ability to 
match Vt to ʃEadi. In particular, the figure plots ʃEadi and Vt for each breath for both 
modes and each patient. Figure 6.5 (Top) shows a much higher Vt variability 
compared to PS. Patient 4 in Figure 6.5 (Bottom) had similar Vt variability when PS 
to NAVA. In these figures, it is clear that PS provides a far more constant range of Vt 
(Supply) despite similar variation in ʃEadi for both ventilatory modes.  
 
Range90 is a novel method of determining the matching using Neuroventilatory 
efficiency (Vt/ʃEadi ratio) for each breath in a patient. The resulting 90% range 
(Range90) value for each mode shows how well outcome Vt was matched by the 
ventilatory mode to inspiratory demand, ʃEadi. A smaller Range90 indicates better 
matching and thus better response to variable demand with equally variable Vt. Thus, 
this approach thus provides a patient-specific comparison of which mode better 
matched Vt and ʃEadi. Equally, the comparison of Range90 values for a given patient 
enable one to quantify how much better one mode matched inspiratory demand and 
resulting tidal volume. 
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Figure 6.5: Vt-ʃEadi plots for NAVA and PS. (Top) Patient 3 with PS/NAVA ratio = 
1.51. (Bottom) Patient 4 with PS/NAVA ratio = 1.24. The dashed lines around the 
data capture the middle 90% of the data for both ʃEadi and Vt for each mode. In both 
patients, the outcome tidal volume range for the middle 90% of breaths is 50-100 ml 
wide for PS and much wider for NAVA, despite similar input ranges of ʃEadi. The 
smaller ratio of width over height of the box between modes is similar to having a 
smaller Range90. 
 
Examining the ratio of Range90 for PS/NAVA (Table 6.5), the median [IQR; 5
th
-95
th
 
percentile] of this ratio is 1.72 [IQR: 1.39-3.14; 0.97-7.18], showing that NAVA 
consistently had much smaller values than PS. The lower quartile of this Range90 
ratio is [0.68-1.39], where only 1 patient had a value less than 1.0, at 0.68. These 
results show that 21 of 22 patients had better matching of Vt and ʃEadi for NAVA 
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than for PS. 4 patients had values greater than, but near to, 1.0, indicating relatively 
comparable matching of Vt and ʃEadi between NAVA and PS. 
 
Range90 values were significantly smaller in NAVA than in PS (p < 0.005). Of 22 
patients, 21 had lower Range90 with NAVA, and only 1 showed a higher ratio with a 
better match of ʃEadi and Vt by PS. Equally, the comparison of Range90 values 
showed that 4 of the 5 patients comprising the lowest quartile had values near to 1.0 
with the 25
th
 percentile value showing the match of Vt and ʃEadi was 1.40x better for 
NAVA than for PS in Range90 value. Hence, ventilation under NAVA is probably 
more physiological and adapted to the patient’s inspiratory demand than under PS.  
 
The importance of normalizing Vt variability to its ʃEadi variability is highlighted 
when it is observed that although there is no significant difference in ʃEadi variability 
over the population in Table 6.2 and Table 6.3. ʃEadi can be substantially different 
between PS and NAVA on a patient-specific basis. Hence, the patient-specific 
comparisons of Range90 are particularly relevant, and, equally, account for all breaths 
directly rather than via a grouped statistic.  
 
Correlation analysis was performed between Range90 with CVRs in ʃEadi and Vt. 
For PS, correlation of coefficient R was 0.71 for ʃEadi, and 0.67 for Vt, compared to 
NAVA, R = 0.16 for ʃEadi, and 0.02 for Vt. These results indicated that Range90 is 
an alternate analysis different from variability analysis, and thus a higher variability 
does not necessarily mean better ‘matching’. 
  
125 
 
The Range90 metric is very simple. Hence, the ventilator Vt in response to (not 
necessarily equally) patient’s inspiratory demand can be calculated in real-time. Thus, 
it could be used to monitor response to ventilator settings and possibly (in future) 
adapt ventilator settings. 
 
Overall, the results show that PS does not adapt or respond to ʃEadi variation, as it 
provided relatively constant tidal volumes regardless of the magnitude of ʃEadi. This 
point is illustrated in Figure 6.4. In both cases of Figure 6.4, the range of tidal 
volumes seen is very narrow for PS, particularly relative to the ʃEadi range. Thus, PS 
was unable to match Vt to the ʃEadi. 
 
6.5 Limitations 
6.5.1 Data Processing and Filtering 
One possible limitation of this study is the definition of a minimum tidal volume that 
defines a breath versus an artefact, where those breaths with Vt < 50 ml were ignored. 
The selection was made through post hoc analysis of the Vt distribution indicating a 
bi-modal distribution, one mode representing physiological respiratory activity and a 
small mode (Vt < 50ml) likely corresponding to artefacts in Eadi. This statement is 
based on the observation that there was no significant ventilator pressurisation 
associated with Vt lower than 50 ml. A re-analysis of the data with a limit of 100 ml 
showed no change in the overall results, wherein NAVA provided a better match to 
patient variability in ʃEadi for 21 of 22 patients, and the lower quartile still had a 
PS/NAVA ratio of 1.40. Thus, the analysis presented is robust to this choice of 
excluding breaths with Vt < 50 ml. 
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Range90 only considers the matching of Vt magnitude of a ‘known’ breathing cycle 
towards the corresponding ʃEadi. Thus, if Vt > 50ml and ʃEadi exist, it is used, and 
any asynchrony is seen as a mismatch of the Vt and ʃEadi magnitude. If Vt < 50 ml 
and ʃEadi exist, this information is not included. However, 300~500 ‘known’ 
breathing cycles are analysed for every patient in each ventilation mode. An average 
of only 30 breaths of ~500 per patient (6%) was discarded in each phase. Thus, the 
loss of this potential data, assuming they are true breaths, is negligible.   
 
6.5.2 Application of Range90 
It is important to note that, while Range90 shows better matching in NAVA than PS, 
it is yet to be applied as a bedside monitoring tool. Range90 in this study used 20 
minutes of breathing pattern of a patient in each ventilation mode, and the total 
duration for the study is not clinically feasible. In addition, the availability of Eadi 
signal for Range90 analysis is dependent on the availability of NAVA nasogastric 
tube. This study is a proof of concept and patient respiratory adaptation time to 
different ventilation mode was taken into consideration (Viale et al., 1998). Thus, the 
results indicate that the use of Range90 as a bedside monitoring tool warrants further 
investigation with shorter monitoring time. 
 
6.5.3  Setting NAVA Gain ‘Similar’ to Pressure Support 
Another limitation is that setting NAVA gain to obtain similar peak pressure as PS, is 
an approximation based on the built in previsualisation system and only one NAVA 
gain value is used to compare with PS. The amplitude of delivered pressure during 
NAVA is variable, as it is proportional to Eadi signal. Therefore, it is possible that the 
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delivered peak pressure may be higher or lower in different patients when comparing 
PS and NAVA. However, it was found that there was no significant difference 
between peak pressure between these two ventilation modes (p > 0.005) as shown in 
Table 6.3. Thus, for this cohort of 22 patients, the peak pressure in both modes can be 
considered as ‘similar’. 
 
6.6 Summary 
Compared to PS, NAVA allowed better match between Vt and Eadi as well as higher 
variability in Vt. As higher variability has been associated with improved oxygenation 
and as higher variability is present in healthier systems, the ability of NAVA in not 
reducing patient’s intrinsic variability could be of potential clinical interest. Studies 
on comparing patient-ventilator interaction on this cohort, mainly time asynchronies 
between PS and NAVA was also carried out and published elsewhere (Piquilloud et 
al., 2011b). Future work is needed to explore if there was a potential effect of this 
maintained variability obtained with NAVA on patients’ outcome.   
 
In this study, only one NAVA level and one PS level was tested and the influence of 
increasing NAVA level towards Vt/ʃEadi was not determined. The effect of Vt and 
ʃEadi related to increase in NAVA level have been extensively described by Passath 
et al. (Passath et al., 2010). Based on the results, we can assume that increasing 
NAVA level will result in a consecutive decrease in Eadi and in a small and only 
initial increase in Vt. As a consequence, we can assume that with increased NAVA 
level, Vt/ʃEadi ratio will also increase. This point is further explored in the next 
Chapter. 
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Chapter 7 
Application of NAVA for the Noninvasively 
Ventilated Patients 
 
Ventilation support can be delivered invasively or noninvasively. Non-invasive 
ventilation (NIV) is ventilator support delivered to the patient without the use of 
artificial airways such as endotracheal tube (ETT). NIV is widely used in cases of 
acute respiratory failure (Esteban et al., 2004) and for patients who are considered at 
risk of post-extubation respiratory failure (Ferrer et al., 2006). NIV is usually 
delivered in pressure support (PS) mode despite the poor synchronization observed in 
intensive care unit (ICU) patients (Vignaux et al., 2009). Neurally adjusted ventilatory 
assist (NAVA) has been shown to improve patient-ventilator interaction in 
comparison to PS both during invasive and non-invasive ventilation (Piquilloud et al., 
2011b, Schmidt et al., 2012, Spahija et al., 2010, Colombo et al., 2008), and increases 
respiratory variability in comparison to PS (Schmidt et al., 2010), as seen in Chapter 6. 
 
7.1 The NAVA Level Setting 
NAVA triggers and cycles the ventilator based on the patient’s diaphragmatic 
electrical activity (Eadi). The amount of pressure delivered by the ventilator is 
proportional to the Eadi amplitude (Sinderby et al., 1999). Clinicians can adapt the 
amount of assist delivered with NAVA by selecting a NAVA level corresponding to a 
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proportionality factor between instantaneously recorded Eadi and delivered pressure. 
However, common to all forms of PEEP and pressure selection, there is limited 
information on how to correctly set patient-specific NAVA level (Rozé et al., 2011, 
Brander et al., 2009, Barwing et al., 2011, Lecomte et al., 2009, Ververidis et al., 
2011). Additionally, implementing the best described method at the bedside (Brander 
et al., 2009) is difficult, potentially limiting the daily use of NAVA. The best way to 
adapt NAVA level on a day-to-day basis for individual patients is also unknown. 
Moreover, it is likely that each patient responds differently to various NAVA levels, 
complicating NAVA selection even further, and creating a patient-specific problem 
subject to significant inter- and intra- patient variability. 
 
The aims of this study were three-fold. The first goal was to study the matching 
analysis (Range90) for PS and NAVA during NIV similar to that for the invasive 
cases in Chapter 6. Second, is to assess the matching between patient-specific 
inspiratory demand (Eadi) with ventilatory supply, tidal volume (Vt) at different 
NAVA levels during NIV. And lastly, is to develop of a new physiological approach 
for titrating NAVA level settings to the individual patients in a consistent fashion. 
 
7.2 Methodology 
This study analyses Eadi-time, flow-time signal and derived parameters during NIV at 
three different NAVA levels. This study was conducted at the University hospital of 
Liege (Liege, Belgium) and Cliniques Universitaires Saint-Luc (Brussels, Belgium). 
Ethics Committees of University Hospital of Liege (Comité d'éthique du centre 
hospitalier universitaire de Liège) and the Ethics Committee of Cliniques 
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Universitaires Saint-Luc (Commission d'Ethique Biomédicale Hospitalo-Facultaire, 
Université catholique de Louvain, Faculté de Médecine) have approved the study 
protocol and use of the data.   
 
7.2.1 Patients 
The study cohort consisted of 13 noninvasively ventilated ICU patients (6 males and 7 
females). Patients were included in the study if they required NIV because of acute 
respiratory failure or were at risk of developing respiratory failure after extubation.  
The specific exclusion criteria were: 1) Severe hypoxemia requiring FiO2 > 0.7; 2) 
Hemodynamic instability; 3) Patient with a hiatal hernia or other oesophageal 
problem; upper gastrointestinal bleeding or any other contraindication to the insertion 
of a nasogastric tube; 4) Poor short term prognosis; and 5) Age < 18 years old. A 
summary of the patient demographic, clinical diagnosis and the detail ventilator 
settings for each patient is shown in Table 7.1 (Piquilloud et al., 2012). 
 
7.2.2 Ventilator and Delivered Ventilation 
All patients were ventilated with Servo-I ventilators (Maquet, Solna, Sweden) 
equipped with a commercially available NAVA module and software version 5.0. 
NIV was delivered though oronasal facemasks (Vygon SA, Ecouen, France) tightly 
attached to the patient in order to minimise the leaks.  
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Table 7.1: Patient demographic and ventilator settings 
Patients Gender 
Age 
(years) 
BMI 
SAPSII 
Score* 
Clinical 
Diagnosis 
FiO2 
PEEP 
(cmH2O) 
Inspiratory 
Trigger 
P 
Slope* 
(ms) 
PS Level* 
(cmH2O) 
ETS* 
(%) 
NAVA 
Level (uV/ 
cmH2O) 
1 F 62 20.27 33 
Exacerbation of 
COPD* 
0.25 5 Flow 150 9 40 0.2 
2 F 69 36.73 26 Pneumonia 0.30 7 Flow 150 10 30 0.6 
3 F 70 22.48 31 
Acute 
bronchospasm 
0.30 7 Flow 150 8 55 0.2 
4 F 56 16.7 33 
Exacerbation of 
COPD 
0.30 5 Flow 150 12 45 0.2 
5 M 64 22.49 54 
Acute renal 
failure 
0.50 5 Pressure/ Flow 150 12 30 0.8 
6 F 68 23.44 33 Asthma 0.25 9 Flow 150 9 30 0.4 
7 M 75 26.12 34 Sepsis 0.40 6 Flow 150 10 30 0.6 
8 M 87 23.67 28 
Exacerbation of 
COPD 
0.23 5 Flow 150 12 30 0.8 
9 M 72 40.04 29 
Exacerbation of 
COPD 
0.30 7 Flow 2000 12 50 0.4 
10 M 87 27.68 30 
Exacerbation of 
COPD 
0.21 6 Flow 50 11 45 0.4 
11 F 64 29.14 29 
Cardiogenic 
pulmonary 
edema 
0.40 5 Flow 200 5 50 1.0 
12 F 79 27.97 30 Pneumonia 0.70 5 Flow 200 10 50 1.0 
13 M 78 27.70 34 
Drug 
intoxication 
0.40 5 Flow 350 10 25 0.5 
Median   70 26.12 31  0.30 5  150 10 40 0.5 
25
th
  64 22.49 29  0.25 5  150 9 30 0.4 
75
th
   78 28.26 33  0.40 7  200 12 50 0.8 
* SAPSII - Simplified acute physiology score, P Slope - Pressurization slope, PS Level - Pressure support level, ETS - Expiratory Trigger Sensitivity, COPD - Chronic 
obstruct pulmonary disease, SIRS - Systematic inflammation response syndrome 
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7.2.3 Study Protocol and Recordings 
The clinical protocol consisted of two phases. Phase 1 compares the Range90 
matching between PS and NAVA during NIV. Phase 2 investigates the effect of 
NAVA levels to patient’s Range90 matching and specific response to each level. Both 
protocols record the patient’s Eadi and airway pressure and flow signals using the 
Servo-I ventilator, sampled at 100Hz using Servo-tracker V4.0 software (Maquet, 
Solna, Sweden). Positive end-expiratory pressure (PEEP), FiO2 and inspiratory trigger 
settings were maintained constant across PS and each NAVA level for a given patient. 
 
7.2.3.1 Phase 1 - PS and NAVA 
After written informed consent was obtained, the patient’s standard nasogastric tube 
was replaced by NAVA tube. For each patient, 20 minutes of continuous recording 
(~300-500 breaths) was carried out at PS. After PS, the ventilation mode was changed 
to NAVA for further 20 minutes. This NAVA level was set to have similar peak 
airway pressure (PIP) as in PS mode using the previsualization system included with 
the ventilator. 
 
7.2.3.2 Phase 2 - Various NAVA Levels 
The NAVA level set to have similar peak airway pressure as PS is denoted 
NAVA100. Two additional NAVA levels after NAVA100, denoted NAVA50 and 
NAVA150, that modified the initial NAVA level by ±50% were also used. Each 
additional NAVA level was maintained for additional 15 minutes of breathing and 
continuous recordings. NAVA50 was set by adjusting the NAVA100 level by -50% 
and NAVA150 was set by +50% of NAVA100 level. The order of NAVA50 and 
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NAVA150 recording were not standardised. While changing PS to NAVA, the initial 
NAVA level during NAVA100 can be either very low or high. Thus, a change of 
±50% is used rather than a specific change of an absolute value. The exact changes 
are thus patient-specific. Patient 3 was excluded from Phase 2 trial. After Phase 1 
trial, Patient 3 was intubated due to worsening of respiratory failure and thus was 
excluded from Phase 2 trial. 
 
7.2.4 Data Analysis 
Studies comparing patient-ventilator interaction for these patients assessing time 
asynchrony between PS and NAVA during NIV is presented elsewhere (Piquilloud et 
al., 2012).  
 
7.2.4.1 Statistical and Correlation Analysis  
Inspiratory demand, ʃEadi, ventilator tidal volume, Vt, neural inspiratory time, 
Ti_Neural, inspiratory time, Ti and peak inspiratory pressure, PIP are calculated for 
every breath during PS and at each NAVA level. Breaths with Vt < 50 ml were 
discarded from analysis based on post hoc analysis of the Vt distribution suggesting 
that breaths with Vt < 50 ml likely corresponded to measurement artefacts (Moorhead 
et al., 2012). 
 
The median value of the distributions of ʃEadi, Vt, Ti_Neural, Ti and PIP at PS and 3 
different NAVA levels were compared using the non-parametric Wilcoxon rank-sum 
test as they were not normally distributed. A Pearson’s correlation analysis was 
carried out for Vt with ʃEadi at different NAVA levels. Non-parametric Robust 
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coefficient of variation (CVR = median absolute deviation/ median) was calculated to 
assess and compare variability analysis in each parameter.  
 
7.2.4.2 Range90 Matching and Patient-Specific Comparison 
The 5
th
-95
th
 range of Vt/ʃEadi (Neuroventilatory efficiency (Passath et al., 2010)),  
Range90 is calculated for each patient in both PS and every NAVA level for 
comparison. A smaller value of Range90 indicates consistently better matching of Vt 
to ʃEadi. Patients with larger values of Range90 have a higher incidence of 
inconsistent Vt/ʃEadi breaths, which is a lesser ability to match Vt and ʃEadi, 
regardless of the patient-specific ʃEadi. The detail description of Range90 can be 
found in Chapter 6 and Appendix 02. 
 
Thus, the ratio of Vt/ʃEadi for each breath and the analysis of its distribution 
(Range90) over a given NAVA settings for a single patient enable a fair comparison 
between different NAVA levels. This simple metric can be readily calculated in real-
time to monitor patient-specific response to different NAVA levels. Hence, it may 
provide a simple solution to titrate NAVA level.  
 
7.3 Results and Discussion 
7.3.1 Phase 1 - Ventilation Matching in PS and NAVA 
The NIV patients’ ʃEadi, Vt, Ti_Neural, Ti and PIP at each NAVA and summary are 
presented in Table 7.2 and Table 7.3. Similar to the findings for invasive ventilation 
in Chapter 6, there is no significance difference in medians of ʃEadi, Vt, Ti_Neural, Ti 
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and PIP between PS and NAVA. While there is no significant difference in median 
values, individual patients had very different, patient-specific outcomes comparing 
NAVA and PS. 
 
Table 7.2: ʃEadi, Vt, Ti_Neural, Ti and peak pressure of the 13 NIV patients  
Patients ʃEadi(µVs) Vt (ml) Ti_Neural (s) Ti (s) PIP(cmH2O) 
1 PS 21.3 [18.5-24.2] 433 [401-468] 0.50 [0.43-0.56] 0.64 [0.60-0.68] 15.4 [15.3-15.5] 
NAVA 23.7 [21.2-26.5] 444 [404-490] 0.62 [0.56-0.65] 0.72 [0.70-0.78] 16.4 [15.3-17.9] 
2 PS 9.6 [7.0-11.9] 495 [460-523] 0.49 [0.45-0.53] 0.65 [0.63-0.68] 18.7 [18.6-18.8] 
NAVA 9.9 [7.8-11.7] 471 [389-544] 0.62 [0.57-0.68] 0.78 [0.72-0.84] 21.3 [18.9-24.3] 
3 PS 12.2 [11.1-12.9] 406 [391-422] 0.50 [0.46-0.54] 0.57 [0.55-0.58] 15.8 [15.8-15.8] 
NAVA 15.9 [14.2-17.6] 394 [372-418] 0.55 [0.49-0.60] 0.69 [0.65-0.74] 15.3 [14.7-16.1] 
4 PS 24.0 [20.2-28.9] 394 [343-448] 0.52 [0.46-0.59] 0.63 [0.56-0.70] 17.9 [17.8-18.0] 
NAVA 22.7 [19.5-25.7] 372 [339-406] 0.52 [0.48-0.59] 0.69 [0.63-0.73] 17.3 [16.2-18.5] 
5 PS 8.4 [4.0-13.5] 714 [689-759] 0.75 [0.71-0.80] 0.95 [0.89-1.02] 18.5 [18.4-18.6] 
NAVA 8.0 [6.5-10.4] 738 [671-810] 0.72 [0.68-0.77] 0.84 [0.80-0.89] 19.8 [17.2-22.6] 
6 PS 17.4 [15.6-19.2] 545 [532-561] 0.29 [0.26-0.33] 0.53 [0.52-0.54] 19.6 [19.5-19.7] 
NAVA 13.9 [10.4-16.1] 631 [594-675] 0.40 [0.36-0.44] 0.54 [0.50-0.57] 27.3 [25.1-29.5] 
7 PS 9.7 [8.8-10.7] 644 [630-663] 0.46 [0.43-0.49] 0.60 [0.59-0.61] 17.9 [17.7-18.1] 
NAVA 9.8 [8.9-10.7] 688 [657-718] 0.51 [0.47-0.55] 0.65 [0.62-0.67] 23.2 [21.9-24.5] 
8 PS 14.1 [10.2-17.7] 732 [671-818] 0.71 [0.60-0.78] 0.94 [0.89-1.00] 18.5 [18.3-20.4] 
NAVA 15.0 [13.1-17.4] 741 [653-833] 0.81 [0.72-0.88] 0.98 [0.91-1.05] 25.0 [22.2-27.9] 
9 PS 17.7 [14.2-20.8] 496 [455-537] 0.72 [0.62-0.86] 0.73 [0.65-0.86] 19.6 [19.4-19.8] 
NAVA 41.1 [31.2-51.3] 646 [451-862] 1.65 [1.33-1.91] 1.89 [1.60-2.10] 22.5 [19.9-24.9] 
10 PS 15.9 [12.8-18.6] 614 [558-672] 0.41 [0.35-0.46] 0.53 [0.48-0.58] 18.6 [18.4-18.8] 
NAVA 13.5 [9.5-18.8] 531 [404-657] 0.51 [0.41-0.65] 0.67 [0.55-0.80] 21.5 [17.5-24.0] 
11 PS 21.4 [4.0-48.1] 341 [112-720] 0.61 [0.29-1.01] 0.95 [0.46-1.35] 10.6 [9.9-11.1] 
NAVA 24.3 [7.6-39.9] 487 [244-908] 0.92 [0.53-1.23] 1.15 [0.74-1.44] 13.2 [11.8-14.4] 
12 PS 4.6 [2.6-6.4] 528 [489-560] 0.69 [0.60-0.74] 0.71 [0.66-0.76] 14.9 [14.5-15.1] 
NAVA 10.1 [7.5-13.4] 653 [585-726] 0.90 [0.80-1.00] 1.08 [0.98-1.15] 22.3 [18.7-25.9] 
13 PS 6.3 [3.9-9.4] 630 [475-794] 0.52 [0.37-0.70] 1.37 [0.86-1.96] 13.4 [12.5-14.1] 
NAVA 6.7 [3.3-10.7] 457 [250-613] 0.64 [0.50-0.82] 0.87 [0.69-1.05] 8.1 [6.7-9.5] 
 
 
Table 7.3: Summary of ʃEadi, Vt, Ti_Neural, Ti and peak pressure median [IQR] 
 ʃEadi(µVs) Vt (ml) Ti_Neural (s) Ti (s) PIP(cmH2O) 
Median of 
Medians 
[IQR] 
PS 
 
14.1
 
  
[9.3-18.6] 
528  
[426-634] 
0.52  
[0.48-0.70] 
0.65  
[0.59-0.94] 
17.9  
[15.3-18.6] 
NAVA 13.9  
[9.9-23.0] 
531  
[454-662] 
0.62  
[0.52-0.83] 
0.78  
[0.69-1.01] 
21.3  
[16.1-22.7] 
p-value > 0.005  > 0.005  > 0.005  > 0.005  > 0.005 
 
Table 7.4 shows the Range90 for these 13 NIV patients during PS and NAVA. 
Overall, 11 of the 13 patients included in the study showed better matching (Lower 
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Range90) during NAVA than in PS. Patient 4 and Patient 6 had PS/ NAVA Range90 
ratios of < 1.00 suggesting that both these patients have lesser matching during 
NAVA.  Equally, Patient 3 has Range90 ratio 1.21, and will not benefit much in terms 
of matching supply and demand matching when changing from PS to NAVA, so 
performance is effectively equivalent. 
 
Table 7.4: PS and NAVA Range90 (ml/µVs) for all 13 NIV patients 
Patients PS NAVA Range90 Ratio PS/NAVA 
1 15.3 8.5 1.80 
2 129.5 38.4 3.37 
3 14.5 12.0 1.21 
4 9.3 16.0 0.58* 
5 239.0 110.9 2.16 
6 24.3 84.0 0.29* 
7 34.6 22.9 1.51 
8 123.4 24.9 4.96 
9 35.0 12.4 2.82 
10 42.4 19.9 2.13 
11 354.5 47.2 7.51 
12 549.3 97.7 5.62 
13 445.8 141.8 3.14 
Median [IQR] 42.4 [22.1-267.9] 24.9 [15.1-87.43] 2.15 [1.44-3.77] 
*Lower Range90 in PS than in NAVA 
 
Similar to results observed in invasively ventilated patients in Chapter 6, NAVA 
consistently showed lower Range90 (better matching) than PS. Range90 results from 
IV and NIV patients (Table 6.5 and Table 7.4) for both PS and NAVA are 
summarised in Figure 7.1. Patient markers below the 1:1 ratio trend line showed 
better matching during NAVA ventilation. Only 3 of 35 patients from the two 
different cohorts (IV Patient 21, NIV Patient 4 and NIV Patient 6) had better 
matching during PS, as shown in Figure 7.1. 
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Figure 7.1: Comparing Range90 in PS and NAVA for 22 patients during invasive 
ventilation and 13 patients during non-invasive ventilation. 
 
It is important to note that the underlying ∫Eadi can be very different for every patient. 
The magnitude of the Eadi signal is dependent on the position of the NAVA tube 
resulting in variable range of Eadi. This difference indirectly affects Vt/∫Eadi ratio. 
Therefore, inter-patient comparison may not be completely suitable. However, the 
trends comparing PS and NAVA are clear. Equally, while small difference may not be 
significant, larger ones show a clear result when comparing patients. 
 
The NAVA level was set to ensure the maximum PIP is similar to the PIP during PS. 
However, it was found that some patients still had significantly different PIP from 
NAVA than during PS, suggesting that shifting PS to NAVA may affect patients 
underlying Eadi, resulting in different support expected from NAVA. This finding 
further verified the limitation pointed out in Chapter 6, questioning the comparison 
between the ‘correct NAVA level’ to the associated PS setting. Thus, setting the 
optimal pressure support remains debatable, and the ‘simplest’ method of NAVA 
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level setting is using the previsualisation software (Moorhead et al., 2012). Thus, the 
previsualisation method is currently, the only method of comparing PS and NAVA 
setting. Titration of an optimal NAVA pressure level thus warrants further 
investigation (Brander et al., 2009) as is the cases for almost all forms of PEEP and 
pressure support. 
 
7.3.2 Phase 2 - Various NAVA Levels  
7.3.2.1 Effect of NAVA Levels towards Patients 
In this section, NIV patients’ ʃEadi, Vt, Ti_Neural, Ti, PIP and duty cycles (Ti/Ttot = 
inspiratory time / total time for inspiratory and expiratory) during different NAVA 
levels are compared (Tables 7.5-7.10). The summary of these parameters is presented 
in Table 7.11. Note that Patient 3 is excluded for the NAVA level comparison in 
Tables 7.5-7.10 for clinical reasons. Patient 3 did not complete the study due to 
worsening of respiratory failure. 
 
Table 7.5: Patient’s inspiratory demand (ʃEadi) 
Patient 
ʃEadi (uVs), Median [IQR] 
NAVA50 NAVA100 NAVA150 
1 24.5 [21.2-27.6] 23.7 [21.2-26.5] 19.1 [16.4-22.4]*+ 
2 11.3 [8.1-13.9] 9.9 [7.8-11.7]* 6.9 [5.1-9.0]*+ 
4 22.6 [17.1-25.6] 22.7 [19.5-25.7] 21.2 [18.3-23.8]+ 
5 10.1 [8.7-11.5] 8.0 [6.5-10.4]* 8.6 [5.6-10.3]* 
6 15.8 [14.5-17.7] 13.9 [10.4-16.1]* 15.2 [12.9-17.3]*+ 
7 10.5 [9.8-11.4] 9.8 [8.9-10.7]* 9.0 [8.1-9.8]*+ 
8 23.3 [19.8-25.9] 15.0 [13.1-17.4]* 9.9 [8.3-11.7]*+ 
9 31.5 [26.3-36.3] 41.1 [31.2-51.3]* 16.6 [14.0-19.1]*+ 
10 21.1 [15.9-28.6] 13.5 [9.5-18.8]* 13.7 [9.3-18.9]* 
11 50.9 [31.5-61.9] 24.3 [7.6-39.9]* 54.9 [36.0-62.9]+ 
12 8.3 [5.2-11.6] 10.1 [7.5-13.4]* 5.9 [4.0-8.7]*+ 
13 4.2 [2.4-7.7] 6.7 [3.3-10.7]* 5.3 [2.6-8.5]+ 
Median of Medians [IQR] 18.5 [10.3-23.9] 13.7 [9.9-23.2] 11.8 [7.8-17.9] 
* p<0.005 compared to NAVA50, + p<0.005 compared to NAVA100 
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Table 7.6: Ventilatory tidal volume (Vt) 
Patient 
Vt (ml), Median [IQR] 
NAVA50 NAVA100 NAVA150 
1 526 [435-564] 444 [404-490]* 474 [424-541]*+ 
2 450 [379-524] 471 [389-544] 481 [399-586]* 
4 324 [294-345] 372 [339-406]* 416 [379-450]*+ 
5 654 [597-698] 738 [671-810]* 788 [584-895]* 
6 549 [525-578] 631 [594-675]* 727 [679-764]*+ 
7 596 [574-621] 688 [657-718]* 763 [725-802]*+ 
8 608 [518-689] 741 [653-833]* 715 [605-836]* 
9 522 [468-559] 646 [451-862]* 621 [544-696]* 
10 523 [411-660] 531 [404-657] 664 [466-854]*+ 
11 496 [343-705] 487 [244-908] 485 [354-689] 
12 543 [486-610] 653 [585-726]* 638 [553-688]*+ 
13 270 [179-391] 457 [250-613]* 413 [208-708]* 
Median of Medians [IQR] 525 [473-573] 581 [464-671] 630 [478-721] 
* p<0.005 compared to NAVA50, + p<0.005 compared to NAVA100 
 
Table 7.7: Neural inspiratory time (Ti) 
Patient 
Ti_Neural (second), Median [IQR] 
NAVA50 NAVA100 NAVA150 
1 0.68 [0.61-0.75] 0.62 [0.56-0.65]* 0.61 [0.54-0.65]*+ 
2 0.64 [0.58-0.68] 0.62 [0.57-0.68] 0.59 [0.53-0.66]*+ 
4 0.54 [0.48-0.59] 0.52 [0.48-0.59] 0.53 [0.49-0.60] 
5 0.78 [0.74-0.82] 0.72 [0.68-0.77]* 0.74 [0.62-0.82]* 
6 0.40 [0.36-0.43] 0.40 [0.36-0.44] 0.40 [0.36-0.44] 
7 0.52 [0.48-0.56] 0.51 [0.47-0.55]* 0.50 [0.46-0.56]* 
8 0.94 [0.85-1.04] 0.81 [0.72-0.88]* 0.77 [0.66-0.85]*+ 
9 1.63 [1.39-1.76] 1.65 [1.33-1.91] 1.25 [1.08-1.48]*+ 
10 0.58 [0.48-0.73] 0.51 [0.41-0.65]* 0.49 [0.40-0.64]* 
11 1.32 [0.98-1.52] 0.92 [0.53-1.23]* 1.27 [1.03-1.49]+ 
12 0.86 [0.78-0.92] 0.90 [0.80-1.00]* 0.90 [0.80-0.98]* 
13 0.77 [0.59-0.93] 0.64 [0.50-0.82]* 0.70 [0.53-0.89]+ 
Median of Medians [IQR] 0.73 [0.56-0.90] 0.63 [0.52-0.86] 0.66 [0.52-0.84] 
* p<0.005 compared to NAVA50, + p<0.005 compared to NAVA100 
Table 7.8: Inspiratory time (Ti) 
Patient 
Ti (second), Median [IQR] 
NAVA50 NAVA100 NAVA150 
1 0.86 [0.77-0.95] 0.72 [0.70-0.78]* 0.73 [0.69-0.77]* 
2 0.78 [0.73-0.83] 0.78 [0.72-0.84] 0.74 [0.68-0.81]*+ 
4 0.70 [0.64-0.74] 0.69 [0.63-0.73] 0.70 [0.65-0.75] 
5 0.90 [0.87-0.94] 0.84 [0.80-0.89]* 0.87 [0.77-0.96]* 
6 0.55 [0.51-0.57] 0.54 [0.50-0.57] 0.55 [0.51-0.57] 
7 0.65 [0.63-0.67] 0.65 [0.62-0.67] 0.65 [0.62-0.67] 
8 1.10 [1.00-1.20] 0.98 [0.91-1.05]* 0.96 [0.86-1.02]* 
9 1.78 [1.58-1.94] 1.89 [1.60-2.10] 1.57 [1.35-1.80]*+ 
10 0.73 [0.63-0.89] 0.67 [0.55-0.80]* 0.62 [0.53-0.81]* 
11 1.55 [1.35-1.71] 1.15 [0.74-1.44]* 1.55 [1.28-1.71]+ 
12 1.01 [0.94-1.06] 1.08 [0.98-1.15]* 1.06 [0.99-1.12]* 
13 0.98 [0.82-1.12] 0.87 [0.69-1.05]* 0.93 [0.75-1.15]+ 
Median of Medians [IQR] 0.88 [0.72-1.06] 0.81 [0.68-1.03] 0.81 [0.68-1.01] 
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* p<0.005 compared to NAVA50, + p<0.005 compared to NAVA100 
Table 7.9: Peak inspiratory pressure (PIP) 
Patient 
Peak Pressure (cmH2O), Median [IQR] 
NAVA50 NAVA100 NAVA150 
1 11.5 [10.6-12.6] 16.4 [15.3-17.9]* 18.7 [17.2-20.7]*+ 
2 17.1 [14.9-19.2] 21.3 [18.9-24.3]* 23.3 [19.8-27.0]*+ 
4 12.1 [11.4-12.9] 17.3 [16.2-18.5]* 21.6 [20.2-23.4]*+ 
5 14.4 [13.1-15.4] 19.8 [17.2-22.6]* 25.4 [20.7-28.6]*+ 
6 20.1 [19.1-21.1] 27.3 [25.1-29.5]* 35.2 [33.4-35.7]*+ 
7 16.9 [16.1-17.9] 23.2 [21.9-24.5]* 28.1 [26.3-30.3]*+ 
8 20.2 [17.4-23.3] 25.0 [22.2-27.9]* 26.4 [21.1-31.0]*+ 
9 16.2 [14.7-17.0] 22.5 [19.9-24.9]* 21.8 [20.4-24.7]* 
10 18.1 [15.9-19.9] 21.5 [17.5-24.0]* 28.4 [22.4-33.0]*+ 
11 13.2 [12.9-13.8] 13.2 [11.8-14.4] 11.5 [10.7-11.8]*+ 
12 15.5 [12.9-18.9] 22.3 [18.7-25.9]* 20.6 [17.1-25.8]*+ 
13 5.9 [5.6-6.6] 8.1 [6.7-9.5]* 7.1 [5.9-8.3]*+ 
Median of Medians [IQR] 15.9 [12.7-17.6] 21.4 [16.9-22.9]* 22.6 [19.7-27.3]* 
* p<0.005 compared to NAVA50, + p<0.005 compared to NAVA100 
 
Table 7.10: Duty cycle (Ti/Ttot) 
Patient 
Duty Cycle (Ti/Ttot), Median [IQR] 
NAVA50 NAVA100 NAVA150 
1 0.35 [0.27-0.48] 0.35 [0.33-0.37] 0.34 [0.30-0.36]*+ 
2 0.41 [0.39-0.44] 0.40 [0.38-0.43]* 0.39 [0.36-0.41]*+ 
4 0.32 [0.30-0.37] 0.31 [0.29-0.34]* 0.30 [0.29-0.33]*+ 
5 0.42 [0.40-0.43] 0.40 [0.39-0.42]* 0.42 [0.40-0.71]+ 
6 0.29 [0.28-0.31] 0.29 [0.27-0.31]* 0.31 [0.29-0.32]*+ 
7 0.40 [0.38-0.41] 0.36 [0.35-0.38]* 0.37 [0.35-0.38]*+ 
8 0.40 [0.36-0.52] 0.41 [0.36-0.59] 0.36 [0.32-0.59]*+ 
9 0.40 [0.37-0.46] 0.39 [0.35-0.45] 0.37 [0.32-0.41]*+ 
10 0.37 [0.29-0.43] 0.38 [0.31-0.43] 0.38 [0.33-0.42] 
11 0.35 [0.31-0.48] 0.41 [0.31-0.70] 0.33 [0.30-0.41]*+ 
12 0.40 [0.38-0.43] 0.39 [0.37-0.41]* 0.39 [0.37-0.42]* 
13 0.43 [0.32-0.96] 0.33 [0.25-0.77]* 0.33 [0.26-0.77]* 
Median of Medians [IQR] 0.40 [0.35-0.41] 0.39 [0.34-0.40] 0.37 [0.33-0.39] 
* p<0.005 compared to NAVA50, + p<0.005 compared to NAVA100 
Table 7.11: Summary of ʃEadi), Vt, Ti_Neural, Ti, PIP and Ti/Ttot 
 
 Median of Medians [IQR] 
NAVA50 NAVA100 NAVA150 
ʃEadi (μVs) 18.5 [10.3-23.9] 13.7 [9.9-23.2] 11.8 [7.8-17.9] 
Vt (ml) 525 [473-573] 581 [464-671] 630 [478-721] 
Ti_Neural (second) 0.73 [0.56-0.90] 0.63 [0.52-0.86] 0.66 [0.52-0.84] 
Ti (second) 0.88 [0.72-1.06] 0.81 [0.68-1.03] 0.81 [0.68-1.01] 
PIP (cmH2O) 15.9 [12.7-17.6] 21.4 [16.9-22.9]* 22.6 [19.7-27.3]* 
* p<0.005 compared to NAVA50, + p<0.005 compared to NAVA100 
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Overall, it is observed that NAVA50 had higher ʃEadi = 18.5 μVs [IQR: 10.4-23.6] 
with lower tidal volume, Vt = 525 ml [IQR: 485-561] corresponding to PIP = 16.20 
cmH2O [IQR: 12.7-17.6]. In contrast, NAVA150 had slightly lower ʃEadi (11.8 μVs 
[IQR: 8.2-17.2]) and higher Vt (630 ml [IQR: 479-718]) with PIP = 22.6cmH2O 
[20.1-26.8]. However, only PIP was found with significant difference (p < 0.005), 
given the low number of patient and comparing the medians. The effect of NAVA 
levels towards Vt and ʃEadi distribution is further illustrated in Figure 7.2 (Top and 
middle panel). The boxed areas in Figure 7.2 showed the 5
th
-95
th
 range of patients 
corresponding Vt and ʃEadi. These two panels showed examples of a NAVA50 Vt-
ʃEadi plot having overall lowest Vt and highest ʃEadi, NAVA150 had overall higher 
Vt and lower ʃEadi, and NAVA100 is located in between. These results clearly show 
the effect of NAVA level towards patient ʃEadi, while maintaining Vt variability.  
 
Median inspiratory time for NAVA50 is slightly higher at 0.88 s [IQR: 0.72-1.03] (p 
< 0.005 for 7 patients in NAVA100 and 7 patients in NAVA150, when compared to 
NAVA50). The patients neural inspiratory time is also higher during NAVA50 with 
0.73 s [0.56-0.90] compared to other NAVA levels (p < 0.005 for 8 patients in 
NAVA100 and 8 patients in NAVA150, when compared to NAVA50). There was no 
significant difference between the medians of these data. However, individually, more 
than half of the patients included in the study had shown significant difference in each 
tested parameters.  
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Figure 7.2: Distribution of Vt-ʃEadi for patients at different NAVA level. (Top) 
Patient 2, (Middle) Patient 8, (Bottom) Patient 11. The boxed areas show the breaths 
included in the 5-95
th
 range. 
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Overall, the results show that patients behaved, in general, as expected from other 
studies (Brander et al., 2009, Colombo et al., 2008, Lecomte et al., 2009, Sinderby et 
al., 2007, Patroniti et al., 2012). More importantly, they also show that NAVA level is 
highly patient-specific due to significant inter-patient variability. Schmidt et al 
(Schmidt et al., 2010) showed that higher NAVA level resulted in lower Eadi 
magnitude with higher tidal volume. Higher NAVA level delivers higher, pressure 
proportional to the level settings, resulting in possible higher ventilator supply, Vt, 
and thus, that the Eadi signal that represents the patient-specific demand may possibly 
decrease. Hence, the overall results in this study match the trend in other published 
results (Brander et al., 2009, Colombo et al., 2008, Lecomte et al., 2009, Sinderby et 
al., 2007, Patroniti et al., 2012).  
 
The difference between this study and previous studies is that previous study analyse 
the effect of specific absolute NAVA level towards ʃEadi, Vt, Ti_Neural, Ti, PIP and 
other related parameters, whereas this study focused on patient-specific response 
towards relative changes (±50%) of NAVA level. Thus, it is a more physiologically 
relevant comparison to assess NAVA level titration. 
 
7.3.2.2 Effect of NAVA Level towards Range90 Matching 
Table 7.12 presents the initial NAVA values and Range90 values for NAVA100, 
NAVA50 and NAVA150. The results show that NAVA levels influence the matching 
between a patient’s demand and the delivered Vt. Overall, NAVA level set as 
proposed by the manufacturer (NAVA100), to match the same peak inspiratory 
pressure as the pressure set under PS; did not give the best matching/ Lowest Range90.  
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More specifically, comparing Range90 in different NAVA levels as shown in Table 
7.12, the Range90 for the entire cohort is the smallest for NAVA50, with median = 
26.6 [IQR: 15.8-59.5]. This result shows that NAVA50 had better matching for the 
cohort, in general, compared to Range90 in NAVA100 = 31.7 [IQR: 18.9-87.4] and 
Range90 in NAVA150 = 36.4 [IQR 19.7-95.3]. 
 
Table 7.12: Patients’ Range90 in different NAVA Level 
Patient 
Initial NAVA 
Level, 
(uV/cmH2O)  
Range 90 (Vt/ʃEadi) 
NAVA50 NAVA100 NAVA150 
1 0.2 14.7 8.5 14.0 
2 0.6 93.7 38.4 138.6 
3 0.2 - 12.0 - 
4 0.2 36.3  16.0 17.1 
5 0.8 48.6 110.9 80.9 
6 0.4 20.5 84.0 40.2 
7 0.6 20.5 22.9 32.5 
8 0.8 7.2 24.9 68.0 
9 0.4 10.8 12.4 17.4 
10 0.4 16.1 19.9 20.4 
11 1.0 30.7 47.2 30.5 
12 1.0 277.9 97.7 207.2 
13 0.5 92.2 141.8 211.9 
Median [IQR] 0.5 [0.4-0.8] 25.6 [15.4-70.4] 31.7 [18.0-90.9] 36.4 [18.9-109.8] 
   24.9 [15.1-87.4]#  
# Include Patient 3 
 
However, cohort results can be misleading for specific patients, and they have better 
matching at different NAVA levels. More specifically, Patient 11 has minimum 
Range90 at NAVA150 and 4 patients have a minimum at NAVA100 (Patients 1-2, 4, 
12). Thus, only 7 patients (Patients 5-10, 13) had the overall lowest median in 
NAVA50.  These results show the clear inter-patient variability, and also the clinical 
potential to use Vt/ʃEadi and Range90 to titrate patient-specific NAVA level over a 
heterogeneous patient cohort.  
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More specifically, it is less suitable to make Range90 comparison in a cohort. 
Practically, such an approach could be used in real-time for specific patient if it was 
implemented in the ventilator in order to choose the best NAVA level for a given 
patient at a given time. Using regular titration, it could be a new and useful approach 
to adapt NAVA level over time and especially during weaning from MV, a topic for 
which only very few data are available (Rozé et al., 2011). 
 
It is observed that several patients have very similar Range90 in two different NAVA 
levels, with only ±10% difference (Patient 4: NAVA100 and NAVA150, Patient 7: 
NAVA50 and NAVA150 and Patient 11: NAVA50 and NAVA150). These results 
show that, the effect of these two different NAVA levels are less significant in the 
matching of ventilator supply and patient demand. This finding also indicates that 
supply and demand matching does not necessarily correspond linearly to NAVA 
level.  
 
Figures 7.3 show Vt/ʃEadi cumulative distributions for Patients 2, 8 and 11 with 
Range90 values at each NAVA level. These cases each have a minimum Range90 
value (best matching) at different NAVA levels. The corresponding Vt and ʃEadi at 
different NAVA levels were also highlighted earlier in Figure 7.2. More specifically, 
Range90 suggests that Patient 2 should be ventilated at the original NAVA100 level, 
Patient 8 could have the original NAVA level of 0.80 can be reduced by 50% for 
better matching (NAVA50), and Patient 11 would be better matched at the higher 
NAVA150 level.  
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Figure 7.3: Cumulative distribution for Vt/ʃEadi in Range90 analysis. (TOP) Patient 
2 - NAVA100 has smaller Range90, (Middle) Patient 8 - NAVA 50 has smaller 
Range90, (Bottom) Patient 11 – NAVA150 and NAVA50 have a similar Range90, 
with NAVA150 smaller. 
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Correlation coefficients in Table 7.13 facilitate examination of the relationship 
between Vt with ʃEadi, independent of the effects of NAVA level on the magnitude 
of Eadi signals. The correlation coefficient between Vt and ʃEadi may potentially be 
another metric to aid in titrating NAVA level. Comparing Pearson’s correlation 
between PS and other NAVA levels, it is clear that NAVA provides better Vt and 
ʃEadi correlation (p < 0.005) suggesting better matching of supply and demand. 
 
Table 7.13: Pearson’s correlation coefficient, R 
Patients 
Pearson’s Correlation Coefficient (Vt-ʃEadi) 
PS NAVA50 NAVA100 NAVA150 
1 0.51 0.79 0.81 0.81 
2 0.44 0.50 0.83 0.76 
3 0.19 - 0.74 - 
4 0.80 0.73 0.81 0.83 
5 0.13 0.53 0.79 0.88 
6 0.28 0.72 0.71 0.77 
7 0.45 0.72 0.76 0.86 
8 0.42 0.77 0.87 0.17 
9 0.54 0.88 0.84 0.93 
10 0.55 0.91 0.95 0.96 
11 0.39 0.77 0.78 0.62 
12 0.36 0.50 0.72 0.67 
13 0.18 0.84 0.69 0.68 
Median [IQR]  0.75 [0.63-0.82] 0.80 [0.74-0.84] 0.79 [0.68-0.87] 
 
0.42  
[0.26-0.52]# 
 
0.79 
 [0.74-0.83]# 
 
# Includes Patient 3 
 
The correlation coefficients for different NAVA levels in this study were similar, 
indicating that NAVA was able to consistently match supply with demand at different 
levels. However, individual patients showed otherwise. For example, Patient 2 
(NAVA50), Patient 4 (NAVA50), Patient 7 (NAVA150) and Patient 11 (NAVA50), 
showed significantly lower R values compared to other NAVA levels, indicating 
significant supply and demand mismatch at a patient-specific level. Equally, the small 
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changes in the value of R between NAVA levels may not be clinically significant, 
indicating that correlation coefficient was not as sensitive to changes in NAVA level 
as the Range90 metric. The Range90 metric consistently identified Vt/ʃEadi 
mismatch between NAVA levels compared to Pearson’s correlation, yielding a 
potentially more sensitive metric. Hence, clinically, large difference would indicate 
the need for the clinician to look deeper or change their approach to patient treatment. 
 
7.4 Limitations 
Several potential limitations of this study should be pointed out. First, NAVA100 was 
defined to match the value of peak airway pressure during PS as set by clinicians for 
the specific patients care. However, there was no standardisation of PS settings 
beyond clinical practice, and thus the appropriate level of assistance may not be 
optimal at NAVA100. This point clearly shows the variability in the field over this 
issue. 
 
This study was conducted during NIV ventilation. During NIV, leaks can occur at the 
patient-mask interface and can influence delivered Vt which could affect the results. 
However, for this study, the mask was tightly attached to the patient by an 
experienced therapist to minimize the chance of leaks. Additionally, the therapist 
remained at the bedside during the whole recording to adapt the mask if necessary. 
These precautions made major leaks at the patient mask interface very unlikely. 
Additional results and discussion on volume leak can be found in Appendix 03. 
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Only 3 levels of NAVA were explored for each patient, separated by ±50% from the 
original NAVA level. At ±50%, the absolute changes of NAVA level can be very 
small or large depending on the initial clinically selected NAVA level. One 
consequence of such widely spaced NAVA levels is that, potentially, none of the 3 
tested NAVA levels in the trials were optimal. Thus, a more refined set of NAVA 
levels might well show a better result with this metric at a different NAVA level. 
However, such refinement in testing is burdensome to the patient and the results 
clearly showed that clinically set values may not remain optimal. 
 
Finally, it is important to note that while the Range90 metric showed better matching 
for specific NAVA levels, the advantage of using Range90 to titrate NAVA level is 
not yet clinically proven. Prior work has shown better matching of Vt to ʃEadi 
demand results in less asynchrony in comparing NAVA and PS (Piquilloud et al., 
2012). However, the use of Range90 to titrate NAVA levels for better physiological 
outcome remains to be prospectively tested. The results here show only Range90 
sensitivity to different NAVA levels and level of inter-patient variability that can be 
encountered, thus, demonstrating its clinical potential.   
 
7.5 Summary 
Patients who suffered from acute respiratory failure may benefit from the NAVA 
ventilation mode during NIV, which can better match patient-specific demand with 
ventilator supply compared to PS. Based on matching and correlation analysis, it was 
found that each patient reacted differently to different NAVA levels. This finding 
indicates significant inter-patient variability and patient-specific response. Using the 
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proposed concept of supply and demand ratios (Range90), more optimal NAVA 
levels can be found and titrated for each patient based on the simple Range90 metric. 
This approach can later be used in real-time to adapt NAVA levels if included in 
software. 
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Chapter 8 
Respiratory Mechanics Estimation for 
Spontaneously Breathing Patients 
 
8.1  Respiratory Mechanics in Spontaneously Breathing Patient 
For fully sedated MV patients, the breathing effort, or work of breathing is fully taken 
over by the ventilator (Robert J. Mason et al., 2010, Hasan, 2010). Thus, patient-
specific respiratory system elastance can be easily determined during the inspiration 
cycle (Bates and Lauzon, 1992, Baconnier et al., 1995, Avanzolini et al., 1997, 
Eberhard et al., 2003, Chiew et al., 2011, Brochard et al., 2012). In contrast, 
spontaneous breathing (SB) patients have individual breathing effort aside from the 
support given by the ventilator. Thus, additional information on the patient-induced 
pressure change in the pleural space of these SB patients is required to determine the 
true respiratory mechanics (Kallet et al., 2007, Grinnan and Truwit, 2005).  
 
Measuring the pressure change in the pleural space (pleural pressure, Ppl) requires an 
invasive manoeuvre. A pressure sensor called a balloon catheter is inserted into the 
oesophageal to measure the pressure change during breathing (Benditt, 2005). This 
oesophageal pressure (Poe) is used as a surrogate of pleural pressure and has been 
suggested as a metric that could be used to guide PEEP titration (Lorino et al., 1981, 
Lorino et al., 1982, Buscher et al., 2000, Benditt, 2005, Talmor et al., 2006, Talmor et 
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al., 2008). However, the measuring equipment for oesophageal pressure, the balloon 
catheter and data acquisition software are not normally available in many 
conventional ventilators.  
 
In addition, oesophageal pressure measurements are questionable due to their 
dependency on the location of the balloon catheter inserted into the oesophagus 
(Talmor et al., 2006, Guérin and Richard, 2012). These uncertainties and invasiveness 
preclude its regular bedside application in most ICUs,  aside from use in specialized 
research studies (Zaccheo et al., 2010, Stenqvist et al., 2012). Thus, estimating 
respiratory mechanics to guide MV is currently limited to patients who are fully 
sedated and is often less reliable when the patient is awake or breathing spontaneously 
(Iotti et al., 1995, Talmor et al., 2006, Talmor et al., 2008, Mulqueeny et al., 2010, 
Brochard et al., 2012). This issue significantly limits the use of model-based methods 
based on estimating respiratory dynamics. 
 
Furthermore, conventional methods estimate linear  respiratory elastance components 
using 2 point measurements (∆P/∆V) from the measured pneumatic signals to obtain 
the chest wall elastance or lung elastance, (Grinnan and Truwit, 2005). Other 
approaches use multiple linear regression (Lorino et al., 1981, Muramatsu et al., 2001, 
Khirani et al., 2010) using the measured pneumatic signals. These methods only 
provide a single average elastance measurement and do not show the time-varying or 
dynamic aspects of the true lung mechanics within a breathing cycle, which also 
contain useful clinical information (Guttmann et al., 1994, Chiew et al., 2011, Zhao et 
al., 2012a). 
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In this chapter, a non-invasive model-based method to estimate respiratory mechanics 
in SB patients is presented. More specifically, the compartment model that describes 
the respiratory system is extended to provide more in-depth and specific 
understanding to existing lung physiology. Respiratory mechanics captured during SB 
potentially provide useful patient and clinical insight in guiding therapy. Such a 
capability, without invasive oesophageal pressure measurement (Benditt, 2005, 
Talmor et al., 2008, Khirani et al., 2010, Terzi et al., 2012); would encourage and 
dramatically extend the application of respiratory mechanics to titrate care in SB 
patients. 
 
8.2 Methodology 
8.2.1 Spontaneously Breathing Respiratory Model 
The ‘standard’ equation of motion for a single compartment linear lung model used to 
monitor patient-specific respiratory mechanics in sedated patients without the 
influence of offset pressure is defined (see also Chapters 4 and 5) (Iotti et al., 1995, 
Bates, 2009a): 
 
 Paw(t) = Rrs ×  Q(t)+ Ers ×  V(t)     (8.1) 
 Paw(t)  = Ptp(t)  + Ppl(t)      (8.2) 
 Ptp(t) = Rlung ×  Q(t) + Elung ×  V(t)      (8.3) 
 Ppl(t) = Rcw ×  Q(t) + Ecw ×  V(t)     (8.4) 
 
Equation 8.1 is derived from combining the influence of pleural pressure (Ppl) to the 
transpulmonary pressure (Ptp) (Bates, 2009a). These equations can be used to 
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separately estimate the components of elastance, resistance and work of breathing 
(Polese et al., 1991, Coussa et al., 1993). The variables in Equation 8.1-8.4 are 
defined in Table 8.1. 
 
In a sedated patient, who is fully dependant on MV for work of breathing, it can be 
assumed that the patient does not have any individual breathing effort. Thus, the 
pressure changes in the pleural space (chest wall) can be assumed to be zero or 
constant (Ppl ≅ 0). This assumption yields: 
 
 Paw(t)  – Ppl(t)  = Rlung ×  Q(t) + Elung ×  V(t)    (8.5) 
 Paw(t)  = Rlung ×  Q(t) + Elung ×  V(t)     (8.6) 
 
Where Equations (8.5)-(8.6) are used in Chapters 4 and 5. 
 
Table 8.1: List of abbreviation 
 Units Physiological Meaning 
Paw cmH2O Airway pressure 
Ptp cmH2O Transpulmonary pressure 
Ppl cmH2O Pleural pressure (Often measured as oesophageal pressure) 
Ers cmH2O/l Respiratory system elastance, also the total of Elung and Ecw 
Elung cmH2O/l Lung elastance  
Ecw cmH2O/l Chest wall elastance  
Rrs cmH2Os/l Respiratory  system , also the total of Rlung and Rcw 
Rlung cmH2Os/l Lung resistance  
Rcw cmH2Os/l Chest wall resistance 
 
The respiratory mechanics estimated from Equation 8.6 and measured data thus 
precludes the effect of the chest wall elastance during inspiration. The previous 
analysis presented in Chapters 4 and 5 had similar assumptions and only focused on 
the change of lung elastance, Elung. Physiologically and clinically, in this situation, 
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Elung is more directly related to alveoli recruitment or overdistension during 
inspiration.  
 
SB patients have time-variant Ppl, and this time-varying Ppl follows a specific wave 
form (Khirani et al., 2010) that is influenced by PEEP. These variables limit the use of 
the single compartment model in SB patients. As a result, a true lung elastance is not 
able to be estimated in SB patients without the aid of invasive oesophageal pressure 
measurement, which is used to estimate the contribution of the chest wall elastance. 
 
In this study, the respiratory elastance for a SB patient is redefined, similar to Chapter 
5, as time-varying respiratory elastance (Edrs). In addition, Edrs defined as a 
combination of 3 elastance components,  instead of just two comprising Elung and Ecw, 
as described in conventional compartment models (Bates, 2009a).  These three 
components are the cage elastance (Ecage), demand elastance (Edemand) and the lung 
elastance (Elung) as shown in Equation 8.7.  
 
 Edrs(t) = Ecage(t) + Edemand(t) + Elung(t)     (8.7) 
 
Where the demand elastance (Edemand), captures time-varying effect of patient-specific 
and breath-specific demand that aids breathing.  
 
Substituting the Edrs(t) into conventional single compartment model thus yields, 
 
 Paw(t)  = (Ecage(t) + Edemand(t) + Elung(t)) V(t) + Rrs ×  Q(t)  (8.8)  
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 Paw(t)  = Pcage(t) + Pdemand(t) + Plung(t) + Prs(t)    (8.9) 
 
A schematic representation of Equations 8.8-8.9 is shown in Figure 8.1. 
 
 
Figure 8.1: The measured airway pressure consists of 3 pressure components: 1) 
Pressure drop due to airway resistance (Prs), 2) pressure change in the pleural space 
(Ppl = Pcage + Pdemand) and 3) pressure in the lung compartment (Plung). 
 
More specifically, these elastance terms define: 
 The patient-specific Elung(t) is similar to the description used earlier in Chapter 
5, where Elung is time-varying, a measure of the lung condition and injury 
within a MV supported breathing cycle.  
 Cage elastance (Ecage) describes the constant elastic properties for the chest 
wall elastance. The elastance of the patient rib cage, intercostal muscles are 
assumed not to vary with disease-state and are thus a patient-specific constant 
(Chiumello et al., 2008).   
 Demand elastance (Edemand) represents the patient-specific demand. This 
Edemand(t) varies depending on patient-specific and breath-specific effort in SB 
patients.  
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Pcage and Pdemand are the pressure components generated from Ecage and Edemand. 
Combining these pressure components will thus give information on pleural pressure 
(Ppl). Plung is the pressure in the lung during MV and Prs is the pressure drop due to the 
airway resistance and endotracheal tube (ETT).  
 
Elung is a measure of lung condition and response to given MV. Thus, Elung(t) is 
always above zero. Next, assuming Ecage(t) as a patient-specific constant, the impact 
of this parameter in monitoring Edrs trends is less significant as it only generates a 
constant offset. On the other hand, Edemand(t) varies within a patient who is 
spontaneously breathing. Equally, the change of pressure in the pleural space is 
negative due to the combined movement of the diaphragm and chest cavity. This 
negative pressure will thus result in ‘negative’ values for Edemand (Edemand < 0), as 
patient demand aids breathing effort and thus reduce effective elastance as seen at the 
airway. Thus, in any given breathing cycle, the time-varying Edrs will capture all three 
elastance components together. 
 
For a fully sedated patient, the time-varying Edrs values were found to be positive (Edrs 
> 0) and had similar elastance to ARDS patients (Suarez-Sipmann et al., 2007, 
Carvalho et al., 2008, Chiew et al., 2011). In particular, combined positive Elung and 
Ecage, and no patient demand (Edemand = 0), result in a positive Edrs > 0 value. Equally, 
if the patient has an inspiratory effort, Edemand  < 0. Edemand < 0 lowers the overall Edrs 
towards 0 or to Edrs < 0. More specifically, Edrs < 0 will occur when patient demand is high at 
the beginning of inspiration and gradually decrease in magnitude as patient demand decreases, 
during the breath. 
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8.2.2 Data Analysis 
For this study, time-varying Edrs are estimated for SB patients. More specifically, data 
from the SB cohort presented in Chapters 6 and 7 are used. These patients are 
ventilated using pressure support (PS) and neurally adjusted ventilatory assist (NAVA) 
ventilation modes. Patients ventilated invasively in Chapter 6 are denoted as IV 
patients, and, patients ventilated non-invasively in Chapter 7 are denoted as NIV 
patients. Patient-specific airway pressure and flow profiles are used to estimate time-
varying Edrs(t) using Equation 8.8. In this study, the airway resistance is set as 
constant (5 cmH2Os/l) based on realistic physiological range (Guttmann et al., 1993, 
Mols et al., 2001, Chiew et al., 2011).  
 
8.2.3 Assessing Edrs Trends 
During PS or NAVA, time-varying Edrs varies depending on patient inspiratory effort. 
In addition, the inspiratory time for every breathing cycle is different, and demand is 
patient-specific and breath-specific. To allow fair comparison for all Edrs trajectories, 
the inspiratory time (Ti) is normalised to its maximum value for each breath, and data 
are interpolated to a new inspiratory time frame (nTi = 1 second). Then, the Edrs for 
each patient is presented as the 5
th
, 25
th
, 50
th
, 75
th
 and 95
th
 percentile across all 
breathing cycles, which in this case, consist of ~300-500 breaths per ventilation mode 
(PS and NAVA) in each patient. The Edrs trends allow patients response to ventilation 
mode to be investigated. More specifically, the patient-specific response to ventilator 
pressure profile can be examined. 
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8.2.4 Assessing Positive Average Edrs 
For every Edrs trend (the 5
th
, 25
th
, 50
th
, 75
th
 and 95
th
 percentile), an average Edrs is 
calculated. The average Edrs is defined as the mean of Edrs >0 values after 0.3 second 
of inspiration. Thus, in general, when:  
 
 Edrs < 0 - indicates significant patient demand with negative Edemand. Similarly, 
when Edrs < 0, there is effectively ‘no harm’ done to the patient, by pressure or 
flow applied, because it is due to a patient’s initial state or demand.  
 Edrs > 0 - implies positive pressure ventilation contributes to the patient-
specific lung elastance. Therefore, Edrs > 0, is a measure of patient lung 
condition and response to MV, and only Edrs > 0 may be considered as a 
potentially ‘harmful’ state to the lung, depending on level and trend through 
the breath.  
 
Fundamentally, this extended model is thus general over SB and sedated MV patients, 
and implies that negative pressure ventilation will generate Edrs < 0, and positive 
mechanical ventilation will result in Edrs > 0. Thus, the average Edrs can be used as an 
indicator to assess patients-specific disease state and response to MV. 
 
For each patient and the cohort, the Edrs trends and  average Edrs over all breaths 
between modes (PS and NAVA) and NAVA levels (NAVA100, NAVA50 and 
NAVA150) are compared using non-parametric Wilcoxon rank-sum test, because as 
they may not be normally distributed, as indicated in Chapters 6 and 7.  
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8.3 Results and Discussion 
8.3.1 Edrs Trends and Average Edrs for PS and NAVA in IV Patients 
In this study, it was found that Edrs trajectories and trends for patients ventilated with 
PS are significantly different from NAVA (p < 0.005 for 15/ 22 patients). The result 
indicates that different MV modes, or more specifically, different pressure delivery 
will result in different Edrs trajectories. An example of inspiratory Edrs, pressure, 
volume, and Eadi curves during PS and NAVA is shown in Figure 8.2 for Patient IV9.  
 
At the beginning of an inspiratory cycle, Edrs < 0. Negative Edrs occurs when air flow 
enters the lung with negative pressure generated inside the patient’s pleural space. As 
the lung volume increases with positive pressure ventilation, Edrs increases above 0, as 
expected from the model definition. Equally, as patient inspiratory demand is met, the 
magnitude of the Edemand component of Edrs reduces toward zero and Edrs becomes 
more positive. 
 
During PS, Edrs increased from a negative value to patient-specific maximum before 
decreasing, as shown in Figure 8.2. This result suggests that during PS, the ventilator 
is triggered by the change of airway pressure or flow. As pleural pressure decreases 
with the patient’s inspiratory demand, the airway pressure or flow changes. When the 
ventilator detects this change, it provides the full, specified pressure support. This 
instantaneous step pressure support, known as the pressurisation slope, stretches the 
lung at the start of ventilation. As the air enters the lung and distributes evenly, the 
value of Edrs drops. If a supported breath overstretches the lung, the overall Edrs will 
increase until the end of the inspiration of a breathing cycle.  
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Figure 8.2: Time-varying Edrs, pressure, volume and Eadi curve for Patient IV 9 
during PS (left) and NAVA (Right). The lines indicate the 5
th
, 25
th
, 50
th
, 75
th
 and 95
th
 
percentile of all breathing cycles. 
 
 
During NAVA, Edrs begins as negative but the specific maximum Edrs is not observed 
at the beginning of inspiration. It was found that Edrs only reaches maximum at near 
peak inspiratory pressure (PIP). This result occurs because NAVA delivers pressure 
proportional to the measured electrical diaphragm activity (Eadi). Thus, the pressure 
delivered during NAVA only reaches a maximum near the end of inspiratory cycle 
and in most cases, Edrs reaches its peak at peak inspiratory pressure.  
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Table 8.2 shows the average Edrs for the 22 IV patients during PS and NAVA. 
Comparing Average Edrs between PS and NAVA for invasively ventilated patients, it 
was found that the overall average Edrs for the 5
th
, 25
th
, 50
th
, 75
th
 and 95
th
 percentile in 
PS is higher than NAVA. This result suggested that the NAVA level selected based 
on similar peak pressure during PS is able to avoid over assistance that may 
overstretch the lung due to the variable pressure assist during NAVA.  
 
In this cohort, it was found that 18 of 22 patients in NAVA had the 5
th
-95
th
 range of 
average Edrs wider than in PS. The 5
th
-95
th
 range is typically wider for NAVA. This 
result was as expected from Chapters 6 and 7, due to a more variable pressure 
delivery in NAVA compared to PS.  
 
It was found that 20 patients in PS and 15 patients in NAVA had their 95
th
 percentile 
average Edrs above 25 cmH2O/l. ARDS patients were noted to have high respiratory 
system elastance with Ers ≥ 25 cmH2O/l (The ARDS Definition Task Force, 2012). 
This result shows that, in most cases, the proposed average Edrs is able to capture the 
similar mechanics of an ARDS patient measured during full sedation. For patients 
with average Edrs < 25 cmH2O/l, it is suggested that the patient lung is more compliant 
compared to an ARDS patient.  
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Table 8.2: Average Edrs (5
th
, 25
th
, 50
th
, 75
th
, 95
th
 percentile) comparing PS and NAVA 
for the 22 intubated patients in Chapter 6  
Patient 
Average Edrs (cmH2O/l) 
PS  NAVA  
5th   25th 50th  75th  95th   5th  25th 50th  75th  95th   
IV1 27.5 28.8 29.8 30.9 32.8 + 11.3 14.0 16.4 18.8 23.7  
IV2 6.3 9.0 10.5 12.2 17.4 + - 3.7 4.2 8.5 17.0  
IV3 52.0 53.8 55.2 56.6 58.9  27.0 31.9 41.4 51.5 68.4  
IV4 23.1 28.1 31.6 35.9 41.3 + 14.2 15.9 18.3 21.5 26.3  
IV5 38.2 40.8 43.1 45.4 48.7 + 16.1 19.7 22.2 25.0 29.1  
IV6 55.6 61.1 64.9 69.4 78.8 + 28.4 44.5 53.9 63.3 80.6  
IV7 22.7 25.1 26.7 28.4 32.6 + 5.24 9.9 12.2 14.3 17.4  
IV8 23.5 26.0 27.6 30.0 34.5 + 14.8 18.1 19.9 22.2 26.0  
IV9 36.8 38.5 40.0 41.5 44.7 + 19.7 25.2 28.9 32.3 38.5  
IV10 6.2 7.5 8.14 9.0 10.6 + - 1.8 2.5 2.6 4.7  
IV11 37.2 39.1 40.1 41.2 43.1  29.2 34.9 39.7 44.5 50.3  
IV12 22.5 25.5 28.1 33.1 48.8 + 5.7 8.2 10.6 15.7 28.3  
IV13 32.8 39.3 43.9 48.4 56.9  15.4 28.4 39.6 51.9 69.7  
IV14 31.1 37.3 41.7 48.1 61.1 + 14.7 19.0 23.1 28.7 46.6  
IV15 36.8 42.4 45.6 49.3 56.1  32.7 42.7 48.8 55.3 73.7  
IV16 24.4 26.5 27.9 29.4 31.6 + 8.7 10.5 12.0 13.8 18.0  
IV17 20.5 25.0 28.2 31.1 35.4 + 8.1 12.6 15.4 18.7 24.4  
IV18 44.0 48.7 50.4 52.2 56.3  27.4 37.2 43.7 51.6 67.3  
IV19 32.3 40.0 45.3 54.4 78.1  46.0 62.2 71.9 81.3 96.8  
IV20 34.4 38.1 40.3 42.7 47.1 + 23.7 29.6 33.1 36.9 43.1  
IV21 5.1 6.3 9.3 55.8 66.1 + 2.1 6.3 9.1 11.7 16.7  
IV22 23.8 34.5 38.7 41.1 44.2  31.4 41.7 48.0 56.7 69.1  
Median 29.3 35.9 39.4 41.4 45.9  15.8 19.4 22.7 26.9 33.8  
25
th
 22.7 25.5 27.9 30.9 34.5  10.0 10.5 12.2 15.7 23.7  
75
th
 
prct* 
36.8 40.0 43.9 49.3 56.9  27.9 34.9 41.4 51.6 68.4  
*prct – percentile, + p<0.005 when compared to NAVA Edrs trends 
 
The estimation of average Edrs for spontaneous breathing patients is dependent on the 
initial pleural pressure or the magnitude of negative Edemand. Thus, a lower average Edrs 
may also indicate that the patients have comparatively higher individual breathing 
effort than others, and obviously more than a sedated patient in Chapter 5. In general, 
SB patients are healthier than sedated patients who require full MV, and the average 
Edrs was able to capture this unique information without the need of oesophageal 
pressure.  
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Of note, the estimation of Edrs is also dependent on the airway resistance. A higher 
resistance assumed would downshift the Edrs trends whereas a lower assumed 
resistance would upshift the Edrs curves. An example of the influence of different 
values of Rrs (Rrs = 1, 5, 10 cmH2Os/l) in the resulting Edrs is shown in Figure 8.3. It 
was found that Edrs increases when Rrs is reduced and Edrs decreases when Rrs is 
increased. Thus, the impact of Rrs towards intra-patient comparison is little or can be 
neglected, as it only provides a bias but does not change trends.  Using a population 
constant thus ensures equal comparison. 
 
 Pressure Support NAVA 
Rrs 
= 5 
  
Rrs 
= 1 
  
Rrs 
= 
10 
  
 
Figure 8.3: Time-varying Edrs for Patient IV 7 during PS (left) and NAVA (Right) at 
different airway resistance. The lines indicate the 5
th
, 25
th
, 50
th
, 75
th
 and 95
th
 
percentile of all breathing cycles. 
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8.3.2 Edrs Trends and Average Edrs for PS and Various NAVA Levels in NIV 
Patients 
Table 8.3 shows average Edrs for the 13 NIV patients under PS and NAVA and Table 
8.4 shows the average Edrs for additional 2 NAVA levels (NAVA50 and NAVA150). 
11 of 13 patients had Edrs trends during PS different from NAVA (p < 0.005). 
Similarly, different NAVA levels also results in different Edrs trends. It was found that 
7 of 12 patients in NAVA50, and all patients in NAVA150 had different Edrs trends 
compared to NAVA100.  
  
Table 8.3: Average Edrs (5
th
, 25
th
, 50
th
, 75
th
, 95
th
 percentile) for PS and NAVA for 
NIV patients in Chapter 7  
Patient 
Average Edrs (cmH2O/l) 
PS NAVA100 
5th  25th 50th  75th  95th   5th  25th 50th  75th  95th   
NIV1 10.5 13.3 16.0 17.7 20.0  7.8 9.8 12.2 14.6 18.1  
NIV2 12.5 15.8 17.7 19.9 25.6 + 11.5 14.8 17.4 22.8 35.0  
NIV3 13.8 15.4 16.5 17.4 18.4 + 8.3 10.1 11.6 12.8 14.4  
NIV4 21.1 25.1 28.2 31.9 38.4 + 10.8 16.5 19.2 21.9 25.8  
NIV5 11.0 17.2 20.4 22.7 27.3  3.6 6.1 8.1 10.6 14.4  
NIV6 6.3 6.9 7.2 7.5 8.1 + 4.1 8.7 10.3 12.2 30.5  
NIV7 6.1 6.6 7.1 7.5 7.9 + 8.8 9.6 10.1 10.9 11.9  
NIV8 11.9 15.1 17.7 19.8 23.1 + 11.2 14.2 16.9 20.3 30.2  
NIV9 16.1 19.1 21.8 24.7 29.7 + 11.0 14.6 18.6 24.9 37.5  
NIV10 4.9 6.8 8.7 10.5 13.6 + 8.6 11.2 12.7 13.8 15.6  
NIV11 1.4 2.4 1.6 11.4 46.5 + 2.5 1.9 7.8 21.4 46.7  
NIV12 3.3 8.5 9.5 10.6 13.5 + 5.8 11.3 15.2 19.4 25.1  
NIV13 2.6 5.0 6.8 9.6 42.8 + 0.8 2.4 3.0 3.0 6.3  
Median 10.5 13.3 16.0 17.4 23.1  8.3 10.1 12.2 14.6 25.1  
25
th
   4.5  6.8 7.2   10.3 13.6    4.0  8.1 9.6  11.9  14.4  
75
th
 
prct* 
12.8 16.2 18.4 20.6 31.9   10.9  14.3   
17.0 
 21.5  31.6  
*prct – percentile, +p<0.005 when compared NAVA100 Edrs trends 
 
 
Similar to the result of the IV patient analysis in Section 8.3.1, a lower median 
average Edrs is observed during NAVA. The lower average Edrs during NAVA for 
both IV and NIV cohorts suggested that during NAVA ventilation, patients had higher 
negative Edemand magnitude. The higher Edemand, indirectly suggested that NAVA 
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patients are more variable and potentially participate more actively in breathing when 
compared to PS.  
 
 
Table 8.4: Average Edrs (5
th
, 25
th
, 50
th
, 75
th
, 95
th
 percentile) for NAVA50 and 
NAVA150 for NIV patients in Chapter 7  
Patient 
Average Edrs (cmH2O/l) 
NAVA50 NAVA150 
5th  25th 50th  75th  95th   5th  25th 50th  75th  95th   
NIV1 2.9 3.9 4.9 5.3 8.0 + 8.2 12.4 15.5 18.3 22.4 +# 
NIV2 5.2 9.0 9.6 10.5 15.7  8.5 15.8 20.7 28.3 44.9 +# 
NIV3 - - - - -  - - - - -  
NIV4 6.1 7.0 7.7 9.1 11.0 + 13.4 23.6 27.7 30.8 36.1 +# 
NIV5 3.4 3.7 4.2 5.5 9.0  7.4 11.2 15.1 20.8 30.6 +# 
NIV6 2.9 3.7 4.9 6.8 7.8  13.5 16.4 22.9 32.1 46.3 +# 
NIV7 5.2 5.9 6.4 6.9 7.4 + 10.4 12.3 13.4 14.7 16.2 +# 
NIV8 10.1 12.7 16.7 21.7 31.6 + 16.1 22.6 27.3 32.9 42.1 +# 
NIV9 6.3 7.8 9.9 12.0 16.2 + 19.9 23.8 26.5 30.9 40.6 +# 
NIV10 6.7 7.7 8.9 10.0 11.7  10.6 14.0 16.4 18.7 21.3 +# 
NIV11 2.4 16.9 27.5 37.4 62.1 + 1.8 8.6 17.6 24.9 34.8 +# 
NIV12 3.1 5.8 7.6 10.0 14.7  5.2 9.0 14.1 20.7 27.5 +# 
NIV13 - 1.1 1.8 2.5 2.1 + - 2.4 3.0 3.2 4.9 +# 
Median 5.2 6.5 7.7 9.6 11.4  10.4 13.2 17.0 22.9 32.7  
25
th
   3.0 3.8   4.9 6.2 7.9  7.6 10.1 14.6 18.5 21.9  
75
th
 
prct* 
6.3 8.4 9.8 11.3 16.0  13.5 19.5 24.7 30.9 41.4  
Note: Patient NIV3 did not undergo ventilation with different NAVA levels *prct – percentile, 
+ p<0.005 when compared to NAVA100 Edrs trends, # p<0.005 when compared to NAVA50 Edrs trends 
 
In most cases, comparing different NAVA gain, NAVA50 had overall lower average 
Edrs as expected due to the lower ‘pressure support’ provided by lower NAVA levels. 
Similarly, NAVA150 had the highest average Edrs. These results should be expected. 
However, it is interesting to note that, in some cases, this outcome is not necessarily 
the case. Figure 8.4 shows an example of Edrs trend for Patient NIV12 during 
NAVA100 and NAVA150. This patient had different Edrs trends during NAVA100 
when compared to NAVA150. However, the average Edrs were almost similar, 
indicating that perhaps a different NAVA gain may have been more or equally 
appropriate based on this metric  
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NAVA100 NAVA150 
 
 
 
Average Edrs (cmH2O/l) Average Edrs (cmH2O/l) 
5th  25th 50th 75th  95th 5th 25th 50th 75th  95th 
5.8 11.3 15.2 19.4 25.1 5.2 9.0 14.1 20.7 27.5 
 
Figure 8.4: Edrs trends and average Edrs in patients during NAVA100 and NAVA150 
for Patient NIV12. 
 
The pressure assist provided by NAVA150 is higher than during NAVA100. 
Therefore, the resulting Edrs trend during NAVA150 is higher. However, the amount 
of pressure support also influences the underlying Eadi, resulting in a lowering of 
overall patient-specific Eadi during NAVA150 (Brander et al., 2009, Colombo et al., 
2008, Lecomte et al., 2009, Sinderby et al., 2007, Patroniti et al., 2012). The reduced 
Eadi during NAVA150 thus provides lower NAVA pressure assist, resulting in 
similar average Edrs as NAVA100 as shown in Figure 8.4. Hence, the trade off at 
NAVA gain and Edrs is nonlinear and not necessarily a simple compromise. 
 
Existing methods in titrating care for the mechanically ventilated patient often focus 
on only one specific pneumatic element, pressure or volume. These methods either 
optimise the ventilation tidal volume (Brochard et al., 1998, Slutsky, 1999, Gajic et al., 
2004, Bonetto et al., 2005, Malhotra, 2007, Meade et al., 2008, Putensen et al., 2009) 
or the pressure support (Slutsky, 1993, Bernard et al., 1994a, Barberis et al., 2003, 
Gattinoni et al., 2003, Slutsky and Hudson, 2006, Grasso et al., 2007, Albert et al., 
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2009, Gattinoni et al., 2010). While these approaches have shown improvement in 
patient mortality and in preventing further lung injury, none of these methods 
investigates the influence of both pneumatic elements simultaneously, which is 
catered to obtaining recruitment (volume) without damage (pressure).  
 
Time-varying Edrs is a measure of patient-specific response towards the ventilator 
(Chiew et al., 2011). Titrating care using this unique and physiologically relevant 
parameter can potentially optimise both pneumatic settings of the ventilator (pressure 
and volume) simultaneously. Equally, the average Edrs is able to capture unique 
parameter in SB patient that is directly relevant to respiratory mechanics without the 
use of oesophageal pressure. The application of Edrs can potentially be used to guide 
PEEP selection, optimal pressure support and NAVA level in SB patients, which is 
currently not available without additional invasive manoeuvre. This proof of concept 
should thus open up new options in selecting the proper SB modes, and its associated 
PEEP or level of pressure support. 
 
8.4 Limitations 
8.4.1 Respiratory Mechanics during Non-invasive Ventilation 
Respiratory mechanics estimated in non-invasive ventilation can be erroneous (Peslin 
et al., 1992, Navajas et al., 2000, Mulqueeny et al., 2010). This error is mainly due to 
tidal volume leak. However, this leak can be minimised through careful conduct 
during experimental trials. Equally, during intra-patient analysis, such as changing PS 
mode to NAVA, or comparing different NAVA levels, the effect of volume leak can 
be assumed to be similar between modes. In addition, the normalisation time-varying 
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Edrs(t) in spontaneously breathing patients significantly reduces the impact of volume 
leaks.  
 
8.4.2 Time-varying Elastance 
8.4.2.1 Negative and Positive Time-varying Elastance 
Time-varying Edrs is not normally calculated in MV patients who are either fully 
sedated or spontaneously breathing. It provides unique information to monitor patient-
specific disease state and response to MV. When applied in SB patients, the negative 
Edrs only corresponds to the negative pressure generated in the pleural space to inflate 
the lung. Existing data on time-varying Edrs or compliance in sedated patients has 
been shown to be positive (Chiew et al., 2011, Zhao et al., 2012a). Thus, Edrs < 0 is 
only possible for patients who are breathing spontaneously. The validity of the 
estimated negative values of Edrs in SB patients thus warrants further investigation as 
a measure of patient-specific demand similar to the use of oesophageal pressure. 
 
8.4.2.2 Average Time-varying Elastance 
The average Edrs was calculated as the mean of Edrs>0 after 0.3 second time frame. 
The 0.3 second time frame was selected after post-hoc analysis of the volume-time 
curves, where most cases had inspiratory lung volumes of 50~100 ml after 0.3 second. 
The average Edrs were recalculated using different time frames such as 0.2 second, 0.4 
second and 0.5 second to test the robustness of this assumption. It was found that 
there was no significant difference in the overall results (p < 0.005), and had 
Pearson’s correlation of coefficient, R > 0.95 in every tested time frames. This result 
shows that average Edrs calculated after 0.3 second remains valid for all cases. 
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Average Edrs can also be calculated through setting tidal volume threshold of 50~100 
ml instead of using an inspiratory time threshold (In this study, the threshold time 
frame is 0.3 second). However, SB patients have variable breathing cycles (with 
different Ti, Vt, flow and pressure). Using normalised inspiratory time as the threshold 
for calculating average Edrs after the time frame of >0.3 have similar effects when 
reference to threshold tidal volume. Thus, using the proposed method to quantify 
average Edrs for SB patients remains valid and robust to other approaches, and can be 
applied continuously in MV patients without interrupting care. 
 
8.5 Summary 
In summary, a new model that defines conventional respiratory elastance into 3 
separate components is presented. The proposed model was able to capture unique 
dynamic respiratory mechanics for spontaneously breathing patients during PS and 
NAVA ventilation at different NAVA levels, which is otherwise not possible in 
conventional models or methods. The work presented here is the first of its kind to 
monitor time-varying Edrs in SB patients without additional measuring equipment or 
interrupt care. Thus, revealing a model that fits all ventilation condition and the 
potential to’ standardise’ MV treatment in a consistent fashion.  
 
 
  
171 
 
Chapter 9  
Conclusions 
 
This thesis presents model-based methods to aid clinicians in guiding mechanical 
ventilation (MV) for the critically ill. Four unique models and metrics are developed, 
and each model is tested in the experimental or clinical trials developed for the 
purpose. These models are capable of capturing physiologically relevant parameters 
that describe patient-specific condition and potential specific response to MV settings.  
 
In Chapter 3, an experiment study that investigates the respiratory mechanics of 
healthy and oleic acid induced ARDS animal was presented. This experimental study 
provides a unique platform for the studies of model-based methods. The first model 
that used this experimental study is the minimal recruitment model. The model is able 
to capture the physiological condition of both the anesthetised healthy and the oleic 
acid induced ARDS lung, thus, showing its specificity in differentiating disease and 
healthy conditions. In addition, a disease state grouping metric (DSG) is developed 
based on model-based estimated threshold opening pressure (TOP) and standard 
deviation (SD). Using this metric, the patient condition in both healthy and ARDS 
scenarios can be monitored and aid clinicians to select the optimal ventilation mode 
that best suits the patient’s specific condition. The results and findings further validate 
and encourage the application of this minimal model to guide therapy in regular 
clinical use or a specifically designed randomised clinical trial. 
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Chapter 4 focused on monitoring respiratory mechanics of the experimental animals 
using a single compartment linear lung model. Similar to the minimal model, the 
parameter estimation for the single compartment model provides unique insight to 
patient condition and its evolution. More specifically, the model was able to capture 
varying respiratory mechanics with disease progression and the change of MV 
settings. The model was also able to continuously monitor the respiratory mechanics 
during disease progression without addition invasive tests or protocols. This model 
has shown higher resolution in terms of monitoring than the minimal recruitment 
model, which requires multiple PEEP changes to distinguish subject-specific 
condition. The single compartment model thus allows an in-depth understanding on 
the subject-specific disease state, response to PEEP, and evolution over time. Hence, 
it offers significant potential to guide PEEP titration in regular clinical use. 
 
Chapter 5 extends the single compartment model to capture time-varying dynamic 
respiratory elastance (Edrs) within a breathing cycle. Edrs describes patient-specific 
lung response to ventilator assisted pressure within each breathing cycle, enabling the 
understanding of overall patient lung recruitment status and overdistension within 
every breathing cycle. Thus, where single constant elastance might not see 
overdistension in a breath, Edrs can capture this behaviour and recommend a different 
mode of MV. Equally, it clearly captures and highlights for clinician the presence and 
impact of COPD and auto-PEEP. To test this model, PV data from ARDS patients 
who underwent a clinical protocol were used. The model is able to uniquely describe 
patient respiratory mechanics breath-by-breath, at different PEEP levels. The model 
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can be applied to titrate patient-specific optimal PEEP based on a metric that balance 
ventilation risk and rewards, both for care and by ventilation mode. 
 
Patients who are spontaneously breathing are ventilated in partially assisted 
ventilation modes. These assisted ventilation modes provide partial ventilation 
support to the patients to reduce their work of breathing and aid them in recovery. In 
this thesis, the comparison between widely used pressure support ventilation (PS) and 
a state of the art ventilation mode, neurally adjusted ventilatory assist (NAVA) is 
presented.  A metric (Range90) is developed to analyse the matching of patient 
demand and respective support provided by the ventilator. The results have concluded 
that NAVA was able to provide better matching than PS during invasive (Chapter 6) 
and non-invasive ventilation (Chapter 7), thus showing the need for patient-specific 
ventilation in this cohort. 
 
In particular, the Range90 metric can also be used in titrating patient-specific NAVA 
level based on the concept of supply and demand matching. The results have shown 
that patient-specific response to NAVA level is different, even in these cohorts, and 
thus concluded that the existing method (NAVA previsualisation) is not appropriate. 
Hence, patient-specific optimal NAVA level remains a huge area of interest with no 
conclusive findings. Titrating NAVA level with Range90 provides a simple and 
unique initial solution for this problem.  
 
Finally, the single compartment model with time-varying Edrs is extended in 
spontaneously breathing patient (SB). Respiratory mechanics estimation in SB 
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patients cannot currently be carried out without additional invasive and costly 
measuring tools. Thus, respiratory mechanics monitoring for SB patients remains a 
research tool and cannot be used to titrate MV in real time. The single compartment 
model is extended to capture clinically useful respiratory mechanics using non-
invasive model-based method and can thus estimate SB patient time-varying elastance 
without compromising patient-model physiological relevance. A metric (average Edrs) 
that defines spontaneously breathing patient’s disease sate response to MV is also 
presented and validated on extensive clinical data. This metric is shown to be capable 
of providing unique information to guide MV for spontaneously breathing patients. 
More critically, it extends the single compartment model-based approach to cover all 
form of MV and MV patients - a single tool to guide MV. 
 
In conclusion, this thesis has presented several unique and physiologically relevant 
models that can capture patient-specific condition and response to MV settings. The 
models have been tested in experimental ARDS animal model and ICU patients. 
Results from the studies have shown the models can be used to guide MV decision 
making in the heterogeneous ICU population. Thus, revealing a path to standardise 
patient-specific MV in a consistent fashion.  
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Chapter 10  
Future Work 
 
The models and metrics developed in this thesis have shown good clinical viability. 
However, the application of these models to guide MV in real-time as a standard part 
of ICU care warrants further investigation in a clinical environment to ensure its 
robustness and validity. In particular, there is a need to show that a proven model can 
improve overall patient outcome; to prove its level of impact. Several potential future 
works that extend the existing research are presented. 
 
10.1 Simulating Actual Clinical Condition in ARDS Animal 
Experimental ARDS animal models are easily recruitable with PEEP at the early stage 
of ARDS (Ballard-Croft et al., 2012).  However, it is possible that the actual ARDS 
patients are exposed to long term lung injury, resulting in consolidated lung regions 
and are not responsive to PEEP changes. These patients are known as non-recruiters, 
and their response to PEEP or recruitability are low (Gattinoni et al., 2006a, Caironi et 
al., 2010). The models ability in capturing these patients’ respiratory mechanics needs 
to be investigated. These symptoms can be modelled with by exposing the animal 
model to long term injury. This prolonged lung injury will result in lung consolidation 
(swelling and hardening of the infected lung regions) (Gattinoni et al., 1998), which 
mimic the lung physiology of non-recruiters ARDS patients.  
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10.2 Different ARDS Animal Models 
Animal models of ARDS provide a rapid, consistent means of clinical testing 
compared to human clinical trials, which is crucial in early model developing and 
before testing on humans to mitigate risk. Respiratory mechanics of 9 piglets during 
healthy state and ARDS state were studied. Only 3 of 9 piglets successfully developed 
ARDS after oleic acid injection. Given the low ARDS animal sample, the result was 
not conclusive with statistical significance. Additional experimental animal trials can 
be carried out to investigate the statistical significance of the thesis finding. However, 
the oleic acid animal model is variable and difficult to achieve. Different ARDS 
animal models, such as the lavage model, endotoxin model or smoke models can be 
used (Rosenthal et al., 1998, Matute-Bello et al., 2008, Ware, 2008, Ballard-Croft et 
al., 2012). Different ARDS animal models will also simulate different ARDS 
pathologics, and thus provide a unique platform to investigate the models robustness. 
 
10.3 Comparison of PS and Variable NAVA Levels 
Compared to PS, it was found that NAVA significantly improved patient-ventilator 
interaction, allowing better matching and improves patient overall gas exchange and 
prevent over assistance.  However, there is no conclusive result on which ventilation 
mode is better  (Terzi et al., 2012). Questions arise from all studies, such as: 1) is the 
comparison between PS and NAVA a fair comparison? And 2) What is the optimal 
NAVA setting?. These questions need to be addressed. The Range90 supply and 
demand matching proposed in this thesis potentially offers a unique approach to 
determine optimal NAVA level. However, utilising this method warrants further study 
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and more specifically, comparison with other of NAVA level titration method 
(Brander et al., 2009) needs to be carried out.  
 
10.4 Validation of Model Findings with Additional Monitoring Tools 
The aim of model-based methods is to guide MV using model derived patient-specific 
parameters from measured data. One of the major concerns of the derived parameters 
is their clinical relevance and validity to actual physiological condition. Thus, it is 
important to compare the model findings with additional monitoring tool. In 
particular, this outcome can be achieved with the use of non-invasive lung imaging 
methods, such as the electrical impedance tomography (EIT) (Denai et al., 2010, Zhao 
et al., 2010a) and lung ultrasound (Bouhemad et al., 2007, Peris et al., 2010). These 
monitoring tools enable the recruitment of collapsed and dependent lung regions to be 
observed in real time. Combining the results obtained from model-based methods and 
monitoring tools will thus validate their respective findings. 
 
The time-varying dynamic Edrs provides unique insight to patient-specific respiratory 
mechanics with time and response to MV. However, the current findings warrants 
further investigation. In particular, the combination of time-varying patients demand 
(Edemand), and constant chest wall elastance (Ecage) are the primary contribution to the 
change of pressure in pleural space. This assumption can be confirmed with 
oesophageal pressure measurements in sedated and/or spontaneously breathing 
patients. These measurements will further validate the model’s definition and 
assumptions, and thus encourage the model’s application to guide MV throughout a 
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patient stay without interrupting therapy, which can have negative consequences on 
outcome and patient-centered quality of care. 
 
10.5 Standard Clinical Protocol and Data Collection 
One of the major issues with ARDS studies is that there is always a lack of patient 
samples in a specific cohort. Thus, recruiting more ARDS patients for clinical trials 
remains the primary focus for model-based studies. This thesis has outlined a non-
invasive clinical protocol that is suitable for data collection (Chapter 5). This protocol 
has several unique features that are designed for this purpose. First, a staircase 
recruitment manoeuvre is carried out to study patient-specific response to PEEP. 
Second, low tidal volume setting and limiting the peak airway pressure thus provide a 
conditional protective lung ventilation strategy. And lastly, recording arterial blood 
gases thus provides information on the effect of recruitment manoeuvre towards 
patient gas exchange. Patients admitted to the ICU, requiring MV can undergo this 
specific protocol allowing patient data to be recorded in a consistent fashion. The 
protocol standardisation will not only improve data sample size, the significant data 
samples can indirectly lead to a development of a virtual patient database. This 
database will lead to more comprehensive study in model-based MV. 
 
10.6 Randomised Controlled Trials 
One important research study that must be carried out in future is a randomised 
controlled trial (RCT). Randomised controlled trials include several patient cohorts 
and provides a platform to evaluate the impact of the model-based methods on patient 
outcome (Esteban et al., 2008, Jadad et al., 1996). In particular, one patient cohort 
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undergoes non-intervention, standard treatment as decided by the attending clinicians. 
The second matched patient cohort would undergo the proposed clinical protocol, in 
which the PEEP will be selected based on mode-based methods.  These 2 cohorts 
analyses their respective patients outcome such as desaturation events (measured as 
oxygen saturation, SpO2 < 90%), improved gas exchange (measured by arterial blood 
gases), length of mechanical ventilation and importantly, the mortality rates. These 
patient outcomes and physiologically relevant markers will provide a fair comparison 
between non-interventional MV and model-based MV, assessing the performance, 
efficacy, and overall impact of model-based MV application in clinical settings. It is 
the last step and answer required to take these, or any, model-based method into 
regular clinical usage. 
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Appendix 01: 
Trend comparison between EStatic and ErsIB, 
RStatic and RrsIB for all 3 Animal Subjects 
 
The Figure 01.1 shows the trend comparison between EStatic and ErsIB, RStatic and RrsIB 
for all cases as presented in Chapter 4. 
Subject 5   
   
Subject 6   
   
Subject 9   
   
Phase 1 (Healthy) Phase 2 (Progression) Phase 3 (ARDS) 
Figure A01.1: EStatic, ErsIB, RStatic and RrsIB for Subject 5 (Top), 6 (Middle), and 9 (Bottom). (From Left to Right) Phase 1, Phase 2 and Phase 3. 
Blue line indicate ErsIB, red line indicates EStatic, black line indicate RStatic, pink line indicate RStatic. EStatic and RStatic are calculated using the 
automated end of inspiratory pause feature in provided in the ventilator. 
Appendix 02: 
Case Examples and Range90 Calculation 
 
This additional document shows the step-by-step method for Range90 calculation for 
this given patient. An example of patient flow and respective Eadi signal is shown in 
Figure 02.1 and 02.2. 
 
 
Figure 02.1: Example of a patient’s flow-time curve. The shaded area is the ventilator 
supply (Tidal volume, Vt) 
 
     
Figure 02.2: Example of a patient’s Eadi-time curve. The shaded area is the patient’s 
demand (∫Eadi) 
 
1. Obtain tidal volume (Vt) and ∫Eadi for each breathing cycle as shown in Figure 
02.1 and 02.1.  
2. The Neuroventilatory efficiency (Vt/∫Eadi ratio) for each breathing cycle is 
calculated.  
(Example: Vt1/ ∫Eadi1, Vt2/ ∫Eadi2, Vt3/ ∫Eadi3, Vt4/ ∫Eadi4 …, Vtn/ ∫Eadin).  
3. The 5th percentile of every Vt/ ∫Eadi ratio is determined (5th Vt/ ∫Eadi). 
4. The 95th percentile of every Vt/ ∫Eadi ratio is determined (95th Vt/ ∫Eadi). 
5. Range90 = 95th Vt/ ∫Eadi - 5th Vt/ ∫Eadi 
6. For a patient who has consistent Vt/ ∫Eadi ratio, Range90 will be smaller. 
7. For a patient who has variable Vt/ ∫Eadi ratio, Range90 will be higher. 
 
Case examples comparing better and less matching 
Example: Vt = 1.0 and ∫Eadi = 1.0 for baseline value 
 
Case A - Patient with better matching  
∫Eadi = 1.0, Vt = 1.0, Vt/ ∫Eadi  = 1.0 (Moderate demand, Moderate supply) 
∫Eadi = 2.0, Vt = 2.0, Vt/ ∫Eadi  = 1.0 (High demand, High supply) 
∫Eadi = 0.5, Vt = 0.5, Vt/ ∫Eadi  = 1.0 (Low demand, Low supply) 
… 
95
th
 -5
th
 of all Vt/ ∫Eadi for Case A will be small resulting in smaller Range90 value. 
 
Case B - Patient with less matching  
∫Eadi = 1.0, Vt = 2.0, Vt/ ∫Eadi  = 2.0 (Moderate demand, High supply) 
∫Eadi = 2.0, Vt = 1.0, Vt/ ∫Eadi  = 0.5 (High demand, Moderate supply) 
∫Eadi = 0.5, Vt = 1.0, Vt/ ∫Eadi  = 1.0 (Low demand, Moderate supply) 
… 
Thus, 95
th
 -5
th
 of all Vt/ ∫Eadi for Case B will be higher, with larger Range90 value 
compared to Case A 
 
 
Appendix 03: 
Additional Findings for Chapter 7: 
Application of NAVA for the Noninvasively 
Ventilated Patients 
 
Table 03.1-03.5 present patients’ robust coefficient of variation (CVR) on inspiratory 
demand ʃEadi, peak inspiratory pressure (Pin), ventilatory tidal volume (Vt) and 
inspiratory time (Ti) at each NAVA level, as summarised in the manuscript. Wilcoxon 
rank sum test for significance was carried out in every patient to compare the effect of 
different NAVA level. The summary of coefficients of variation (CVR) in ʃEadi, Vt, 
Ti_Neural, Ti, and PIP are shown in Table 03.6-03.7.  
 
Volume leaks (V_leaks) for using NIV face mask are calculated and result is 
presented in Table 03.8. This leak is calculated as the difference between inspiratory 
tidal volume (Vt) and expiration tidal volume (Vte) (V_leaks = Vt – Vte). Inspiratory 
and expiratory tidal volume is obtained through flow integration. However, during, 
flow integration, the near zero flow value during expiratory cycle will cause a volume 
drift. This drift is often corrected for each breath for better comparison in a standard 
ventilator. During spontaneous breathing, patient will have variable breath, with 
variable Vt and variable Vte. This variability will thus affect the calculation of leaks. 
However, if the drift is assumed to be constant for each breath, this will allow a fair 
comparison of intra patient volume leaks, and not for inter patient comparison.  
 
Table 03.1: CVR for patient’s inspiratory demand (ʃEadi) 
Patient PS NAVA50 NAVA100 NAVA150 
1 0.14 0.13 0.11 0.16 
2 0.25 0.24 0.20 0.29 
3 0.08 - 0.11 - 
4 0.18 0.18 0.14 0.12 
5 0.54 0.13 0.26 0.27 
6 0.11 0.10 0.19 0.15 
7 0.10 0.08 0.09 0.09 
8 0.26 0.14 0.14 0.17 
9 0.19 0.16 0.25 0.15 
10 0.18 0.36 0.33 0.35 
11 0.87 0.29 0.68 0.21 
12 0.42 0.39 0.30 0.38 
13 0.46 0.52 0.54 0.55 
Median 
[IQR] 
 
0.17 [0.13-0.33] 0.23 [0.14-0.32] 0.19 [0.15-0.32] 
 0.19 [0.13-0.43]#  0.20 [0.13-0.31]#  
# Include Patient 3 
 
Table 03.2: CVR for Ventilatory tidal volume (Vt) 
Patient PS NAVA50 NAVA100 NAVA150 
1 0.08 0.12 0.09 0.12 
2 0.06 0.16 0.17 0.19 
3 0.04 - 0.06 - 
4 0.13 0.09 0.09 0.09 
5 0.05 0.07 0.09 0.17 
6 0.02 0.05 0.07 0.06 
7 0.03 0.04 0.05 0.05 
8 0.09 0.14 0.12 0.16 
9 0.08 0.09 0.32 0.12 
10 0.09 0.23 0.24 0.30 
11 0.72 0.34 0.63 0.34 
12 0.07 0.12 0.11 0.10 
13 0.26 0.35 0.39 0.54 
Median 
[IQR] 
 
0.12 [0.08-0.20] 0.12 [0.09-0.28] 0.14 [0.10-0.25] 
 0.08 [0.05-0.10]#  0.11 [0.09-0.26]#  
# Include Patient 3 
 
 
 
 
 
 
Table 03.3: CVR for Neural Inspiratory Time (Ti_Neural) 
Patient PS NAVA50 NAVA100 NAVA150 
1 0.14 0.10 0.05 0.08 
2 0.08 0.08 0.10 0.10 
3 0.08 - 0.11 - 
4 0.13 0.09 0.10 0.09 
5 0.06 0.05 0.06 0.14 
6 0.10 0.10 0.10 0.10 
7 0.07 0.08 0.07 0.10 
8 0.13 0.10 0.10 0.13 
9 0.17 0.10 0.18 0.17 
10 0.15 0.21 0.24 0.22 
11 0.57 0.19 0.38 0.17 
12 0.09 0.08 0.11 0.10 
13 0.32 0.21 0.25 0.26 
Median 
[IQR] 
 
0.10 [0.08-0.15] 0.10 [0.09-0.21] 0.12 [0.10-0.17] 
 0.08 [0.05-0.10]#  0.10 [0.09-0.20]#  
# Include Patient 3 
 
Table 03.4: CVR for Inspiratory Time (Ti) 
Patient PS NAVA50 NAVA100 NAVA150 
1 0.06 0.10 0.04 0.05 
2 0.05 0.06 0.08 0.09 
3 0.04 - 0.06 - 
4 0.11 0.07 0.07 0.07 
5 0.06 0.04 0.05 0.10 
6 0.02 0.05 0.06 0.05 
7 0.02 0.03 0.03 0.03 
8 0.05 0.09 0.07 0.08 
9 0.15 0.10 0.12 0.15 
10 0.09 0.17 0.19 0.18 
11 0.48 0.12 0.32 0.13 
12 0.07 0.06 0.08 0.07 
13 0.38 0.16 0.21 0.20 
Median 
[IQR] 
 
0.08 [0.06-0.11] 0.08 [0.06-0.16] 0.09 [0.06-0.14] 
 0.06 [0.05-0.12]#  0.07 [0.06-0.14]#  
# Include Patient 3 
 
 
 
 
 
 
 
 
 
 
 
Table 03.5: CVR for Peak Inspiratory Pressure (Pin) 
Patient PS NAVA50 NAVA100 NAVA150 
1 0.09 0.09 0.08 0.09 
2 <0.01 0.13 0.12 0.16 
3 <0.01 - 0.05 - 
4 <0.01 0.06 0.07 0.08 
5 0.01 0.08 0.13 0.16 
6 <0.01 0.05 0.08 0.01 
7 0.01 0.05 0.06 0.07 
8 0.02 0.15 0.11 0.19 
9 0.01 0.08 0.10 0.09 
10 0.01 0.11 0.14 0.18 
11 0.05 0.03 0.10 0.03 
12 0.02 0.19 0.16 0.23 
13 0.06 0.08 0.17 0.17 
Median 
[IQR] 
 
0.08 [0.06-0.12] 0.11 [0.08-0.14] 0.13 [0.08-0.17] 
 0.01 [0-0.03]#  0.07 [0.06-0.14]#  
# Include Patient 3 
 
 
 
Table 03.6:  Robust Coefficient of Variation (CVR) in Vt, ʃEadi, Ti_Neural, Ti and PIP 
(Median [IQR]). (NAVA with Patient 3) 
 Median [IQR] 
 PS NAVA 
ʃEadi  0.19 [0.13-0.43] 0.20 [0.13-0.31] 
Vt 0.08 [0.05-0.10] 0.11 [0.09-0.26] 
Ti_Neural 0.08 [0.05-0.10] 0.10 [0.09-0.20] 
Ti 0.06 [0.05-0.12] 0.07 [0.06-0.14] 
PIP 0.01 [0.00-0.03]* 0.07 [0.06-0.14]* 
* p-value <0.005 
 
Table 03.7: Summary CVR ʃEadi, Vt, Ti_Neural, Ti, PIP (Median [IQR]). (NAVA100 
without Patient 3) 
 
CVR, Median [IQR] 
NAVA50 NAVA100 NAVA150 
ʃEadi  0.17 [0.13-0.31] 0.22 [0.14-0.31] 0.19 [0.15-0.32] 
Vt  0.12 [0.08-0.19] 0.12 [0.09-0.28] 0.14 [0.09-0.24] 
Ti_Neural 0.10 [0.08-0.15] 0.10 [0.09-0.21] 0.12 [0.10-0.17] 
Ti  0.08 [0.06-0.11] 0.07 [0.05-0.16] 0.09 [0.06-0.14] 
PIP  0.08 [0.06-0.12] 0.11 [0.08-0.14] 0.12 [0.07-0.18] 
* P>0.05 for every parameter 
 
 
 
 
 
 
 
 Table 03.8: Leaks (Vt_leak) 
Patient 
 Vt_leak (ml), 
Median [IQR] 
  
PS NAVA50 NAVA100 NAVA150 
1 43 [23-67] 112 [48-211] 56 [29-97]* 65 [35-116]*+ 
2 71 [55-96] 55 [37-76] 75 [49-109]* 66 [42-89]*+ 
3 22 [11-34] - 25 [12-52] - 
4 44 [21-82] 50 [28-130] 44 [22-73]* 44 [24-78]* 
5 215 [182-290] 201 [161-258] 217 [182-270]* 346 [242-455]* 
6 79 [68-91] 84 [71-101] 79 [59-100]* 100 [79-120]*+ 
7 24 [10-38] 28 [13-45] 38 [25-51]* 43 [29-59]*+ 
8 66 [31-139] 66 [34-173] 94 [49-284]* 103 [40-305]* 
9 27 [11-55] 35 [18-72] 135 [66-231]* 57 [20-93]+ 
10 99 [57-157] 49 [22-88] 45 [22-83] 81 [37-147]*+ 
11 274 [96-614] 141 [54-273] 177 [61-312] 95 [43-178]*+ 
12 40 [15-244] 43 [18-126] 40 [16-85] 49 [23-86]+ 
13 232 [96-536] 134 [34-274] 181 [78-407]* 197 [83-509]* 
Median of 
Medians 
[IQR] 
 61 [46-123] 77 [45-156] 74 [53-102] 
 66 [37-128]#  75 [43-146]#  
* P<0.05 compare to NAVA50 
+ P<0.05 compare to NAVA100 
# Include Patient 3 
 
 
